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Background: There is compelling evidence of the benefits that women with breast 
cancer can experience by participating in physical activity during or post cancer 
treatment. However, research in this field has been largely conducted with younger 
women with breast cancer (aged up to 60 years). Evidence from older women with 
breast cancer is very limited, despite the higher incidence of diagnosis and lower survival 
rates in this population. Pilot and feasibility work is considered essential to evaluate the 
feasibility and acceptability of intervention procedures and trial design especially with 
an under-researched population and is strongly recommended by the Medical Research 
Council (MRC) when designing or conducting complex healthcare interventions (Craig et 
al., 2008). To redress this imbalance, the aim of this research was to conduct a pragmatic 
pilot randomised controlled study of a supervised exercise intervention for older women 
(aged 60 years and over) with breast cancer to consider whether a 12-week supervised 
exercise intervention and home-based exercise programme versus usual care was 
feasible and acceptable. This was done by assessing trial intervention procedures and 
outcome measures, along with interviews to consider barriers to and motivators for 
physical activity, with the aim of informing the viability of progressing to a full-scale 
randomised controlled trial with this population. 
Methods: Study 1: a pragmatic pilot randomised controlled trial (RCT) of a 12-week 
supervised exercise intervention was conducted recruiting participants from two 
hospital sites and a breast cancer charity. Participants were all women over 60-years 
old, very recently diagnosed with breast cancer (< 2-years) stage I-III (mean=8.34-
months post diagnosis, SD=4.50-months). All participants were post-surgery, but may 
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have been undergoing or recently completed radiotherapy treatment. Most participants 
were on hormone treatment (77.1%). Patients were randomly assigned to either the 
exercise intervention or usual care groups. Outcomes to assess the feasibility and 
acceptability of trial parameters were: recruitment rates and time-scales, 
randomisation, adverse events, retention and attrition rates at all follow up time-points. 
Acceptability of the supervised sessions was assessed using Ratings of Perceived 
Exertion (RPE), implementation fidelity, verbatim comments from the participants 
recorded at the time and adherence rates to the intervention. Study 2: was a qualitative 
study design, using a purposive sampling strategy with face to face semi-structured, 
individual interviews, utilising the framework analysis method (Ritchie and Spencer, 
1994). Women over 60-years old (mean=67.3-years, SD=5,.14) were recruited via a 
national breast cancer charity educational programme (< 11-months since diagnosis) or 
by attendance at an established exercise class for breast cancer patients at the 
University of Huddersfield (<5-years since diagnosis). 
Results: Study 1: Eighty-four women were approached who met the inclusion criteria at 
two hospital sites and a breast cancer charity resulting in thirty-five breast cancer 
survivors (BCS) (mean age = 67-years ± 5.02) and were randomly assigned to either a 
supervised exercise intervention group (n=16) or a usual care control group (n=19). The 
recruitment rate was 35/84 = 41.6%. (11/33 = 33% from hospital sites; 24/51 = 47% from 
breast cancer charity). Recruitment lasted 22 months. Attrition rates were 12.5% for the 
intervention group and 26% for the control group. No adverse events were reported. 
The questionnaire completion rate was 100% at all time-points, as was the 12-minute 
walk. Body composition assessment was 96.5% completion at baseline and all follow up 
points (one participant was claustrophobic and did not undertake body composition 
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assessments). Intervention adherence to the supervised sessions was 87.5%, although 
home-based exercise adherence was not monitored. Study 2: 15 participants were 
interviewed, all aged over 60-years old (range 60-77-years, mean 67.3-years, SD 5.14). 
Interview questions were developed from a topic guide using a priori themes from Study 
1 and utilising existing behaviour change models and frameworks. Three main themes, 
and eight sub-themes were identified:  
Theme 1: Obstructions affecting physical activity with three sub-themes: 
accommodating other features of the life world; negative consequences of treatment; 
environmental influences. Theme 2: Factors enabling physical activity with three sub-
themes: perceived health and well-being impact; personal and interpersonal 
considerations; and environmental influences. Theme 3: Wider environmental context 
with two sub-themes: timing of exercise advice and family and friendship support.  
The main barriers to starting or maintaining a physical activity or exercise programme 
was related to the negative consequences of breast cancer treatment, such as; joint 
pain, shoulder mobility problems, fatigue and muscle and joint aches. In addition, not 
knowing what exercise or how much exercise was safe to do also hindered some from 
starting to be physically active. The main motivators for starting or maintaining physical 
activity were also related to the negative consequences of treatment, as women 
reported how they wanted exercise or physical activity to improve these side-effects, 
such as, reduce fatigue and increase energy levels, help lose weight, improve joint pain 
and shoulder mobility and to help recover from treatment.  
Conclusions: The strengths of this study were the novel population recruited, 
considering the age of the participants and how recently they had received a breast 
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cancer diagnosis. It is the first ever study to only recruit older women (>60 years) very 
recently diagnosed with breast cancer onto a supervised exercise intervention and 
longitudinally follow them for 12-months. Air Plesythmography (BOD PODTM) was a 
novel measurement technology used in the study to assess all participants’ body 
composition using air plethysmography. This was the first study to use this measure with 
older women with breast cancer and to also follow up participants for nine months after 
the intervention had finished to assess any ongoing body composition changes. The 
feasibility and acceptability data collected all add to the knowledge and evidence base 
with this under-researched population. A number of aspects of the intervention worked 
well. It appeared that once recruited onto the study, attrition rates were favourable 
(7/35 = 20%) and the trial outcomes and supervised exercise intervention were 
acceptable with high adherence rates to the supervised intervention (87.5%) and high 
completion rates to the whole trial. What appeared to be a useful and novel approach 
to recruiting this population was through a cancer charity and should be considered as 
an additional recruitment approach alongside the more traditional methods of a 
hospital setting. One of the main study limitations was not being able to fully assess the 
feasibility of the intervention because home-based exercise adherence and additional 
physical activity (PA) outside of the supervised intervention was not monitored. 
Therefore, we cannot ascertain how effective the overall programme was. An additional 
limitation was not being able to assess heart rates during the supervised intervention, 
although RPE was monitored. This would have provided novel, objective data as to the 
intensity of the intervention, however, it demonstrated, that assessing heart rates with 
this population in a group setting may be time-consuming and potentially problematic 
for an exercise instructor on their own to manage. This pragmatic pilot study 
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demonstrates the difficulties in recruiting this population, particularly from a hospital 
setting by breast care nurses (31% of study participants). That the exercise intervention 
was not local to either hospital site appeared to add a further barrier to recruitment 
(16/84 reported distance to exercise sessions as a reason for non-participation; 19%). 
The time taken to recruit the number of participants (22-months) could also question 
the viability of any larger future trials. The barriers and motivators reported by this 
population appeared to be specific to breast cancer, with the majority related to the 
disease or treatment side-effects. It may be possible to reduce some of these barriers 
by better and more education about the benefits of exercise and physical activity. It is 
also important to further educate health care professionals (HCPs) and family and 
friends, as the timing of exercise advice and by whom it is given may play an important 
role in encouraging physical activity during and after treatment. With only the chief 
investigator able to deliver the exercise intervention at the University site, the distance 
for some to travel to the University to participate was also a noticeable barrier. For 
future trials, stop/go indicators (as suggested by the Medical Research Council [MRC]) 
should be put in place to further ascertain whether a larger scale trial is feasible. 
Strategies to improve recruitment from the hospital setting need to be developed and 
more options for local access to the exercise intervention or outcome assessments 
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Brief overview of each chapter of the PhD thesis 
The content of this thesis broadly follows the process of investigation recommmended 
by the Medical Research Council, (Campbell et al., 2000; Campbell et al., 2007; Craig et 
al., 2008; Craig et al., 2013), described in the introduction and shown below in Fig. 1. 
The early chapters 1-3 introduce the subject of this thesis and provide the theoretical 
background and rationale for the research. Chapter 1 provides an introduction which 
briefly summarises the size and scale of breast cancer, the common side effects that 
may accompany treatment and introduces the concept of physical activity as an 
important mechanism that could be used to help treat or prevent some of these 
treatment-related side effects. The aims and objectives of the thesis are also stated 
along with a brief overview of the MRC guidelines that have helped to frame this PhD 
study. Chapter 2 considers the journey of a breast cancer patient covering referral 
mechanisms, screening and tests to diagnose breast cancer along with common curative 
treatments. Finally, the often debilitating side effects that can be experienced from 
these life-saving treatments are discussed. Chapter 3 introduces and explores the role 
that exercise and physcial activity can play in reducing breast cancer treatment-related 
side effects and the effects of physical activity on the quality of life of breast cancer 
survivors. The evidence of the role physical activity has in reducing breast cancer 
recurrence and mortality is explored and the mechanisms underlying this relationship 
are considered. To conclude this chapter a summary of the exericse literature for older 
adults without cancer is briefly explored to highlight the benefits of exercise and physical 
activity that older adults without cancer can obtain. Chapter 4 completes the first stage 
identified by the MRC guidelines for the development of complex interventions (Phase 
0 – pre-clinical/theory) with a rapid evidence review of the quantative literature of 
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exercise and physical activity with older women with breast cancer, following a 
recognised and rigourous systematic process, with the aim to reduce the possibility of 
bias whilst determining what we know about exercise with this specific but under-
researched population. This chapter concludes with the rationale for this PhD research 
project and the aims and objectives of the thesis. Chapter 5 is a critical appraisal of the 
philosophical assumptions about the scientific methodology used in this thesis, 
suggesting why they are considered the most approriate for meeting the research aims 
and objectives. The chapter will cover the design of the research and the underpining 
theoretical framework, such as the MRC guidelines for the design and conduct of 
complex interventions, that has been followed and utilised. Chapters 6 and 7 detail the 
research studies that have provided new data in this thesis. Chapter 6 details the 
feasibility of the intervention procedures and outcome measures, as recommended by 
the MRC , to be evaluated before a full RCT should be undertaken or considered. This 
chapter explores the feasibility of recruitment rates and timescales, randomisation 
procedures, adverse events, retention and attrition rates to the study overall, the 
acceptability of the intervention and adherence to the intervention outcomes measures 
were also explored. Chapter 7 provides further feasibility information to whether a full 
RCT is warranted by exploring the barriers to and motivators for exercise and physical 
activity for this population following a diagnosis of breast cancer. The participants in this 
second study were a mixture of recently-diagnosed women over 60 years old, 
participants who had been involved in the feasibility trial from either the intervention 
group or the control group and older Chapter 8 is a general discussion of the key findings 
and the contribution of new knowledge that has emerged from both studies reported in 
this thesis. It concludes this PhD research by summarising the main recommendations 
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for future research based on the results of the research and interprets the scope, 
significance and limitations of any findings that have emerged that may contribute to 
clinical practice and furthering the knowledge of cancer and exercise required by 























Figure 1: The structure of this PhD thesis according to the Medical Research Council 
Framework for complex interventions (Craig et al., 2008) 
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Chapter 1: Introduction 
1.1 Introduction 
This thesis details an investigation into the feasibility of a 12-week exercise intervention 
with women aged over 60 years recently diagnosed with breast cancer. Although major 
advances have been made in managing breast cancer, patients still have to deal with 
severe side-effects and psychological distress during and after adjuvant therapy 
(Furmaniak, Menig, & Markes, 2016). Furthermore, many of the adverse side effects are 
often long-lasting because of the disease and treatments. These may include cancer-
related fatigue (CRF), changes in body composition, lymphoedema (swelling of the arm 
due to an accumulation of lymphatic fluid), osteoporosis (due to accelerated bone 
mineral loss), anxiety and depression (Demark-Wahnefried et al., 2012; Hormes et al., 
2010; Mishra et al., 2012). 
Breast cancer is the most frequently-occurring cancer in women in the United Kingdom, 
with approximately 53,400 women being diagnosed with breast cancer in 2013, 
although it is rare in men (Cancer Research UK, 2016). Maddams, Utley, and Moller 
(2012) estimated that by the end of 2008, there were more than 2 million cancer 
survivors in the UK and it is forecasted that there will be more than 3.2 million people 
living with and beyond a diagnosis of cancer by 2020. Cancer survivors who have 
successfully completed their treatment often expect to continue with work and 
“normal” life at levels similar to those experienced before their diagnosis of cancer; 
however, whilst cancer treatment can prolong survival it can often be very intensive, 
leading to a number of negative and unwanted physiological and psychological side-
effects that can hinder a cancer survivors return to normal life (Fong et al., 2012).. 
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Female breast cancer is strongly related to age, with much higher incidence rates with 
increasing age. In 2011-13 almost half of all breast cancer diagnoses were in women 
over 65 years old (Cancer Research UK, 2016). These statistics are also strongly related 
to survival, with advancing age lowering survival rates. However, the generalizability of 
research findings of exercise and breast cancer may not be applicable to the whole 
breast cancer population because the majority of cancer survivors (60%) in the UK are 
aged over 60 years with the mean age of diagnosis between 60-64 years, with 25% of all 
breast cancer diagnoses made between the ages of 60-69 years (Cancer Research UK, 
2016). In the USA, the median age of breast cancer diagnosis among women is 62 years 
(Howlader et al., 2012). Even with this knowledge, it appears that the majority of women 
recruited to breast cancer and exercise studies are much younger than this. In a 
Cochrane review and meta-analysis of exercise and breast cancer, of the 1,042 women 
from 15 exercise interventions during adjuvant treatment for breast cancer that were 
included in the review, the mean age of the women was 50 years (Markes, 2009). A 
series of other large–scale breast cancer and exercise trials and reviews have also 
reported a similar mean age of 51.7 years with 3,777 women having been recruited and 
taken part in these trials (McNeeley et al., 2006; Courneya et al., 2007; Mutrie et al., 
2007; Kim at al., 2009; Fong et al., 2012). 
However, exercise is becoming increasingly recognised as an important treatment for 
the recovery and rehabilitation of cancer patients (Spence, Heesch, & Brown, 2010), and 
has long been considered a useful therapy to offset the declines in physical and mental 
functioning brought on by ageing and long-term medical conditions Courneya et al., 
2004). Physical activity has been consistently identified as a fundamental element of 
rehabilitation for many chronic diseases and disabilities and has been successful in 
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improving quality of life and reducing all-cause mortality (McNeely et al., 2006). Cancer 
survivors are at greater risk for other cancers, cardiovascular disease, osteoporosis, 
diabetes and accelerated function decline, than those who have not had a diagnosis of 
cancer (Demark-Wahnefried et al., 2006). Therefore, it is even more important that 
cancer survivors become physically active. The evidence of the benefits of exercise for 
cancer survivors has been steadily increasing over the past twenty years, specifically in 
the areas of quality of life outcomes (Maryam, Fazlollah, Eesa, Ebrahim, & Abbas, 2010; 
McNeely et al., 2006), cancer related fatigue (Schneider, Hsieh, Sprod, Carter, & 
Hayward, 2007), functional capacity, strength and endurance (Pinto et al., 2005; 
Cheema et al., 2008; Adamsen et al., 2009) and improved body composition (Courneya 
et al., 2007; Schmitz et al., 2005) 
It appears the existing evidence from older women with breast cancer involved in 
exercise intervention studies is very limited. Therefore, the focus of this PhD 
investigation was to examine the feasibility of women aged over 60 years old recently 
diagnosed with breast cancer being recruited to participate in a 12-week exercise 
programme. Another research gap identified in the literature is that of long term 
outcome measures. Thus, follow up of outcome measures over 12-months would also 
be reported. This in itself appeared to be a relatively simple and straightforward 
intervention; however, it became apparent that the process of investigation was far 
more complex, as exercise intervention studies in the UK have not specifically targeted 
this older breast cancer population before. From an ontological and epistemological 
standpoint, the author’s “worldview” of research paradigms is to consider pragmatism 
and mixed methods research as the most appropriate approach when conducting this 
research. The aim of this research is not to solve the methodological differences 
24 
 
between the purist positions (qualitative vs quantitative), but rather to use a method 
and philosophy that attempts to fit together the insights provided by qualitative and 
quantitative research into a practical and workable solution (Johnson & Onwuegbuzie, 
2004).  
 
1.2 Aims and objectives 
From the outset the key aim from which this work evolved was as follows:  
“To determine the feasibility and acceptability of a 12-week supervised aerobic and 
resistance training programme on females over the age of 60 who have very recently 
been diagnosed with breast cancer and are undertaking treatment or have just finished 
adjuvant treatment”. 
The objectives considered during the study were: 
1. To assess the feasibility of the recruitment of older women with breast cancer during 
and immediately after adjuvant therapy; 
2. To assess the feasibility and acceptability of the trial intervention; 
3. To assess the feasibility and acceptability of the trial outcome measures; 
4. To record and report any adverse events from the exercise programme (injury, 
lymphoedema); 
5. To examine barriers to and motivators for exercise after breast cancer diagnosis. 
 
In order to ensure a systematic process of investigation, a step-wise process was 
proposed following the MRC guidance for the development and evaluation of complex 
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interventions (Craig et al., 2008). This framework, originally developed in 2000 and later 
updated in 2008 has helped researchers to adopt appropriate methods to answer the 
key questions when evaluating complex interventions; are they effective in everyday 
practice and how does the intervention work: what are the active ingredients and are 
they effective? (Craig et al., 2008). This framework was used as a guide throughout this 
study. Campbell et al. (2000) consider complex interventions are those that include 
several components and evaluation of complex interventions requires the use of both 
qualitative and quantitative evidence with the aim of considering all the components 
that are required to enable a well-informed decision before committing to a definitive 




   
Figure 2: Relationship between context, intervention and evaluation of complex 
interventions (Craig et al., 2008) 
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To address the aims and objectives of this PhD thesis, and by following the step-wise 
process proposed by the MRC framework, this thesis has focussed on the preliminary 
work required before a definitive RCT could be considered or undertaken. It followed 
partly the suggestions by Campbell and colleagues (2007) who found it useful to 
consider phases 0, 1 and 2 of the step-wise approach as part of one larger activity rather 
than sequential stages (Campbell et al., 2007) and considered it in a parallel approach – 
pragmatic in nature. This thesis considered the three phases to assess the feasibility and 
acceptability of trial procedures and outcome measures of a pragmatic pilot RCT and a 
qualitative study to explore thoughts and feelings about exercising and being more 
physically active after a recent diagnosis of breast cancer.  
 Phase 0 – “Pre-clinical or theoretical” stage (why should we do this intervention?); the 
existing research evidence was synthesised in order to examine and establish what was 
already known about this older population and exercise after a breast cancer diagnosis 
and identify what kind of intervention was required. Phase 1 – “Modelling” (how does it 
work?) and Phase 2 - “Exploratory” stage; a pragmatic pilot RCT to assess the feasibility 
of the study design, protocol, outcome measures conducted, and to provide important 
information about the proposed design of the intervention, the subsequent outcomes 
measures and the evaluation of these methods (Craig et al., 2008). This was followed by 
a qualitative study to explore the barriers to and motivators for exercise and physical 
activity for women over 60 after a diagnosis of breast cancer. The experiences of 
designing and then conducting the intervention and the subsequent interviews of the 
target population provided valuable research skills for the PhD researcher and helped 
to generate new knowledge to inform learning and provide lessons regarding how to 
approach future research with this population and whether or not it would be advisable 
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to proceed with the implementation of a full-scale RCT (Phase 3 – Definitive randomised 
controlled trial and Phase 4 – Implementation). This invaluable learning will be discussed 
in the conclusion of this thesis. 
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Chapter 2: Diagnosing and treating breast cancer  
2.1 Introduction 
In 2012, it was estimated that nearly 1.7 million women worldwide were diagnosed with 
breast cancer, accounting for around 522,000 deaths (Ferlay, Steliarova-Foucher, Lortet-
Tieulent et al., 2013). This was an increase in breast cancer incidence by nearly 18% since 
2008. It has been predicted that worldwide the incidence of breast cancer will reach 3.2 
million new cases per year by 2050. These predicted figures reflect the magnitude of 
breast cancer, its effect on society worldwide and the urgent need for better 
preventative and treatment measures (Tao et al., 2014).  
 


















Table 1: Global incidence and survival of breast cancer 




Table 1 shows the global incidence, mortality and survival rates for breast cancer. Whilst 
the mortality rate is significant, progress has been made in terms of prognosis and 
survival. Although the incidence of breast cancer is increasing, mortality rates from 
breast cancer have fallen steadily since 1990, having been previously stable or increasing 
for a number of decades. The fall in mortality rates during this period has been 
attributed to three key factors. These are: improved screening and detection 
programmes; a greater public awareness of the early signs and symptoms; and the 
widespread use of systemic therapies with Tamoxifen (Benson et al., 2009; Berry et al., 
2005). 
Women are now living longer with a diagnosis of breast cancer than ever before. More 
than 90% of women diagnosed early with stage 1 breast cancer survive the disease for 
at least 5 years. Almost 8 in 10 women will now survive for longer than 10 years following 
diagnosis and almost 70% beyond 20-years (Quaresma, Coleman & Rachet, 2014). These 
increases in cancer survival rates will have implications for health care required by 
cancer survivors, with a greater focus on community care and self-management of the 
long-term effects and consequences of cancer treatments. As the population of cancer 
survivors increases in both numbers and with advancing age, cancer has now largely 
become considered a long-term condition. Efficient and effective management by a 
range of healthcare providers and specialist clinicians will be required to support many 
more elderly cancer survivors (Maddams et al., 2012). 
To continue to improve cancer survival rates the Department of Health published: 
Improving Outcomes: A Strategy for Cancer (DoH, 2011). This strategy has resulted in 
initiatives such as the National Awareness and Early Diagnosis Initiative (NAEDI), which 
is a partnership between the Department of Health, National Cancer Action Team, and 
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Cancer Research UK. The role of NAEDI is to promote the benefits of an early diagnosis 
of cancer, and involves research to further improve survival from cancer. 
2.2 National policies on cancer care delivery 
In the UK, cancer treatment is mainly delivered through the National Health Service 
(NHS). To improve cancer care delivery and to try to reduce inequalities in treatment 
provision, the NHS Cancer Plan (2000) was a strategy produced to shape and standardise 
cancer services in England. This has been a priority of the Department of Health since its 
ten-year Cancer Plan was produced. For the first time this plan provided a 
comprehensive strategy for bringing together prevention, screening, diagnosis, 
treatment and care for cancer. Following on from the progress of the NHS Cancer Plan, 
the Department of Health published its five-year Cancer Reform Strategy (2007) to set 
out aims of developing cancer services to be among some of the best in the world by 
2012. This strategy set out a programme of action across ten areas: six to improve cancer 
outcomes (preventing cancer, earlier diagnosis, better treatment, living with and 
beyond cancer, reducing inequalities in cancer care and delivering care in the 
appropriate setting) and four to ensure delivery (using information to improve quality 
and choice, better commissioning, improved funding and building for the future). The 
government and NHS appear committed to ensuring that cancer services “are among 
the best in the world” Improving outcomes: A strategy for cancer  (DoH, 2011) and more 
recently the Independent Cancer Taskforce published their strategy: Achieving World-
Class Cancer Outcomes (2015-2020): Cancer Strategy for England. This sets out how 
England wants to radically improve the outcomes that the NHS delivers for people 
affected by cancer. This key report describes provision over the next five years and sets 
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out six strategic priorities. First, a radical upgrade in prevention and public health, 
including a new tobacco policy and a national obesity plan. Second, to achieve earlier 
diagnosis, whereby 95% of patients referred for cancer testing are definitely diagnosed 
or cancer is excluded within four weeks. Third, to improve patient experience through 
improving communication and information. Fourth, every person with cancer to have 
access to elements of a recovery package and follow-up care for common cancer. Finally, 
to make investments in high quality equipment to be able to deliver faster and more 
effective services and overhaul the process for commissioning to ensure that it is clearer, 
establishing Cancer Alliances across the country to bring together key partners to drive 
and support improvement at a local level. 
 
2.3 Evaluating the effect of cancer care policy 
Since the introduction of the NHS Cancer Plan in 2000 and the publication of the five-
year Cancer Reform strategy in 2007, significant progress has been made in improving 
cancer services, with falling mortality rates whilst incidence rates have increased. 
According to the Cancer Strategy for England (2015) the number of people being 
diagnosed and living with cancer will continue to grow rapidly even with major 
improvements in prevention, due to the ageing population and the success of increasing 
survival. Variations and inequalities in outcomes and access to services persist 
throughout the country, especially for older patients and particularly those from lower 
socio-economic groups who are more likely to experience worse outcomes. 
Furthermore, data for the cost-effectiveness of cancer care have not improved in line 
with the development of data on cancer treatments and outcomes; it appears that this 
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lack of cost-effectiveness data restricts commissioners’ ability to make fully-informed 
decisions about which treatments offer the best value for money or whether resources 
are being used to best effect (NAO, 2015).  
The introduction of the Cancer Strategy for England (2015) has resulted in the 
establishment of a number of Cancer Alliances across the country. Breast cancer survival 
rates are higher now than those reported for any other cancer afflicting females, but 
evaluating success purely on length of survival is limited as the quality of life during 
survival is important. Other measures should be used to assess the quality of life during 
survival in view of the treatment-related side-effects and long-term consequences of 
treatment, all of which can be a burden on physical and psychological morbidity.  
 
2.4 Screening and tests to diagnose breast cancer 
2.4.1 Referral guidelines 
The majority of women attending a specialist breast clinic will have been referred to it 
by their GP. The Department of Health in 2000 and the National Institute for Health and 
Clinical Excellence in 2005 (NICE, 2005) published referral guidelines for patients 
presenting with breast cancer symptoms. These guidelines allow for prompt 
appointments to be made to ensure urgent referrals are seen by a breast specialist 
within the national targeted time-frame of two weeks. All patients presenting with 
breast symptoms should undergo a triple assessment, involving history taking and 





2.4.2 History and physical examination  
The clinical history is important in establishing cancer risk and the presence or absence 
of symptoms indicative of breast cancer. It should include age at menarche, menopausal 
status, previous pregnancies, use of oral contraceptives and post-menopausal hormone 
replacement. In addition, a family history of breast cancer in first-degree relatives should 
be assessed (Shah, Rosso, & Nathanson, 2014). An estimated risk for breast cancer may 
be determined by using prediction models which indicate risk followed by physical 
examination. The most well-known and widely used risk prediction screening tool is the 
Breast Cancer Risk Assessment Tool (BCRAT), or the Gail model, developed by Dr. 
Mitchell Gail (Benichou, Gail, & Mulvihill, 1996). Prediction models are used to stratify a 
person’s risk of developing breast cancer based on the presence of known and 
quantifiable risk factors. The concordance statistic or “c-statistic” of 0.5 indicates that 
the prediction model is no better than chance at discriminating patients who are at risk 
from those who are not. The c-statistic of the Gail model has been reported to be 
between 0.55-0.67 (Rockhill, Spiegelman, Byrne, Hunter, & Colditz, 2001). Other 
commonly-used prediction model are the Claus model with a c-statistic of 0.56 (Amir, 
Evans, Shenton, Lalloo, & Moran, 2003) and the Breast Cancer Pro (BRCAPRO), a 
computer model which assesses a women’s risk of developing breast cancer or carrying 
the BRCA gene mutation. The c-statistic for the BRCAPRO is 0.72-0.92 (Parmigiani, Chen, 
Iversen, Friebel, 2008). Physical examination will check for skin changes such as dimpling, 
visible lumps, nipple retraction and peau d’orange with a patient in both sitting and 
supine position with the cervical supraclavicular and axillary lymph node basins palpated 




2.5. Radiological assessment 
2.5.1 Mammography 
One of the most important advances in the treatment of breast cancer is early detection 
of non-palpable masses, and mammography remains the mainstay in breast cancer 
detection and the gold standard for breast imaging (Smetherman, 2013). Mammograms 
have a sensitivity of up to 90% in women over the age of 50 years. All women in the UK 
from the age of 50 should have a routine mammogram every three years, although 
mammograms are not routinely performed in women under the age of 50 because an 
accurate assessment is difficult due to denser breast tissue. Mammograms are 
performed in women who have a palpable mass or other symptoms of breast disease, a 
family history or have been recalled because of an abnormal previous mammogram. 
Typically, a two-view mammogram of each breast is performed to allow comparison of 
potential abnormalities between both sides with carcinomas usually presenting as 




Ultrasound scanning should be used as an adjunct to mammography. It may be used in 
high-risk patients with dense breast tissue where mammographic sensitivity is lower, 
allowing the clinician to screen for breast cancers that may have not been detected by 
traditional mammography, to assess for abnormalities on mammography or magnetic 
resonance imaging (MRI), problems with breast implants and is particularly useful in the 
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assessment of discrete lumps (Berg, Blume, Cormack, Mendelson, & Lehrer, 2008; Kelly, 
Dean, Comulada, & Lee, 2010). 
 
2.5.3 Magnetic Resonance Imaging (MRI) 
Breast magnetic resonance imaging (MRI) is an expensive technique which is reserved 
for certain clinical settings (Bansal & Gower-Thomas, 2010). MRI scanning of the breast 
is indicated if there has been a discrepancy between the clinical, mammographic and 
ultrasound measured size of the tumour, if breast augmentation has been considered 
or mammographic evaluation is limited by augmentation, if the density of the breast 
tissue is not appropriate for mammography and to assess the size of lobular carcinomas 
(Osbourne & Vaughan-Williams, 2010). Other uses of breast MRI include evaluation of 
response to neo-adjuvant chemotherapy with imaging before, during and after 
treatment and identification of any disease present in patients with positive margins 
after lumpectomy (Shah et al., 2014). An important application of MRI is in the screening 
of women with increased familial breast cancer and especially those carrying BRCA1 or 
BRCA2 genes, in which mammography may be ineffective. With a lifetime risk of 60-85% 
for developing breast cancer, NICE have published guidelines recommending MRI 
screening in these women (NICE, 2006; Bansal & Gower-Thomas, 2010). However, the 
value of pre-operative MRI remains controversial. Although high-quality MRI in a multi-
disciplinary setting can help with surgical planning, the concern remains that the lack of 
specificity in detecting multi-centric lesions could lead to unnecessary mastectomies 
(Gonzales, Sandelin, Karlsson et al., 2014; Sung, Li, Da Costa et al., 2014;). Furthermore, 
Harbeck and Gnant, (2017) suggest multicentric tumours need to be properly diagnosed 
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before surgical planning and mastectomies should not be indicated based solely on an 
MRI. 
 
2.6 Pathological assessment 
2.6.1 Biopsy 
A breast mass warrants biopsy with the exception of a simple cyst, a fluid filled mass 
that may be aspirated and the removal checked by ultrasound or palpation (Pengally, 
Lambert, Khan, & Groome, 2014). Core biopsy of a breast lump is carried out, preferably 
under guided imaging via ultrasound or mammography to enhance the accuracy of the 
technique, and provides an image of the biopsy being performed, which may be useful 
in the multi-disciplinary team (MDT) meeting (see Section 2.8 below for further 
discussion) and if conducting further investigations. Biopsy options may include core 
needle biopsy, fine needle aspiration cytology (FNAC) and incisional or excisional 
procedures that partially or completely remove the suspicious lesion (Zhang, Wei, Li et 
al., 2013). Using core biopsy, clinicians are provided with a wealth of information, 
including cytological information, grade and tumour receptor status, prior to surgery. 
This is particularly useful in treating elderly women as hormonal therapy may be the 
primary form of treatment. Core biopsy has become the preferred method to investigate 
breast abnormalities, allowing the removal of small slivers of tissue and can be 
undertaken in the clinical setting with little preparation or with ultrasound guidance. 
Core needle biopsies provide pathological information that can be used for planning 
local treatment (Zhang et al., 2013). Although it is a relatively invasive procedure 
requiring local anaesthesia and can lead to extensive bruising it is generally well 
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tolerated (Osborne & Vaughan-Williams, 2010). The role of FNAC is to obtain cells from 
a lesion for the histopathology laboratory to analyse. It is a safe and quick procedure to 
perform, allowing cytology results to be available quickly but does not give much 
information about the pathological characteristics and does have a high false-negative 
rate. Open incisional or excisional biopsies are usually performed as follow-up biopsies 
when the initial biopsy has not provided adequate information to confirm the nature of 
the lesion. 
 
2.7 Cancer staging 
The clinical stage of breast cancer is defined describing the size of tumour in 
centimetres, presence or absence of axillary node enlargement and involvement, skin 
involvement and the presence or absence of regional or distant metastatic disease 
(Lester, 2015; National Cancer Institute, 2015). The patient is clinically staged using the 
acronym TNM (Tumour, Node, Metastasis) using the American Joint Commission on 
Cancer (AJCC) guidelines (O’Connell, Maggard, & Ko, 2004). Neo-adjuvant 
chemotherapy may be given before surgery to help achieve tumour reduction and offer 
less aggressive surgery, especially in patients presenting with locally advanced breast 
cancer or in borderline cases where the tumour to breast ratio will not allow for removal 
and acceptable cosmetic results (American Cancer Society, 2014; Shah et al., 2014). Even 
if neo-adjuvant chemotherapy is administered the clinical stage (before chemotherapy) 
is often considered the accurate stage rather than compared to a downgraded outcome 
subject to effective chemotherapy (Bhoo-Pathy et al., 2015). The histological 
classification of invasive breast cancers indicates the anatomical source of the 
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malignancy and includes: infiltrating ductal (70-80%), invasive lobular (8%-10%) and 
inflammatory (2%) breast cancer, the most lethal form of breast cancer with very fast 
progression of local tumour and metastasis (Yamauchi, Woodward, Valero et al., 2012; 
American Cancer Society, 2014).  
 
2.8 Multi-disciplinary teams 
Best practice in breast care is provided by a range of breast specialists and form the basis 
of multi-disciplinary teams (MDT). Therapy concepts and decisions regarding the best 
and most appropriate treatment are made in conjunction with the patient after 
discussions and recommendations within a multi-disciplinary team meeting. Prognostic 
factors, tumour size, nodal involvement, spread of the disease, hormonal status 
(oestrogen and progesterone receptor status), biological tumour subtypes such as triple 
negative breast cancer or human epidermal growth factor receptor 2 status (HER2 
receptor status) will be carefully scrutinised and considered. Additional factors relating 
to age, menopausal status, medical history and family history of breast or ovarian cancer 
will be discussed in the decision-making process. Many patients with early breast cancer 
require combination adjuvant treatment therapy, making it a complex planning process 




2.9 Treatment of invasive breast cancer 
2.9.1 Surgery 
The majority of patients who are diagnosed with breast cancer will undergo surgical 
treatment. This may be followed by adjuvant chemotherapy, radiotherapy and hormone 
therapy. Surgical treatment is a primary intervention intended to provide local control 
by removing the tumour and any visible or microscopic tumour cells and to identify the 
pathological stage of the disease. Several combinations of surgical procedures may be 
performed depending on the size and site of the tumour and the clinical stage of the 
disease (Lester, 2015). 
 
2.9.2 Breast conserving surgery 
Breast conservation is established as the intended surgical standard for most clinical 
situations in breast cancer (McLaughlin, 2013). Conservation surgery represents 75-85% 
of all breast cancer operations (Veronesi et al., 2005). Developments in surgical 
techniques and multi-disciplinary approaches (including neo-adjuvant systemic 
therapy), as well as increased treatment of patients in dedicated breast units have 
improved women’s access to this life-saving treatment (Mansfield, Agrawal, & Cutress, 
2013). Patients with a single lesion measuring 4cm or less (either invasive or Ductal 
Carcinoma in Situ) are suitable for breast-conserving surgery (often known as a 
lumpectomy or local wide excision). There is no significant difference in local recurrence 
rates or overall survival when breast-conserving surgery is compared to mastectomy 
Local recurrence rates with either method should be less than 5% at 5 years (Fisher, 
Anderson, & Bryant, 2002; Osborn & Vaughan-Williams, 2010). Breast conserving 
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surgery is contraindicated in women with a history or previous radiation therapy to the 
chest or breast, current pregnancy, widespread disease, positive margins that were not 
cleared with a repeat lumpectomy or suspicious microcalcifications (Jorns, Daignault, 
Sabel, & Wu, 2014). 
2.9.3 Mastectomy 
Total removal of the mammary gland (mastectomy) may be needed with invasive, 
extensive, large or inflammatory carcinomas, local recurrence following breast 
conserving surgery, inherited genetic mutations, a significant family history, tumours 
which have not been reduced enough by neo-adjuvant chemotherapy or a combination 
of these factors (Veronesi et al., 2005). Prophylactic mastectomies are performed to 
take out the breast tissue bilaterally and remove all of the breast tissue. Since the 
complete removal of all breast cells is virtually impossible, long term follow-up is still 
necessary (Lester, 2015). Prophylactic contralateral mastectomy is a common request 
from patients who require a mastectomy on the affected side or in lieu of breast-
conserving surgery. According to Berry and Gomez (2010) between 48-52% of patients 
in the UK undergo a mastectomy to treat their breast cancer, which is considerably 
higher than figures they report from Paris and Milan (although these are not country-
wide statistics). In the United States, Shah et al. (2014) suggests approximately 30% to 
40% of patients are eligible for mastectomy or chose to have one. However, according 
to (Hamelinck et al., 2014; Jatoi & Parsons, 2014) and, the increasing trend of patients 
being directed to have voluntary bilateral mastectomies is of concern. Although they 
accept patient choice as important, the increase in the number of these surgeries does 
not align with the evidence that contralateral mastectomy either lowers mortality or 
improves survival (Kurian et al., 2014). Published evidence that supports the decision-
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making process for this more aggressive treatment is lacking. Hamelinck et al., (2014) 
conducted semi-structured interviews with nine women who voluntarily elected for 
contralateral prophylactic mastectomy over other surgical choices. A number of factors 
that influenced their decision-making process included: personal evaluation of the risks 
and benefits, future avoidance and worry of further biopsies and cancer assessments, 
and a desire to maintain or maintain breast appearance. Preferences for this type of 
surgery may relate to perceptions of disease recurrence and survival and concerns about 
body image; however, clinicians have a clear ethical responsibility to ensure that 
patients have all the information about options and consequences of this surgery 
including the evidence of survival to ensure that patients are not making decisions based 
on fear alone (Jatoi and Parsons, 2014; Kurian et al., 2014). 
 
2.9.4 Axillary surgery 
Axillary node status is the single most important prognostic indicator in breast cancer 
staging. All patients undergoing surgery to the breast for invasive cancer or extensive, 
high grade ductal carcinoma in situ (DCIS), requiring mastectomy should have an axillary 
staging procedure. This test provides prognostic information to guide the use of 
appropriate adjuvant therapy and provide local disease control (Berry & Gomez, 2010). 
One of the areas of most significant change in breast cancer management is that 
complete lymph node dissection (ALND) or removal of level I and II axillary nodes are no 
longer standard practice. A sentinel lymph node biopsy (SLNB) has superseded both 
axillary node sampling and axillary node clearance as the initial staging choice due to its 
much reduced rate of complications (Berry & Gomez, 2014). A sentinel lymph node 
biopsy can be performed at the time of surgery. It is based on the principle that breast 
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cancer drains into a chain of lymph nodes. If the first lymph node in the chain (the 
sentinel node) does not show any sign of cancer, the other nodes should also be free of 
cancer. If a sentinel lymph node biopsy provides evidence of metastatic spread to the 
lymph nodes then further axillary treatment will be required.  
In one of the very earliest randomised trials into SLNB, Veronesi et al. (2003) randomised 
516 patients to receive SLNB followed by routine ALND, or SLNB, followed by ALND only 
if metastatic disease was found during the SLNB. At 10 year follow-up, no differences 
were observed between the groups in recurrence of axillary cancer (0% in the SLNB vs 
2% in the ALND group) or disease free survival (89.9% vs 88.8%)(Veronesi et al., 2010). 
These research findings question whether all patients with a positive SLNB require 
complete ALND. For patients who have node-negative disease, it raised the question 
whether ALND was required for all patients.  
Findings from the American College of Surgeons Oncology Group (ASOCOG Z0011) trial 
(Caudle et al., 2012) helped to address these questions. Patients identified with T1 and 
T2 tumours undergoing lumpectomy who were found to have metastatic disease in the 
sentinel node were randomised to undergo either ALND or no further treatment to the 
axilla. At 5-years, the local recurrence rate was 1.6% in the SLNB group compared to 
almost double (3.1%) in the ALND group. There was also no difference in 5-year disease 
free survival. The results from the trial and at 5-year follow appear to suggest that for 
select patients with non-positive breast cancer, SLNB alone does not result in inferior 




2.10 Adjuvant radiotherapy in the treatment of early breast 
cancer 
Radiation therapy is an essential component of local treatment of the breast and is most 
commonly administered after lumpectomy, following mastectomy or in those patients 
with multiple positive lymph nodes (Bauer & Lester, 2014; Marta et al., 2015). Patients 
who have undergone breast conservation surgery for primary invasive breast cancer are 
usually treated with post-operative adjuvant radiotherapy, as long-term follow up has 
confirmed significant increased rates in local recurrence and possible risk of distant 
disease recurrence when radiotherapy has been omitted, and improved survival in those 
patients treated with radiotherapy with more aggressive disease(BASO, 2009; Fisher et 
al., 2002). In a systematic review and meta-analysis of five randomised clinical trials with 
a sample of 3,190 patients, those who received radiotherapy had a lower relative risk of 
local recurrence (pooled odds ratio [OR] 0.36; 95% CI 0.25-0.50). The 5-year absolute 
risk was 2.2% (95% CI 1.6-3.1) among patients who received radiotherapy compared to 
those who did not (6.5%, 95% CI 5.3-7.9) (van de Water et al., 2014). These results 
suggest that patients who received radiotherapy had a lower relative risk of local 
recurrence, the absolute risk was low, and overall survival was no different. Whole 
breast radiation therapy following lumpectomy has demonstrated similar mortality 
rates as mastectomy but with fewer long-term consequences of treatment reported 
(Moran & Truong, 2014; Wobb et al., 2015). Passant and Borley (2013) continue 
suggesting that radiation to the whole breast reduces local recurrence after wide local 
excision by two-thirds.  
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The Early Breast Cancer Trialists Collaborative Group (EBCTCG) demonstrated that 
radiotherapy gives significantly better control of local recurrence than no radiotherapy 
but with little effect on mortality within the first 5-years of treatment (Clarke et al., 
2005). A relatively new approach to breast radiotherapy following breast conserving 
surgery is accelerated partial breast irradiation (APBI). This approach reduces the 
number of days receiving radiation, the area of breast needed to be treated and the 
overall amount of radiation required. Bauer and Lester, (2014) found that larger and 
more frequent doses of radiation may be superior to whole breast radiation; however, 
there are insufficient large scale, prospective, randomised trials to fully assess the value 
and benefits of APBI to whole breast radiation (Bauer & Lester, 2014; Moran & Truong, 
2014). 
Patients who have undergone adequate surgical axillary assessment do not usually 
receive axillary radiotherapy. Axillary node positive patients who have undergone 
axillary clearance are also not usually treated with radiotherapy unless the MDT suggest 
high risk of relapse. A further option of a positive sentinel node could be radiotherapy 
to the axilla; however, the benefits of these dual treatments options have to be 
considered against the increased risk of lymphoedema (BASO, 2009). Donker et al. 
(2014) in their AMAROS trial reported that axillary radiotherapy was not an inferior 
option versus axillary lymph node dissection, although because of the low numbers of 
level III dissections and wound infections in the surgery group that could have affected 
the data, caution should be taken when interpreting the results. However, further 
research and evidence into this radiotherapy approach of targeting the axilla has gained 
momentum. In a 10-year follow up of the EORTC trial, Bartelink et al. (2007), suggested 
a 5-year overall survival benefit (82.3% in the nodal radiotherapy group vs 80.7% in the 
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control group (no nodal radiation)[Hazard Ratio (HR) for death, 0.87, 95% CI 0.76-1.00, 
p=0.06]). The MA-20 trial suggested the addition of regional nodal radiotherapy to 
whole-breast radiotherapy did not improve overall survival but did reduce recurrence 
of breast cancer (Whelan et al., 2015). In a meta-analysis of the above trials (EORTC and 
MA-20) both overall and metastasis-free survival were significant in the nodal irradiation 
groups, supporting the increasing promotion of this adjuvant therapy. 
 
2.11 Adjuvant systemic therapies in the treatment of early 
breast cancer 
Even with effective local treatment as described above, Passant and Borley, (2010) 
consider that micro-metastases are often present with early stage breast cancer 
because many patients develop metastases over time. Improvements in local control 
provide only a small decrease in distant metastases. The increasing and improved 
survival rates for patients with early-stage breast cancer have been achieved by systemic 
treatments. 
 
2.11.1 Neo-adjuvant systemic therapy 
Neo-adjuvant systemic treatment has emerged as a standard of care for treatment when 
primary breast conservation surgery is not possible because of large, locally advanced 
or inoperable tumours or inflammatory breast cancer. Both cytotoxic and endocrine 
therapy are used, and targeted therapy may be used depending on the tumour biology 
(Teshome & Hunt, 2014). These treatments can down-stage inoperable cancers to be 
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operable and reduce the size of large cancers so that they can be treated with breast-
conserving surgery (Osborn & Vaughan-Williams, 2010).  
 
2.11.2 Adjuvant chemotherapy 
In what is considered a landmark study, Bonadonna and his colleagues demonstrated 
that with post-operative adjuvant chemotherapy consisting of cyclophamide, 
methotrexate and fluorouracil (CMF) with women with positive axillary lymph nodes 
that after being given 27 months of treatment decreased the risk of breast cancer 
recurrence (Bonadonna et al., 1976). Since this trial much research has been conducted 
to understand the most beneficial chemotherapy agents, combinations of 
chemotherapy drugs, doses and durations of treatment (Clarke et al., 2005). Adjuvant 
systemic treatments are offered to patients to reduce their risk of relapse and to 
improve disease-free survival and overall survival with treatment of breast cancer by 
surgery and/or radiation alone (Shah, Rosso, & Nathanson, 2014). In general, breast 
cancer patients with an estimated risk of over 10% of recurrence over the course of 10-
years are viewed as potential candidates for adjuvant chemotherapy (Harbeck & Gnant, 
2017). Predictive markers are required to select the most appropriate and optimum 
treatment for each patient. The oestrogen receptor, the progesterone receptor and the 
human epidermal growth factor receptor 2 (HER2) are considered the best predictive 
markers. High rates of recurrence are probably related to the presence of micro-
metastatic disease in 10-30% of lymph node negative patients and 35%-90% of lymph 
node positive patients at the time of diagnosis which was not eradicated with surgery 
or radiotherapy (Jaiyesimi, Buzdar, Decker, & Hortobagyi, 1995).  
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Adjuvant chemotherapy helps to eliminate residual or distant micro-metastases, but the 
absolute benefit varies according to disease stage, patient age and underlying prognosis 
(Passant & Borley, 2013). Our understanding was advanced by research conducted by 
Bonadonna et al. (1976). They investigated chemotherapy treatment with 
anthracyclines-based combination regimens (e.g. 5-fluoruracil, epirubicin and 
cyclophosphamide, given every 3 weeks for six cycles) which were shown to significantly 
reduce recurrence and breast cancer mortality when compared to cyclophosphamide, 
methotrexate and fluirouracil (CMF) regimens, and may be used unless there is a 
contraindication of cardiac dysfunction (Passant & Borley, 2013). Additional research 
which has focused upon chemotherapy treatment combinations has demonstrated that 
the addition of taxanes (paclitaxel and docetaxel) to anthracycline-based chemotherapy 
combinations leads to a 17% reduction in recurrence risk (Henderson et al., 2003; 
Mamounas et al., 2005). A meta-analysis conducted by De Laurentiis et al. (2008) 
demonstrated that taxane-based chemotherapy combinations provided disease-free 
survival and overall survival benefit with an absolute 5-year risk reduction of 5% for 
disease-free survival and 3% for overall survival when compared to the standard 
anthracycline regimens. Patients with endocrine-unresponsive breast cancer, with no 
expression of oestrogen or progesterone receptors, are usually offered chemotherapy 
for 6 weeks, whereas on the other hand, patients with endocrine-responsive disease are 
offered adjuvant systemic therapy based on endocrine treatments (Goldhirsch et al., 




2.12 Adjuvant endocrine therapy 
Adjuvant hormone therapy is given to women diagnosed with endocrine-sensitive 
tumours for a period of 5-10 years (Harbeck and Gnant, 2017). Breast cancer is an 
oestrogen-dependent cancer in approximately 70% of patients and is thus hormone 
sensitive. Attempts to disrupt the interaction of the oestrogen hormone and the 
oestrogen hormone receptor signalling pathways have been demonstrated to cause 
tumour regression. This can be done by interfering with the oestrogen receptor 
signalling pathway, in the case of Tamoxifen, or by decreasing the production of 
oestrogen with ovarian ablation, ovarian suppression or aromatase inhibition (Passant 
& Borley, 2013). 
 
2.12.1 Pre-menopausal endocrine therapy 
In pre-menopausal patients Tamoxifen is the standard endocrine treatment. The 
responsiveness of breast tumours to hormonal manipulation allows opportunity for 
targeted therapy via the anti-oestrogen Tamoxifen. Tamoxifen acts by blocking the 
action of oestrogen by binding to one of the two activating regions of the oestrogen 
receptor (ER). By doing this it stops both the translocation (joining together) and binding 
of the oestrogen receptor. Clarke et al., (2005) demonstrated that in women with ER-
positive breast cancer who took Tamoxifen for 5-years the annual recurrence rate was 
decreased by 50%, the rate of contralateral cancers decreased by 41% and breast 
cancer-related mortality reduced by 31%. They noted a dose-response relationship, with 
a 5 year course of tamoxifen therapy being more effective than a course of one or two 
years (Clarke et al., 2005). A later meta-analysis (2011) reported by the same group 
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(EBCTCG) showed that 5-years of tamoxifen treatment in women with ER-positive 
disease reduced not only recurrence risk in the first 4 years (RR 0.53, p<0.0001) but also 
in years 5-9 (RR 0.68, p<0.0001), demonstrating the importance of endocrine therapy 
for reducing recurrence and mortality long term.  
 
2.12.2 Post-menopausal endocrine therapy 
In post-menopausal women the production of oestrogen by the ovaries stops; however, 
oestrogen can still be produced by other tissues particularly in subcutaneous adipose 
tissue. (Cohen, 2001). Aromatase inhibitors (AIs) stop the production of oestrogen 
through this mechanism (Passant & Borley, 2013). AIs represent an important advance 
in endocrine therapy treatment for breast cancer. These include non-steroidal 
(anastrazole and letrazole) and steroidal (exemestane) oral agents which are particularly 
valuable if tamoxifen is contra-indicated, or prescribed as an initial treatment, or as a 
treatment sequenced after tamoxifen (Lyman et al., 2005). However, for post-
menopausal patients, both tamoxifen and aromatase inhibitors are important treatment 
options, either given in sequence (switching from AI to tamoxifen after 2-3 years to 
complete 5-years in total) or on their own. The ATAC trial (Baum et al., 2003) compared 
the use of anastrozole with tamoxifen, either alone or in combination in women with 
early stage post-menopausal breast cancer. At 10-years, anastrozole as initial therapy 
was demonstrated to increase disease free survival (HR 0.86, p=5.003), increased time 
to local or distant recurrence (HR 0.79, P=5.0002, HR 0.85, p=5.02, respectively), and 
reduced reports of contralateral breast cancer (HR 0.62, p=05.003) when compared to 
tamoxifen (Cuzick et al., 2010). To date, research has supported the use of aromatase 
inhibitors for a total of 5 years, either as part of a first line treatment or as extended 
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adjuvant therapy (Dowsett et al., 2009). However, more recent research has 
concentrated on longer durations of endocrine therapy of up to 10 years and with 
different combinations of AIs and tamoxifen, with positive results. Goss et al. (2016) 
demonstrated that after 5-years of tamoxifen, with letrozole treatment added from 5-
10 years, is beneficial in post-menopausal women for a 5-year disease-free survival of 
95%, when having letrozole treatment for 10-years vs 91% for women only taking 
letrozole treatment for 5-years, HR 0.66, p=0.01. Prolonging endocrine use beyond 5-
years must be carefully balanced against potential risks, previous use of tamoxifen, side 
effects and the risk of recurrence (Harbeck & Gnant, 2017). 
 
2.13 Adjuvant management of HER2-positive disease 
The increased knowledge about tyrosine-kinase family receptors combined with the 
growth in the number of bio-molecular markers has led to the development of the first 
targeted therapies such as trastuzumab (Herceptin). Herceptin is a monoclonal antibody 
which can localise to a single site on or in a breast cancer cell, blocking the effects of 
HER2 – a growth factor for breast cancer. Treatment with Herceptin improves disease-
free survival rates and overall survival for patients who are HER2 positive with early 
stage breast cancer, independent of age, oestrogen or progesterone receptor status or 
node metastases. Although Herceptin is generally well tolerated it can be cardiotoxic, 





2.14 Side effects and long-term consequences of breast cancer 
treatment 
In the process of destroying cancerous cells, breast cancer treatments can cause 
considerable physiological changes, damage and death to normal tissues, organs and 
body functions, causing many unwanted side effects and psychological distress. This can 
result in declines in performance and functional status during and after adjuvant therapy 
(Furmaniak et al., 2016; McNeely et al., 2006). In addition, many of these adverse side-
effects can often be prolonged because of the disease and treatments and can hinder a 
patient’s return to normal life (Fong et al., 2012). 
 
2.14.1 Fatigue 
The most common problem reported by cancer survivors is cancer-related fatigue (CRF) 
(Dimeo, Thomas, Raabe-Menssen, Propper, & Mathias, 2004; Dodd et al., 2010; 
Schwartz, Mori, Gao, Nail, & King, 2001; Velthuis, Agasi-Idenburg, Aufdemkampe, & 
Wittink, 2010). CRF is differentiated from fatigue or tiredness reported by healthy 
individuals by its severity, impact on quality of life and the fact that it is not relieved by 
rest or sleep (Curt et al., 2000; Escalante, 2003). Reported prevalence levels of fatigue 
are as high as 60-100%; although the actual prevalence of CRF varies across studies, a 
consensus exists that it is high both during and after treatment and survivors report 




2.14.2 Pain and upper-limb morbidity 
Cancer-related pain is one of the most prevalent symptoms reported by cancer survivors 
attributed to their cancer or its treatment. The aetiology of cancer-related pain can be 
attributed to a variety of reasons, such as surgery (e.g. damage to nerves and tissues 
from removal of the tumour, scarring), radiotherapy (e.g. radiation sunburn reaction), 
chemotherapy (e.g. peripheral neuropathy, damage to nerves from chemotherapeutic 
agents) (Keating, Nørredam, Landrum, Huskamp, & Meara, 2005; McNeely et al., 2006). 
Further surgery side-effects may also include shoulder stiffness and a reduced range of 
movement (ROM) around the shoulder girdle, a weakness of the shoulder muscles and 
lymphoedema and can impact on everyday functioning and health-related quality of life 
(Ahmed, Thomas, Yee, & Schmitz, 2006).  
 
2.14.3 Obesity and body composition changes  
Weight gain commonly occurs after the diagnosis of breast cancer (Harvie, Campbell, 
Baildam, & Howell, 2004). Although adjuvant chemotherapy has improved survival, 
weight gain and unfavourable changes to body composition, with increased fat mass 
and decreased fat-free mass, are frequently reported following this treatment, even 
when overall weight gain or an increase in body mass is negligible (W. Demark-
Wahnefried et al., 2008). Obesity is a well-established risk factor for a number of 
cancers, including breast (post-menopausal), colon, kidney, oesophagus and 
endometrium. Demark-Wahnefried et al. (2012) suggest that 71% of cancer survivors 
are overweight or obese so it appears to be extremely important for weight 
management interventions to be developed to respond to this. 
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2.14.4 Cardiovascular changes 
Treatment-related effects can damage all parts of the heart including the muscle, 
electrical conduction systems and valves. Several chemotherapeutic agents and 
targeted therapies, including anthracyclines, taxanes and trastuzumab, can cause 
cardio-toxicities and damage heart muscle, leading to congestive heart failure, 
arrhythmias, significant electrocardiogram (ECG) changes, cardiomyopathy and death. 
(Floyd et al., 2005; Hequet et al., 2004). These potential side-effects can occur during 
treatment, within one year or many years after treatment has ceased (Piccart-Gebhart 
et al., 2005). Symptoms appear to be reversed following cessation of the treatment 
(Suter et al., 2004). Radiation to the chest wall can cause cardiotoxicity with increased 
inflammation in the heart and chest cavity. This can lead to fibrosis and scarring to the 
heart muscle, resulting in cardiomyopathy, which can cause severe breathlessness. Late 
cardiomyopathy can present years after treatment (Floyd et al., 2005). 
 
2.14.5 Bone loss 
Breast cancer survivors are at increased risk of bone loss, bone fractures, osteopenia or 
osteoporosis as a consequence of adjuvant hormone therapy and chemotherapy. Pre-
menopausal women may experience chemotherapy-induced amenorrhea or ovarian 
suppression treatment with previous studies demonstrating a 4%-8% lumbar spine bone 
loss within the first year after menopause (Shapiro & Recht, 2001). In postmenopausal 
women, aromatase inhibitors accelerate bone loss and increase the risk of fracture, 
especially during treatment and within the first few years post adjuvant therapy (Lester 




It is suggested by Petrek, Senie, Peters, and Rosen (2001) that 49% of breast cancer 
survivors self-report symptoms of lymphoedema with or without clinical diagnosis. 
Breast cancer-related lymphoedema is a chronic and progressive swelling of the arms, 
shoulder, neck or torso as a result of a physical disturbance, damage or removal of the 
axillary lymphatic vessels from surgery or radiotherapy (Ahmed et al., 2006). Damage 
cause by cancer treatment interrupts lymph transport in such a way that volume 
exceeds drainage capabilities leading to an accumulation of tissue fluid including 
protein, oedema and inflammation within the arm (Ahmed et al., 2006; Schmitz et al., 
2009). Physiological changes that may result from lymphoedema are a decreased range 
of movement and function, decreased muscle strength, a reduction in activities of daily 
living, discomfort and pain, sleep disturbances and an increased risk of infection and 
cellulitis (Mortimer, 1998). Significant psychosocial morbidities have also been reported 
such as depression and anxiety and a reduced quality of life (Velanovich & Szymanski, 
1999). 
 
2.14.7 Psychological distress and reduced quality of life 
Breast cancer treatment and the combined effects of surgery and adjuvant therapies 
can cause considerable changes in a woman’s physical and psychological well-being. 
These can cause suffering and distress, all of which can have an influence on how women 
cope with a diagnosis of breast cancer and on their quality of life (QoL) many years after 
treatment (Hormes et al., 2010; Kirshbaum, 2007; Mustian et al., 2007; Mutrie et al., 
2007; Schwartz et al., 2001). However, often psychological distress and physical 
symptoms may continue (e.g. joint and muscle pain, fear of recurrence, uncertainty) 
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beyond the end of treatment and during the transition to survivorship. Therefore, 
ensuring the quality of that survival becomes a crucial priority (Mishra et al., 2012). 
Research on the quality of life of cancer patients has increased steadily over the last 15 
years, consistent with the recognition that endpoints in addition to survival and disease-
free survival are important when considering cancer treatments (Hormes et al., 2010; 
Kirshbaum, 2007; Mishra et al., 2012). It is no longer just “how long” patients are 
surviving but research on quality of life addresses the “how well” patients are surviving 
(Jacobsen & Jim, 2011). Exercise has been identified as an intervention that can support 
and alleviate the stressors of a cancer diagnosis and subsequent treatments during and 
after therapy (Knobf, Musanti, & Dorward, 2007). 
 
2.14.8 Endocrine side-effects 
Hormone therapy is the mainstay in the long-term management of oestrogen and 
progesterone receptor positive breast cancer. Tamoxifen has historically been the 
hormone treatment of choice with reports of a decrease in incidence of recurrence and 
death from the diseas by 47% and 26%, respectively (EBCTCG, 1998). Tamoxifen (TAM) 
and aromatase inhibitors (AIs) are the most widely used, although AIs appear to be 
better tolerated than tamoxifen, they both have different negative consequences that 
have often not been well publicised in practice (Garreau et al., 2006). The most 
frequently reported negative consequences of hormone therapy use were hot flushes, 
weight gain, insomnia and joint aches, musculoskeletal disorders, mood changes, 
vaginal dryness and fractures (Baum et al., 2002; Goss et al., 2003; Coombes et al., 2004). 
These negative consequences of these treatments effects goes further with compliance 
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Owing to the ageing of the population, the high incidence of breast cancer and 
continually-improving survival rates, there is an increasing number of older breast 
cancer survivors in middle and higher income countries. Optimising the physical 
functioning of this population is an important public health imperative (Cadmus et al., 
2009). Cancer survivors who have successfully completed their treatment now routinely 
expect to continue with work and normal life at similar levels to those preceding their 
diagnosis of cancer. However, it has become clear that whilst cancer treatment can 
prolong survival, it can be very intensive leading to a number of negative and unwanted 
physiological and psychological treatment side-effects that can hinder return to normal 
life (Fong et al., 2012). Although physical activity is often considered fundamental in the 
rehabilitation from many long term conditions to offset declines in physical and mental 
functioning brought on by ageing and disease progression (Courneya et al., 2004), very 
little research has targeted this older population and there is a need to explore the 
efficacy of interventions that can promote a return to normal life and counter the side-
effects of treatment.  
The next chapter will explore how exercise is now more frequently being recognised as 
a way to try and reduce the often debilitating consequences of breast cancer treatment 
(Spence et al., 2010). With breast cancer survivors at greater risk of long-term conditions 
compared to those without cancer it is very important that breast cancer survivors 
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become physically active (Demark-Wahnefried et al., 2006). The evidence for the 
benefits of exercise for breast cancer survivors has been increasing over the last two 
decades and will be explored in more detail in the next chapter.  
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Chapter 3: The role of exercise in reducing breast cancer-related 
morbidity and mortality 
 
3.1 Introduction  
Chapter 2 presented the journey that a breast cancer patient would follow, finishing 
with the most common treatments and the common side-effects, highlighting both the 
acute and long-term problems that patients may experience during and after treatment. 
This chapter will consider the role of exercise as rehabilitation during and after breast 
cancer treatment, as a way of trying to reduce these often debilitating consequences of 
treatment and improve participation in work and social activities (Spence et al., 2010).  
 
3.2 Exercise guidelines for cancer patients 
To date, no formal exercise guidelines specific to cancer survivors have been published 
in the UK (Campbell, Stevinson, & Crank, 2012). However, exercise guidelines for cancer 
survivors have been published by the American College of Sports Medicine (Schmitz et 
al., 2010). These guidelines suggest that cancer survivors should follow the 2008 Physical 
Activity Guidelines for Americans (US Department of Health & Services, 2008), but that 
specific exercise programmes may have to be adapted based on an individual’s health 
status, disease trajectory and treatment-related adverse effects (ACSM, 2013). The US 
Department of Health and Services (2008) guidelines for aerobic activity are a weekly 
accumulation of 150 minutes of moderate intensity activity or 75 minutes of vigorous 
activity. Resistance training recommendations are to take part in two to three sessions 
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per week to include exercises for major muscles, with stretching of the major muscle 
groups on days that exercise is performed (Haskell et al., 2007; Nelson et al., 2007; US 
Department of Health & Services, 2008). In the UK, the British Association of Sport and 
Exercise Science (BASES) published an expert statement on exercise and cancer 
survivorship (Campbell et al., 2012). They suggest that health-related physical activity 
guidelines for the general population are appropriate for most cancer survivors and that 
those with cancer-related complications or co-morbidities that prevent moderate 
intensity exercise should be encouraged to avoid being sedentary. 
A number of RCTs of exercise during and after treatment for breast cancer have reported 
on any adverse events experienced by participants when exercising, such as injuries or 
lymphoedema (McGuire, & Kearney, 2005; Courneya et al., 2007; Mutrie et al., 2007; 
Schwartz, Winters-Stone, & Gallucci, 2007; Campbell, Mutrie, White, Demark-
Wahnefried et al., 2008; Cadmus et al., 2009, and all have concluded that exercise was 
safe.  
  
3.3 Physiological benefits of exercise for breast cancer patients  
When assessing physiological changes during and after treatment for breast cancer, 
physical functioning was found to have been significantly improved (cardiovascular 
fitness and muscular endurance). Interventions ranged from walking only, home-based 
exercise programmes, to supervised and structured training programmes in fitness 
facilities (Courneya et al., 2003; Campbell et al., 2005; Courneya et al., 2007; Nikander 
et al., 2007; Schwartz et al., 2007; Adamsen et al., 2009; Schmitz, 2010; Speck, Courneya, 
Mâsse, Duval, & Schmitz, 2010). Resistance training has also demonstrated benefits of 
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increased strength (upper and lower body), improved bone health and the maintenance 
of lean muscle (Speck et al., 2010; Winters-Stone et al., 2011, 2012). Myths connecting 
lymphoedema risk with exercise continue to be a barrier to physical activity (Speck et 
al., 2010). However, Cheema et al. (2008) reviewed the evidence of resistance training 
in breast cancer by evaluating 10 trials; four uncontrolled trials, one controlled trial and 
five RCTs. The authors concluded that no exacerbation of lymphoedema was reported 
in any of the trials with exercise. Sprod et al. (2010) compared physiological and 
psychological outcomes in breast cancer patients following 3 months and 6 months of 
exercise compared to a control group that did not exercise. They found significant 
differences (p<0.05) in cardiovascular endurance, fatigue and depression in those 
participants in the exercise groups. Additional benefits in pulmonary function and 
muscular endurance (p<0.05) was found in the 6-month exercise group only. This is very 
similar to Schneider et al.’s (2007) results from a 6-month exercise intervention. The 
exercise group attended exercise sessions 2-3 times week for the duration of the study. 
Limitations to this study appear to be the lack of randomisation so those exercising may 
have been more motivated to begin and continue with the exercise. In addition, as with 
many exercise studies, the study was not placebo-controlled or blinded, thus participant 
expectancy and researcher bias may have contributed to the improvements described. 
Despite the limitations to the study, it demonstrated that motivated BCS can gain a 
number of physiological and psychological benefits in the short term, with additional 
benefits gained by continuing to exercise for a longer period of time. 
A multi-centred RCT assessing the effects of aerobic and resistance exercise on 242 
breast cancer patients during chemotherapy (Courneya et al., 2007) concluded that 
neither aerobic or resistance training significantly improved quality of life but did 
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improve self-esteem, physical fitness, body composition and chemotherapy completion 
rates. The median length of the exercise intervention was 17 weeks. Training sessions 
were three times per week increasing in duration and intensity as the programme 
progressed. The intensity of the aerobic training increased at week six and week 12 with 
duration of sessions increasing by five minutes every three week. Resistance training 
was increased by 10% when participants completed more than 12 repetitions of an 
exercise. The effects of the exercise interventions may have been slightly diluted by 
inadequate adherence or insufficient volume and/or intensity of the exercise. However, 
whether positive changes to these parameters would have yielded further significant 
results remains unclear. Although aerobic and resistance exercise training did not 
significantly improve QoL, fatigue or depression and anxiety, trends did favour the 
exercise groups. Aerobic training preserved aerobic fitness, an important factor, when 
chemotherapy can cause anaemia, tachycardia, dehydration and cardiac dysfunction, 
which can lead to a downward trajectory of aerobic fitness (Jenson et al., 2002). 
Resistance training significantly improved muscular strength and lean body mass, all 
important for health. 
Campbell et al. (2005) in a pilot study of supervised group exercise during adjuvant 
treatment reported significantly higher levels of physical functioning and reported 
higher QoL scores than controls. Changes in reported levels of fatigue and satisfaction 
with life were positive in the exercise group but did not reach significance. In a follow-
up RCT study (Mutrie et al., 2007) 177 women completed the 12-week group exercise 
programme and responded to a follow up questionnaire 6 months later. They reported 
significant effects on distance walked in 12 minutes, amount of weekly moderate 
activity, shoulder mobility and positive mood after the 12-week intervention when 
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compared with the control group. The benefits to quality of life using a validated breast 
cancer specific QoL questionnaire (FACT-B) from the intervention only emerged at the 6 
month follow up, when most women were post treatment. 
Markes et al. (2009) led a Cochrane review of exercise for women receiving adjuvant 
therapy. Nine trials involving 452 women met the inclusion criteria. Their subsequent 
meta-analysis of these trials suggested that exercise improves cardiorespiratory fitness 
(207 participants) but they did not find any significant improvements for fatigue (317 
participants) or weight gain (147 participants) when the exercise intervention groups 
were compared to control groups. They concluded that exercise during adjuvant 
treatment is beneficial for improving physical fitness and thus the capacity to perform 
activities of daily living, which could be impaired with de-conditioning due to sedentary 
behaviour during treatment. 
Ahmed et al. (2006) examined the effects of supervised upper and lower body weight 
training on the incidence and symptoms of lymphoedema in 45 breast cancer patients 
taking part twice weekly over 6 months. All participants were between 4-36 months post 
treatment and had axillary dissection as part of their treatment. They found that none 
of the participants experienced any significant changes in arm circumference > 2.0cm 
after the 6-month intervention and self-reported incidence of a clinical diagnosis of 
lymphoedema or symptom changes over 6 months did not vary by intervention. They 
suggest that additional research to determine whether exercise leads to physiological 
structural and functional change of the lymphatic system of the affected arm and also 
the timing of exposure to risk and the incidence of lymphoedema should be conducted.  
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Kilbreath et al. (2012) examined the effects of progressive upper limb resistance training 
and stretching exercises on reducing upper limb impairments in women treated for early 
stage breast cancer. Participants were randomised to an 8-week programme of exercise 
or to a control group and followed up at 6 months. They concluded that changes in 
symptoms from baseline were not significantly different between the groups 
immediately following the intervention or at 6-months post intervention; however, the 
change in range of movement for flexion (p=0.01) and abduction (p=0.05) and shoulder 
abductor strength (p=0.04) was significantly greater in the exercise group immediately 
after the intervention. The exercise intervention group did not report less arm 
symptoms than the control group, although both groups reported little impairment. A 
notable finding was that the resistance training programme commencing with low 
resistance but quickly progressed to what participants considered “Hard” on the Borg 
Scale did not cause or exacerbate lymphoedema. By the end of three months post-
operatively, participants were lifting up to 4kg free weight above their heads without 
developing lymphoedema. A potential limitation to the study was that the group of 
participants were younger on average than women diagnosed with breast cancer, 
although the age range for the study was 24-82 years. This appears to be a common 
limitation with exercise studies in that that those recruited have a history of exercise 
and are typically younger (Courneya et al. 2007).  
In the Physical Activity and Lymphoedema trial (PAL), an update of a resistance training 
research protocol carried with breast cancer survivors, Schmitz et al. (2009) agreed with 
Ahmed et al.’s (2006) suggestion that clinical guidelines which indicate women at risk of 
lymphoedema should protect the affected arm from overuse can in practise translate 
into avoiding the use of the affected arm. This may increase the likelihood of injury from 
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common activities of daily living and poses a severe barrier to remaining or increasing 
their physical activity levels (Ahmed et al., 2006). Schmitz et al. (2009) hypothesized that 
a slow programme of resistance training with no upper limit on weight will increase the 
capacity of the at risk arm/limb, so that activities of daily living become easier and are 
carried out at a lower percentage of maximal capacity. They continued to suggest that 
the resistance training programme was safe as no participant was referred for follow-up 
because of suspected lymphoedema and no-one left the study due to onset or flare up 
of lymphoedema. 
Schmitz et al. (2010, as part of the PAL trial, randomised 154 women whose lymph nodes 
had been removed but without signs of breast cancer-related lymphoedema  into a 
weight lifting and control group (no exercise). The weight lifting group was instructed 
for 13 weeks by a certified fitness professional in small groups of 2-6 participants and 
then continued unsupervised twice weekly to one year. This study found that BCS who 
performed slowly progressive weight lifting twice weekly for one year were actually less 
likely to experience clinically significant increases in arm swelling (p<0.003) or clinician 
defined lymphoedema (p<0.001) than women in the control group who did no exercise. 
These findings should be considered clinically significant and help to clarify clinical 
advice to BCS regarding upper body exercise and should alleviate patients’ concerns 
regarding the safety of resuming or beginning a weight training programme. This study’s 
findings concur with previous RCTs’ findings of weight lifting programmes during or post 
treatment for breast cancer (McKenzie & Kalda, 2003; Johansson et al. 2005; Ahmed et 
al. 2006; Courneya et al. 2007). This was a well-conducted, large study, delivered in the 
community setting over a long duration for an exercise intervention (1 year). The 
applicability of the findings can be useful for primary care staff involved in the 
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rehabilitation of breast cancer patients by removing concerns that resistance exercise 
will increase the risk of lymphoedema. These results combined with previous findings 
suggest that BCS can gain the many health benefits associated with weight training. 
In a study utilising both aerobic and resistance training Garner and Erck (2008) examined 
the effects of exercise and weight bearing activities on maintaining bone health.  
Maintenance or improvement in bone mineral density (BMD) in the spine and hips is 
very important for women especially postmenopausal women because a decline of one 
SD in BMD can be associated with a twofold increase in fracture risk (Waltman et al., 
2003). Garner and Erck (2008) reported a 60% improvement in hip BMD and 22% 
improvement in spine BMD after 8 weeks of aerobic and resistance training. Although 
this could be an important finding and could further strengthen the importance of 
resistance exercise and weight bearing activity to BCS to maintain bone health, this was 
a pilot study of only 11 participants who were not randomised to an intervention or 
control group but recruited by word of mouth or using flyers. This will limit the 
applicability of the study’s finding although it highlights an important area for further 
research. 
Winter-Stone et al (2013) investigated the effects of resistance training + impact training 
to improve BMD and body composition in prematurely-menopausal BCS utilising RCT 
methodology. They recruited 71 BCS (mean age 46.5 years) to either an impact+ 
resistance training group or to a flexibility only group for 12 months. They reported that 
the resistance group increased BMD at the hip (p<0.01) and slowed down BMD loss at 
the spine (p=0.03) when compared to the flexibility only group. An interesting 
observation was that women who were less than one year past the onset of menopause, 
the resistance + impact exercise did not appear to affect bone health (BMD or bone 
66 
 
turnover markers). However, the authors suggest that the phase of menopause may 
have masked the effects and benefits of the exercise. They report that it was only the 
women who were a year or more post-menopause that the resistance + impact exercise 
stopped bone loss at the spine and increased BMD at the hips. Conversely, the flexibility 
only group lost bone at both sites. A possible reason for this lack of improvement in BMD 
in the very early stages of menopause could be that during oestrogen deficiency, 
exercise may be competing with the resorptive processes resulting from low oestrogen 
and therefore at these times exercise may not be able to influence bone remodelling 
during these periods of high turnover (Dalsky, 1990; Lanyon, 1996). Dalsky further 
suggests that increases in bone resorption are at the highest in the first 12 months of 
menopause but much slower thereafter, which may then allow exercise to have a 
beneficial effect. 
Winters-Stone et al. (2011) targeted postmenopausal BCS (mean age 62 years) in an RCT 
examining whether strength training would stop bone loss and build muscle. This study 
was the first to target specifically older BCS with resistance training, as previous research 
(Ahmed et al., 2006; Schmitz et al., 2009; Twiss et al., 2009) has only included older 
women as part of a broader age range. Thus, these studies cannot evaluate the specific 
capacity of older BCS to tolerate and respond to resistance training interventions. 
Primary endpoints were BMD of the hip and spine and whole body bone-free lean and 
fat mass assessed by Dual Energy X-ray Absorptiometry (DEXA) along with biomarkers 
of bone turnover [serum osteocalcin (ng/ml) and urinary deoxypyrodiniline cross links 
(nmol/mmolCr)]. Women in the resistance and impact exercise group preserved BMD at 
the spine (p=0.001) when compared to the control stretching only group, although no 
significant effect was seen on BMD at the hips. The resistance only group reported 
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smaller increases in osteocalcin (p=0.03) and a larger decrease in deoxypryrodine 
(p=0.06) than controls, suggesting bone resorption was improved in the exercise groups 
although it did not reach a level of significance. The authors suggest that the intensity 
of the impact training and modest jump number may have not placed sufficient stress 
and stimulus on the hip to incur a positive adaptation. They further consider that the hip 
may also require a longer time period to adapt to the moderate intensity training 
programme in the study. Snow et al. (2000), utilising a similar exercise programme but 
for 9 months, reported no effects on hip BMD. In this study, participants were followed 
up longitudinally at 5 years and the women who continued to exercise preserved BMD 
compared to reported losses in the inactive women. Therefore, Winters-Stone et als’. 
(2011) study may have longer-term benefits for women adhering to exercise that may 
reduce their chance of falls and fractures as they age. 
In further analysis of this research intervention with older BCS Winters-Stone et al. 
(2012) demonstrated significantly improved leg strength (p<0.02) and bench press 
strength (p<0.02) of women randomly assigned to a 1-year resistance and impact group 
when compared to a stretching only group. Older BCS appeared to be able to tolerate a 
moderate-vigorous resistance training programme with good reported compliance rates 
(85% of participants in the resistance group) although using the study’s definition of 
compliance to the programme as the percentage of participants who completed the 
study exercises without significant modification for six months or more, 98% were 
compliant. No injuries or adverse events were reported. This additional analysis 
demonstrates the benefits BCS can gain from resistance training on lower and upper 
body strength which may help reduce their fall and fracture rate in older age. 
68 
 
3.4 The benefits of exercise on body composition in breast 
cancer patients  
 
Weight gain and changes in body composition are common problems amongst women 
during adjuvant treatment for breast cancer. These are well-established side-effects 
which are also associated with reduced survival, decreased QoL and increased risk of co-
morbidities, such as cardiovascular disease and diabetes and could exacerbate the risk 
of functional decline and may even contribute to cancer recurrence and cancer-related 
death (Harvie, Campbell, Baildam, & Howell, 2004; Jones & Demark-Wahnefried, 2006; 
Ingram & Visovsky, 2007). Harvie et al. (2004) reported significant weight gains of 5.0kg 
+/-3.8; p<0/01) and body fat (7.1kg +/-4.5; p<0.01) over a year following chemotherapy 
treatment and there was also a decline in fat free mass of 1.7 +/-2.5kg; however, they 
found no significant changes in dietary habits or physical activity. According to Demark-
Wahnefried et al. (2008) two thirds of studies that have assessed body composition 
change in cancer patients have observed no improvements in muscle mass but reported 
losses in muscle mass as body weight and adipose tissue increase. They term this pattern 
of loss of muscle mass and an increase in fat mass and body weight as sarcopenic 
obesity. They noted it to be a common side effect of chemotherapy and hormonal 
therapy and suggest that these recognised common changes in body composition call 
for interventions that promote exercise, especially resistance training. Demark-
Wahnefried et al. (2005) suggest that 71% of cancer survivors are overweight or obese; 
therefore, it appears to be extremely important for weight management interventions 
to be developed to respond to this. 
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A systematic review conducted by Ingram et al. (2006) concluded that despite the 
recognition of adverse body weight and body composition changes during and post 
breast cancer treatment, very few studies had focused on these measurements as their 
primary outcomes. A number of limitations to the studies that have included 
bodyweight or body composition (pre-2006) could be noted. The length of interventions 
ranged from 6-26 weeks, with only three studies exceeding 12 weeks in duration. 
Significant changes to bodyweight and composition take time, something that these 
shorter duration studies did not allow for. Exercise interventions were different. A 
number of studies examined aerobic exercise only; however, the type of aerobic 
exercise was often different (cycling, walking or stepping). A number of studies 
examined both aerobic and resistance exercise, some were supervised exercise classes 
(often in a fitness facility) and some were unsupervised (home-based). The frequency of 
exercise sessions did appear to closely follow the American College of Sports Medicine 
guidelines specifying three to five times per week; however, the duration of exercise 
was often different or the time not reported. Intensity of exercise sessions ranged from 
40-75% of maximum heart rate, low to moderate or did not include information about 
exercise intensity. No studies were adequately powered to examine bodyweight and 
composition and none of the studies specifically tried to recruit overweight or obese BCS 
or used highly validated and reliable instruments for the estimation of body 
composition. Studies did not control for dietary intake, which had the potential to be 
altered during the course of adjuvant treatment of an exercise intervention. Low sample 
sizes were also noted in the studies; however, high retention rates could be reflective of 
highly motivated participants as the majority had to attend exercise facilities a number 
of times each week. 
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Courneya et al. (2007) in a large RCT of breast cancer patients receiving chemotherapy 
(n=242) assessed the independent effects of both aerobic and resistance exercise on 
body composition. The groups were balanced at baseline and the median length of the 
exercise intervention was 17 weeks (95% CI, 9-24 weeks) and the mean length of 
treatment was 17 +/- 4 weeks. They found that neither exercise intervention prevented 
weight gain, but each altered body composition. Aerobic exercise prevented fat gain 
whilst resistance training added lean body mass. What was interesting was that 
improvements in body composition resulted in reported improvements in QoL, self-
esteem and depression, suggesting that not only will these changes in body composition 
have physiological benefits, but they may have additional psychosocial social benefits as 
well. These findings concurred with Schmitz et al. (2005) who noted significant effects 
of weight training on lean mass and body fat % but not for body weight, BMI, body fat 
or waist circumference in her study of the effects of twice weekly weight training on 
bodyweight and composition in BCS who were randomised into an immediate and 
delayed treatment groups. The immediate treatment group trained for one year whilst 
the delayed treatment group did not start training until the seventh month of the 
intervention. Although the changes in body composition were significant between the 
groups, they may not be considered clinically significant in the short term. It could be 
suggested that if the BCS continue to weight train over the long term the body 
composition changes between these exercisers and sedentary BCS may become 
clinically important by preventing an increase in body fat that often occurs over time 
during advancing age. However, currently there is no research that has longitudinal data 
examining these outcomes.  
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A Cochrane review conducted by Markes et al. (2009) did not find statistically significant 
results after a meta-analysis of weight change in BCS participating in exercise when 
compared to non-exercisers. However, this meta-analysis was conducted only on a small 
number of studies (n=5) and a limited number of participants. A number of different 
approaches were used for assessing body weight and composition (body weight, BMI, 
skinfolds and lean muscle mass). Also, there was a considerable degree of clinical 
heterogeneity between trials regarding adjuvant cancer treatment and exercise 
interventions. With such potential limitations these results should be interpreted 
cautiously.  
 An updated systematic review and meta-analysis by Speck et al. (2010) demonstrated 
that after pooling data from seven RCTs conducted during treatment, slight increases in 
lean body mass were noted along with significant reductions in body fat (p=0.04). This 
was considered to be a small to moderate effect size of physical activity on body weight 
during treatment. This comprehensive review of 82 studies utilised weighted mean 
effect sizes (WMES) from 66 high quality studies and applied them to evaluate 60 
outcomes. Significant small reductions in body fat were also reported after they pooled 
the data from 15 RCTs conducted after treatment (p=0.006) and demonstrated increases 
in muscle mass when five RCTs were pooled on interventions after treatment. A small 





3.5 The benefits of exercise on Health Related Quality of Life 
(HRQoL) in cancer patients 
 
In a comprehensive Cochrane review of evidence, Mishra, Scherer, Snyder, et al. (2012) 
evaluated the effectiveness of exercise on overall health-related QoL (HRQoL) and 
specific HRQoL domains during and at the end of active cancer treatment. They included 
56 RCTs and quasi-randomised clinical controlled trials (CCTs), comparing exercise 
interventions with usual care or other types of non-exercise comparison interventions. 
A total of 4826 participants were analysed (2286 = exercise intervention and 1985 = 
control/comparison group). Thirty-six trials were conducted with participants during 
active treatment and 10 trials were during and post active treatment. The results from 
the pooling of study data suggested that exercise interventions had a more positive 
effect on HRQoL and certain HRQoL domains. The modes of exercise interventions and 
physical activities were heterogeneous across the different trials and included walking, 
cycling, resistance training and yoga or Qigong (slow flowing movements, breathing and 
meditation). The methods used to assess HRQoL were also wide-ranging. Exercise 
interventions demonstrated a positive impact on overall HRQoL when compared to 
control interventions. These improvements included HRQoL from baseline to 12-weeks 
follow-up (SMD 0.33, 95% CI 0.12 to 0.55) in physical functioning from baseline to 12-
weeks follow-up (SMD 0.69, 95% CI 0.16-1.22), role functioning from baseline to 12-
weeks follow-up (SMD 0.48. 95% CI 0.07-0.90), social functioning at 12-weeks follow-up 
(SMD 0.54, 95% CI 0.03-0.44). Exercise interventions also demonstrated a decrease in 
fatigue from baseline to 12-week follow-up (SMD –0.38, 95% CI -0.57to -0.18). They also 
found consistency between the differences in follow up scores and change scores, 
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further suggesting the robustness of these results. They also found that when examining 
exercise effects by subgroups, exercise interventions had significantly greater 
reductions in anxiety when examining breast cancer participants alone. However, they 
did report greater reductions in depression, fatigue, sleep disturbances and 
improvements in HRQoL, emotional wellbeing, physical functioning and role functioning 
for cancers other than breast cancer but not for breast cancer. When examining the 
intensity of the exercise interventions they reported that a more positive effect on 
HRQoL and in physical functioning, fatigue, anxiety and better sleep was evident for 
participants who followed a moderate or vigorous exercise programme compared to a 
mild exercise programme. However, they reviewed all trials at high risk of performance 
bias and the majority of trials at high risk of detection, attrition and selection bias; thus, 
the results of the review should be interpreted with a degree of caution. 
In a further Cochrane review examining exercise interventions among adults after 
completing active cancer treatment, Mishra, Scherer, Geigle, et al. (2012) included all 
RCTs and CCTs comparing exercise interventions with usual care. They included 40 trials 
and 3694 participants in their subsequent analysis with 1927 randomised to an exercise 
group and 1764 in a comparison group of usual care or no-exercise. The modes of 
exercise interventions included walking, resistance training, cycling, yoga or tai-chi. They 
found similar results to their other review; exercising post cancer treatment had a 
positive impact on HRQoL and certain HRQoL domains. Exercise resulted in 
improvements in global HRQoL (SMD 0.48, 95% CI 0.16-0.81) body image / self-esteem 
(MD 4.50, 95% CI 3.40-5.60) emotional well-being (SMD 0.33, 95% CI 0.05 to 0.61) and 
social functioning (SMD 0.45, 95% CI 0.02-0.87) Not only did exercise result in the above 
described improvements but the exercise interventions also demonstrated decreased 
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anxiety (SMD -0.26, 95% CI -0.07 to -0.44), a reduction in fatigue at 12-weeks (SMD -
0.82, 95% CI -1.50 to -0.14) and between 12 weeks and six months follow up (SMD -0.42, 
95% CI -0.02 to -0.83) when compared to the usual care / no exercise group. The review 
also noted positive trends in favour of the exercise interventions groups for depression 
and body image, although they did not have many other studies to compare these 
findings against, therefore, a degree of caution should be used. The limitations to these 
Cochrane reviews appear to be a common problem in exercise and breast cancer 
research. Many studies are heterogeneous, using a wide range and variety of 
assessment tools and modes of exercise and intensity of exercise, which makes it 
difficult to ascertain what types of exercise or specific duration or intensity of exercise 
is most beneficial or effective in improving these HRQoL domains. The authors also 
urged caution when interpreting the results due to risk of bias – detection, attrition and 
selection bias. 
 
3.6 Exercise and cancer-related fatigue  
The most common problem reported by cancer survivors is cancer-related fatigue (CRF) 
(Schwartz et al., 2000; Dimeo et al., 2004; Dodd et al., 2010; Veltuis et al., 2010). The 
National Comprehensive Cancer Network defines CRF as a distressing, persistent, 
subjective sense of physical, emotional and/or cognitive tiredness or exhaustion related 
to cancer or cancer-related treatment that is not proportional to recent activity and 
interferes with usual functioning (NCCN, 2009). High levels of fatigue during or after 
cancer treatment are reported by 60-96% of patients (Lucia et al., 2003). According to 
Velthuis, Agasi-Idenburg, Aufdemkampe, and Wittink (2010) the rationale for exercise 
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interventions supporting CRF is based on the theory that the combined effect of the 
cancer, subsequent adjuvant treatment and a decreased level of activity during 
treatment cause a reduction in physical capacity. Thus, with this reduced physical 
capacity the workload of normal daily activities demands a higher percentage of physical 
capacity, resulting in premature fatigue. Maintaining physical activity of sufficient 
duration, intensity and frequency throughout treatment and survivorship improves 
physical capacity through increasing cardiac output, increasing capillarisation, an 
increased number of mitochondria and mitochondrial activity in the periphery. These 
beneficial factors may lead to a reduction or even a prevention of CRF (McNeely et al., 
2006; Cramp & Daniel, 2008).  
Cramp and Byron-Daniel (2012) reviewed 56 RCTs and identified the most appropriate 
amount of exercise for reducing CRF. This review included not only breast cancer but 
also studies examining the effects of exercise and CRF with other cancer survivors. They 
included studies that compared exercise with no exercise (a usual care group) or an 
alternative treatment or exercise regime for fatigue associated with cancer. All types of 
physical activity were included; however, studies that investigated multi-dimensional 
programmes in which the effects of exercise alone could not be determined were 
excluded. Half of the studies (28) investigated breast cancer only (n = 1671 participants). 
In total, eighteen interventions provided data for 672 participants in an exercise group 
and 511 in a control arm were compared. They concluded that aerobic exercise was 
statistically more effective than the control group for improving CRF (SMD -0.35, 95% CI 
-0.51 to -0.19) with a moderate level of statistical heterogeneity detected (p = 0.06; I2 = 
36%). To find out the most beneficial type of exercise to reduce CRF, Cramp and Byron-
Daniel (2012) assessed 22 studies providing data on 832 participants following an 
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aerobic only intervention and 701 in the control arm. At the end of these programmes, 
aerobic exercise was statistically more effective that the control arm (SMD -0.22, 95% CI 
-0.34 to -0.10). When they applied the same analysis to five studies that used resistance 
training as an intervention to improve CRF, they found that after analysing 237 
participants in the resistance groups and 164 in the control arms resistance exercise was 
not statistically more effective than the control intervention (SMD -0.18, 95% CI -0.39 to 
0.19). It appears from these comprehensive meta-analyses that exercise is a beneficial 
and useful treatment for improving and reducing CRF and aerobic exercise such as 
walking and cycling is recommended. 
 
3.7 The role of physical activity in reducing breast cancer risk 
The role that exercise and physical activity can play in reducing the risk of breast cancer 
and reducing the risk of breast cancer recurrence and mortality is well established and 
becoming increasingly convincing with over 100 studies worldwide having examined and 
investigated some aspect of a cancer and PA association (Friedenreich & Cust, 2008; Li, 
Wei, Shi, Pang, Qin et al., 2016). Freidenreich & Cust, (2008) reviewed the evidence from 
34 case-control and 28 cohort studies examining the impact of different parameters of 
activity and its effect on the association between PA and breast cancer risk. They found 
an approximately 25% decrease in the risk of breast cancer between the most physically 
active women when compared to the least physically active in over 70% of studies and 
a dose-response relationship in nearly half of the studies. They also reported that all 
modes of exercise and physical activity were associated with a decreased risk of breast 
cancer but those women who reported actual recreation activity as opposed to 
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occupational or household activities had a stronger association with a reduced risk. 
Ballard-Barbash et al. (2012) within their systematic review of physical activity, 
biomarkers and disease outcomes in cancer survivors,  examined 17 observational 
studies of physical activity before and/or after diagnosis and the effects on breast 
cancer-specific and overall survival. Although, the studies demonstrated a high degree 
of heterogeneity in cohort sizes, length of follow-up, range of sub-group populations, 
and physical activity assessments and metrics, they summarised, that the strongest 
evidence of an inverse relationship between physical activity and cancer outcome was 
for BCS. Nearly all of the breast cancer studies reported an association with physical 
activity and reduction in breast cancer-specific mortality as well as all-cause mortality. 
They reported a risk reduction (RR) that was statistically significant in nearly half of the 
studies and evidence of a dose-relationship response effect of lowering mortality risk 
with increasing levels of physical activity was demonstrated in half of the studies. Zhong 
et al. (2014) carried out a meta-analysis of sixteen cohort studies involving a total of 
42,602 breast cancer patients examining the association between physical activity and 
breast cancer mortality. When examining pre-diagnosis physical activity involving 
27,805 patients, those patients who participated in moderate to high levels of PA before 
diagnosis had a RR of 0.82 (95% CI 0.74-0.91, p<0.01) for breast cancer specific mortality 
when compared to participants reporting low levels of PA. The RRs of breast cancer 
specific mortality for moderate versus low PA and high versus low PA were 0.83 (95% CI 
0.73-0.94, p<0.01) and 0.81 (95% CI 0.72-0.90, p<0.01), respectively. Regarding all-cause 
mortality from their analysis they determined that pre-diagnosis PA was also associated 
with a protective effect. Moderate to high levels of PA before diagnosis reported a RR 
of 0.79 (95% CI 0.73-0.85, p<0.01) for all-cause mortality compared to low levels of PA. 
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When they further analysed PA levels and all-cause mortality and compared moderate 
versus low PA and high versus low PA, they reported RRs of 0.80 (95% CI 0.73-0.88, 
p<0.01) and 0.76 (96% CI 0.69-0.83, p<0.01), respectively. All these studies demonstrate 
a very strong association between physical activity levels and risk of breast cancer.  
 
3.8 Physical activity to reduce risk of breast cancer recurrence 
and mortality 
Zhong et al. (2014) examined the association of post-diagnosis physical activity on 
mortality among 23,360 patients. The results suggested that patients who took part in 
moderate to high levels of PA after breast cancer diagnosis had a RR of 0.71 (95% CI 
0.58-0.87, p<0.01) for breast cancer specific mortality compared to those who reported 
low PA levels. The RRs of breast cancer-specific mortality for moderate versus low PA 
and high versus low PA were 0.81 (95% CI 0.70-0.94, p<0.01), and 0.68 (95% CI 0.57-
0.82, p<0.01), respectively. When they considered all-cause mortality, moderate to high 
levels of PA reduced all-cause mortality by 43%, RR 0.57, (95% CI 0.45-0.72. p<0.01) 
when compared to low levels of PA. When they analysed moderate versus low PA and 
high versus low PA levels, they reported that high moderate and high levels of PA 
decreased all-cause mortality by 39%, RR 0.61 (95% CI 0.46-0.81, p<0.01) and 48%, RR 
0.52 (95% CI 0.43-0.64, p<0.01), respectively.  
Li et al. (2016) not only analysed the association of physical activity on cancer mortality 
in the general population and in cancer survivors but also examined the amount of 
exercise that was required to have an effect. They found that individuals who 
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participated in the most physical activity had an HR of 0.83 (95% CI 0.79-0.87) and 0.78 
(95% CI 0.74 to 0.84) for cancer mortality in the general population and among cancer 
survivors, respectively. Their analysis found that in the general population, a minimum 
of 2.5h/week of moderate intensity activity resulted in a 13% reduction in cancer 
mortality, whereas cancer survivors who completed approximately five hours a week of 
physical activity reduced their risk of cancer mortality by 27%. They also found that 
physical activity post-diagnosis (HR 0.60, 95% CI 0.50-0.71) seemed to offer more of a 
protective effect than pre-diagnosis physical activity (HR 0.86, 95% CI 0.80-0.92), where 
the same amount of activity (5 hours/week) decreased the risk by 35% and 21%, 
respectively. They also confirmed an inverse relationship between physical activity and 
breast cancer mortality, findings which are consistent with Zhong et al. (2014) who 
revealed a similar non-linear dose-response relationship.  
 
3.9 Mechanisms underlying the relationship between physical 
activity and breast cancer 
The biological mechanisms that underlie the relationship between physical activity and 
breast cancer are not completely understood; however, a number of mechanisms have 
been postulated to explain the inverse association between PA and mortality in breast 
cancer patients (Zhong et al., 2014). Clarifying the precise biological mechanisms 
through which physical activity and exercise may exert a protective effect on the risk of 
breast cancer, recurrence and mortality is very challenging, mainly due to the difficulties 
in measuring physical activity precisely and the different modes of exercise, duration, 
intensity and the effects of the exercise on the physiological systems either before, 
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during or after treatment. A further limitation to understanding these mechanisms is 
that  there are no suitable or very specific biomarkers of exposure or a known biological 
dose of physical activity to ascertain any changes (Friedenreich & Cust, 2008).  
Despite these methodological challenges, experimental and epidemiological data have 
provided some possible hypotheses of how these biological mechanisms of physical 
activity may reduce the risk of breast cancer (Ballard-Barbash et al., 2012; Irwin et al., 
2009; Payne, Held, Thorpe, & Shaw, 2008; Zhong et al., 2014). The proposed 
mechanisms can be broadly categorised into the following physical activity effects on: 
insulin levels and insulin resistance, a reduction in the levels of circulating sex hormones 
and cumulative exposure to sex steroid hormones, changes and lowering of 
inflammation markers and immune function, hormonal and cellular metabolic processes 
and the effects on adiposity and BMI.  
Breast cancer has a complex aetiology and it is unlikely that any one mechanism is 
responsible but that any of these mechanisms could interact at differing stages of the 
cell cycle during carcinogenesis, including DNA mutations, initiation, promotion and 
progression of the disease (Rundle, 2005). Also, the potential mechanisms may often 
differ depending on the type of cancer, hormone sensitivity, the population, age and the 
mode of exercise, duration and intensity. Evidence regarding steroid hormones is 
particularly convincing (Berstein, 2009). Oestrogen and progesterone are implicated in 
breast cancer risk considering that rates increase rapidly during reproductive years but 
decline after menopause. This link has been supported in a number of studies  
demonstrating that increases in oestradiol increase mitotic activity in breast epithelial 
cells and regulation of the cell cycle progression (Friedenreich & Cust, 2008). Several 
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studies have demonstrated that physical activity is inversely associated with reduced 
circulating levels of oestrogen and progesterone (McTiernan, Wu, Chen et al., 2006).  
There appear to be two postulated mechanisms by which physical activity could reduce 
exposure to oestrogen and other circulating endogenous hormones. One is that physical 
activity can maintain energy balance and reduce adiposity, with reduced body fat likely 
to have a stronger effect on breast cancer risk in postmenopausal women rather than 
premenopausal women because of the production of oestrogen by the aromatase 
enzyme in adipose tissue, which becomes the major source of endogenous oestrogen 
(Key, Appleby, Reeves et al., 2003). The second mechanism by which regular or 
moderate (and vigorous) physical activity could reduce circulating endogenous 
hormones and cumulative exposure to these hormones is through altering menstrual 
function through delayed menache, disruption to menstrual cycles, abnormal luteal 
function, a loss in the surge of the luteinising hormone and longer menstrual cycle 
(Tworoger, Missmer, Eliassen et al., 2007; Friedenreich & Cust, 2009). Excess weight is 
also associated with early menarche and delayed menopause, so physical activity may 
also have an effect on this.  
Exercise has been demonstrated to improve insulin sensitivity, lower fasting insulin 
levels, improve insulin-like growth factor (IGF-I) and insulin-like growth factor binding 
protein 3 (IGFBP-3) synthesis, all of which have been related to breast cancer 
progression, recurrence and mortality among BCS. Insulin is thought to play a role in 
breast cancer development by indirectly increasing the bioavailability of oestrogen and 
androgen levels by downregulating sex hormone binding globulin (SHBG) and 
upregulating sex steroid production (Ligabel et al., 2008; McTiernan et al., 2008; Irwin 
et al., 2009; Boyle, Boniol, Koechlin et al., 2012). Insulin also increases the synthesis and 
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bioavailaibity of IGF-I and both insulin and IGF-I and may act directly on mitogenic and 
anti-apoptotic growth factors involved in malignant breast tissue growth (Lorincz & 
Sukumar, 2006).  
Another potential mechanism that physical activity may exert on reducing breast cancer 
risk is the reduction in inflammation and inflammatory markers. Evidence suggests that 
inflammation may up regulate aromatase which could result in a higher production of 
these circulating endogenous oestrogens (Morris, Hudis, Giri et al., 2011). Physical 
activity can have a positive effect on the balance of pro- and anti-inflammatory cytokines 
in the systematic circulation and although strenuous exercise induces increases in the 
production and concentration of pro-inflammatory cytokines, it appears the body 
produces more anti-inflammatory cytokines and cytokine inhibitors to control and 
compensate for this overexpression (Moldoveanu, Shepherd, & Shek, 2001). This 
balance of inflammatory cytokines may depend on the mode of exercise, duration and 
intensity and long-term physical activity may enhance natural immunity and a positive 




There is compelling evidence as to the range of benefits that breast cancer patients can 
experience by participating in exercise during active treatment or post-treatment. 
Research involving younger cancer survivors and older “cancer free” adults has 
demonstrated that exercise plays an important part in maintaining and improving 
general health and can help with ameliorating the effects of cancer treatment (Courneya 
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et al., 2004). However, evidence from older cancer survivors appears to be extremely 
limited with the focus of research with younger patients, despite the higher incidence 
of diagnosis and lower survival rates among older cancer survivors (Whitehead & 
Lavelle, 2009). They proposed that further research direction should provide the 
evidence to refine exercise guidelines and characterise the exercise requirements for 
this population. Unfortunately, still very little has been done focusing on this population. 
There is now a need to build the evidence base for exercise in older women with breast 
cancer. It is important to understand whether the same benefits from exercise in a 
younger breast cancer population can be obtained by older women, particularly 
considering feasibility and acceptability of an exercise intervention, along with the 
efficacy and any potential risks. The next chapter will present the results of a rapid 
evidence synthesis of the quantitative literature on exercise for older women with 
breast cancer. Investigation of these factors will help to further inform the design of an 
exercise intervention for older women surviving breast cancer. 
Although, there are a number of different definitions of old age, there appears to be no 
consensus for the age at which a person is classified as “old”. Without an agreed and 
acceptable definition for old age, the age at which a person becomes eligible for a 
statutory retirement pension often has become the default definition. Thus, the ages of 
60 and 65 years for women and men respectively are often used, despite their arbitrary 
nature (Roebuck, 1979; Thane, 1978, 1989). For the purpose of the rapid evidence 




Chapter 4: Exercise for older breast cancer survivors: a rapid 
evidence review of the quantitative literature 
 
4.1 Introduction 
The aim of this chapter is to comprehensively review and critically examine the literature 
on exercise interventions for older breast cancer survivors, following the Medical 
Research Council Framework guidelines. Craig et al. (2013) as part of the process for 
developing a complex intervention, (Craig et al., 2008). The previous chapters have 
examined in detail the background evidence relating to breast cancer treatments and 
common side effects. The role of exercise and physical activity as a benefit both during 
and after treatment to support with reducing or ameliorating the consequences of 
treatment has also been examined. This chapter will focus on identifying and appraising 
the most relevant literature relating to older women with breast cancer and exercise to 
gain an in-depth understanding about exercise and physical activity with this population.  
 
4.2 Why it is important to do this review 
The benefits of taking part in regular physical activity and exercise in older adults have 
been extensively researched and studied (M. E. Nelson et al., 2007). In ageing 
populations, regular physical activity has been demonstrated to reduce the risk of 
cardiovascular disease, stroke, high blood pressure, high cholesterol, osteoporosis, Type 
II diabetes, colon and breast cancer and all-cause mortality and improve metal health 
conditions of anxiety and depression (Haskell et al., 2007; Lim & Taylor, 2005). An 
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important benefit of exercise particularly for older adults is the substantial evidence that 
physical activity can prevent falls and fall-related injuries (pooled rate ratio 0.84, 95% CI 
0.77-0.91) (Sherrington, Tiedemann, Fairhall, Close, & Lord, 2011).  
Older adults can substantially increase their strength with resistance training with 
reported increases ranging from less than 25% (Carmeli, Reznick, Coleman, & Carmeli, 
2000) to over 100% (Ferketich, Kirby, & Alway, 1998). Supervised aerobic exercise 
programmes of an intensity (>60% of pre-training VO2max), frequency (>3/day/week) and 
length (>16 week) can significantly increase VO2max in older adults, with the average 
improvements in VO2max reported of over 16% when compared to non-exercise controls 
and larger improvements have been demonstrated with longer interventions but not 
necessarily higher intensities (Huang, Gibson, Tran, & Osness, 2005). Significant 
improvements in VO2max have also been reported in adults >75 years but the magnitude 
of improvement is significantly less, although men and women in their 60s and early 70s 
have shown similar relative increases in VO2max after aerobic training compared to 
younger adults (Binder et al., 1999; Malbut, Dinan, & Young, 2002).  
Reductions in total body fat without dietary modification have been demonstrated with 
older adults involved in moderated-intensity aerobic training (>60% of VO2max), with 
average losses during 2-9 months ranging from 0.4 to 3.2 kg (1%-4% of total body 
weight) (Kay & Fiatarone Singh, 2006; Toth, Beckett, & Poehlman, 1999) . However, in 
contrast to the effects on body fat, aerobic training appeared to have no effect on fat 
free mass, as Tracy et al. (1999) reported in their meta-analysis of 36 studies. Only 8 
reported increases in fat-free mass and these increases were less than 1kg. Resistance 
training has also been demonstrated to improve both fat free mass and decrease body-
fat in older adults who participate in moderate or high intensity resistance training 
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(Hunter, Bryan, Wetzstein, Zuckerman, & Bamman, 2002). There is a substantial amount 
of evidence of the benefits of exercise and physical activity with older adults without 
cancer (Nelson et al., 2007; Skelton, Dinan, Campbell, & Rutherford, 2005) and exercise 
has been demonstrated to be effective in reducing cancer treatment-related side effects 
in women aged 55 years and younger (Furmaniak et al., 2016). However, to date, very 
limited research has focused on exercise to manage side effects in older women during 
or after adjuvant therapy for breast cancer.  
The risk of cancer increases significantly with increasing age and functional decline is 
much more likely with a cancer diagnosis (Demark-Wahnefried, 2003). Thus, 
maintaining and improving functional capacity in later life is crucial. Relatively little is 
known about what exercise or physical activity interventions may alleviate symptoms or 
reduce these side-effects in this older population, or to what extent older BCS may 
benefit from these interventions (Penedo, Schneiderman, Dahn, & Gonzalez, 2004). As 
the majority of exercise studies have recruited younger BCS there appear to be 
limitations to the generalisability of the current exercise and breast cancer research 
evidence to the whole breast cancer population. Although the age range of participants 
in many research studies did include some older women (>60 years), the mean age of 
the women included in a number of large exercise and breast cancer trials and reviews 
of the evidence was approximately 50 years (Courneya et al., 2007; C.-J. Kim, Kang, & 
Park, 2009; McNeely et al., 2006; Mutrie et al., 2007). What appears to be a common 
limitation with exercise studies is that those recruited have a history of exercise and are 
typically younger (Courneya et al., 2007). In addition to the normal ageing process, older 
BCS often face the demands and challenges of managing often more than one 




To identify and evaluate the international evidence on exercise or physical activity 
interventions with women ≥ 60 years old recently diagnosed with breast cancer to 
answer the following questions:  
1. Is it feasible and safe for women aged over 60 years recently diagnosed with breast 
cancer to participate in an exercise or physical activity intervention? 
2. What are the health benefits that women aged over 60 years, recently diagnosed with 




This rapid evidence review used a comprehensive and systematic approach (Higgins & 
Green, 2011) to identify and evaluate internationally published primary research 
relating exercise and physical activity interventions with older women with breast 
cancer. Rapid evidence reviews have gained popularity more recently as a way of 
providing policy makers and healthcare decision makers with information in a timely 
fashion while still following and trying to maintain the rigour of the systematic review 
process, but with some components of the process omitted or simplified (Khangura, 
Konnyu, Cushman, Grimshaw, & Moher, 2012). They provide an evaluated and critical 
appraisal of what is known about policy or practice issues, using systematic review 
methods but make concessions to the extent and depth of a full systematic review 
process by limiting certain aspects of the process (Grant & Booth, 2009). The 
Government Social Research Service lists this method of review in its Rapid evidence 
assessment Toolkit (Thomas, Newman, & Oliver, 2013) and the National Institute for 
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Health and Care Excellence (NICE) has commissioned and used a number of rapid 
reviews recently to inform care in dementia, disability and frailty in later life (Dementia, 
2015). With no exercise or physical activity policies or guidance for older adults with 
breast cancer this method of review was considered appropriate by providing 
information and evidence in a timely manner. 
 
4.3.2 Search methods for identification of studies 
Relevant studies were identified and considered for inclusion by individually searching 
the electronic databases AMED (Allied and Complimentary Medicine), CINAHL 
(Cumulative Index to Nursing and Allied Health Literature), MEDLINE (Medical Literature 
Analysis and Retrieval System Online) and EMBASE (Excerpta Medica Database) 
between the years of 2003-2018. The search term dates were set to follow on from the 
review of exercise issues with older cancer survivors by Courneya et al. (2004), thus, 
searching from 2003-2018. Limitations were added to the searches if allowed by the 
database and where possible, which were: non-English language studies were excluded, 
female only studies, human only studies, only articles published between the dates of 
2003-2018 and age groups of middle age, aged 60 - 80 years or aged >80 years to further 
focus the searches.  
Further studies were identified by reviewing reference lists of relevant published clinical 
trials, reviews and qualitative studies. Search terms included words associated with 
breast cancer, exercise, physical activity and older adults or the elderly to ensure a wide 
range of related and relevant studies were identified, which specifically targeted women 
with breast cancer who were aged over 60 years. Boolean logical operators were 
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incorporated and used for the search strategy, predominately “AND” or “OR” to search 
for alternative concepts or synonyms and to combine the different search terms used 
above. (For a list of the full search terms see Appendix 1).  
 
4.3.3. Screening and selection of studies 
All searches were conducted and screened by the researcher (KK) according to the 
selection criteria. All titles and abstracts of all articles identified by the database and 
bibliographic search were screened and those that fulfilled the inclusion and exclusion 
criteria (see Table 2) for this rapid evidence review were selected. All duplicates of the 
same records were removed. Full-text articles of potentially relevant studies were 
retrieved for a closer inspection and detailed evaluation. Multiple reports of the same 
studies were also linked together. Articles included in the final synthesis were also 
reviewed by SB (researcher supervisor) to avoid selection bias by independently 
assessing for compliance of studies meeting the eligibility criteria. 
 
4.3.4. Data extraction and synthesis 
The main characteristics and methodological details on study design and outcomes from 
the identified articles were extracted by KK and characteristics of included studies were 
summarised in Table 4 and study findings reported as narrative. Multiple publications of 
the same trial were considered together and the most relevant ones that met the aims 
of the synthesis were included. This information was organised under the headings of: 
study design, participants (including sample size, ages and date of breast cancer 
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diagnosis), intervention details (duration, type, intensity) outcome measures (time-
points and threats to validity/bias). (McNeely et al., 2006; Kirshbaum, 2007). 
4.3.5. Inclusion and exclusion criteria for considering studies for this review 







Women ≥ 60 years old with breast cancer during or after 
adjuvant treatment. 
Early stage, curative breast cancer treatment 
Intervention 
 
Randomised controlled trials (RCTs), quasi-controlled trials, 
non-randomised trials. Home-based and supervised exercise 
programmes. Mean age ≥ 60 years 
Feasibility and pilot studies 




Studies with or without a control group 




Feasibility outcomes: recruitment, acceptability, retention, 
completing and implementation fidelity 
Health, physical and psychosocial benefits of exercise 




Full text journal articles written in English published between 
2003-2018 






4.3.6 Methodological quality assessment 
The methodological quality of trials included in the review was assessed by KK using the 
following criteria (McNeely et al., 2006): 
1. Was there adequate concealment of allocation? 
2. Was the method of randomisation well described and appropriate? 
3. Was the outcome assessment described as blinded? 
4. Was the method of blinding of the assessment of outcomes well described and 
appropriate? 
5. Was there a description of withdrawals and drop-outs? 
6. Was the analysis intention to treat? 
7. Were withdrawals and drop outs less than 10%? 
8. Was adherence to the exercise intervention (attendance or completion of the exercise 
intervention) greater than 70%? 
All items were scored as positive (Y), negative (N) or unclear (?). Studies were defined 







The electronic search strategy identified a total of 1401 titles (see Figure 3). After 
applying the selection criteria to titles and abstracts and removing duplicates, two 
articles were identified from citation tracking, resulting in 27 being included for a closer 
inspection. Reasons for exclusion at this stage were predominantly not recruiting breast 
cancer patients only, or not being related to an exercise programme or physical activity 
that did not target older cancer survivors. After retrieving and reading the full papers, a 
further 16 articles were excluded. These papers were excluded because they did not 
recruit older breast cancer survivors (5), did not target only breast cancer survivors (3), 
were not a journal article (1) were not an exercise or physical activity intervention (6), 
or involved one-off exercise testing and did not involve exercise or physical activity (1). 
The search resulted in identifying 11 articles that were directly relevant to the aims of 





Figure 2: Flow diagram of study selection process (adapted from Moher et al., 2009) 
  
4.4.1. Study characteristics 
Of the 11 studies selected six were RCTs but three of these(Dobek, Winters-Stone, 
Bennett, & Nail, 2014; Winters-Stone et al., 2012b; Winters-Stone, Leo, & Schwartz, 
2012a) were further analyses of Winters-Stone et al. (2011) the other two RCTs were 
both pilot studies; (Crane-Okada, Kiger, Sugerman, et al., 2012; Payne et al., 2008), four 
were non-randomised trials; one of two parallel groups examining the effects of 
resistance training on difference ages of BCS (Benton, Schlairet, & Gibson, 2014), and 
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three were single group pre-post design (Damush, Perkins, & Miller, 2006; Nyrop et al., 
2014; Tunay, Akbayrak, & Kaya, 2012), two of which classed themselves as feasibility 
studies (Damush et al. 2006;  Nyrop et al. 2014). One study was a cross-sectional design 
(Boyle, Vallance, Ransom, & Lynch, 2016). 
All the RCTs were undertaken in North America. Two of these compared exercise groups 
against usual care (Payne et al., 2008; Crane-Okada et al., 2012) whilst one compared a 
progressive, resistance and impact training programme against a stretching only group 
(Winters-Stone et al., 2011). The only intervention study that did not come from North 
America was Tunay et al. (2012) which was from Turkey. The cross-sectional study (Boyle 
et al. 2016) originated in Australia. 
 
4.4.2. Programme length 
The length of interventions varied; one intervention was for seven days (Boyle et al., 
2016); two were of six weeks’ duration, (Tunay et al., 2012; Nyrop et al., 2014); one of 
eight weeks’ duration (Benton et al., 2014); one of 12 weeks’s duration (Crane-Okada et 
al., 2012); one of 14 weeks’ duration (Payne et al., 2008); one of six months’ duration 
(Damush et al., 2006;) and one of 12 months’ duration (Winters-Stone et al., 2011).  
 
4.4.3. Age of participants 
Age was reported as a mean or range. Mean ages ranged from 51.7 years (Benton et al., 
2014), although this was a comparison study of younger BCS to older BCS (mean = 68.3 
years) to 71 years old (Nyrop et al., 2014) with an average age of 63.4 years across eight 
intervention studies. The only study not to report mean ages was Tunay et al. (2012) 
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who reported that all participants (n=40) were over 65 years of age. The range of ages 
of the participants in the intervention studies included in this review was between 50-
90 years. 
 
4.4.4. Time since diagnosis 
Most studies reported the mean time since cancer diagnosis; ranging from 3-years 
(Damush et al., 2006; Boyle et al. 2016); five years (Winters-Stone et al., 2011); 6.3 years 
for Benton et al. (2014); with Crane-Okada et al. (2012) being on average 9.8 years since 
cancer diagnosis. Two studies did not report a mean time since diagnosis (Payne et al., 
2008; Nyrop et al., 2014) and Tunay et al. (2012) only mentioned the time since surgery 
(8-44 months) with no indication whether participants had completed adjuvant therapy 
or not.  
 
4.4.5. Exercise intervention characteristics 
The setting for the exercise interventions was varied. Four studies reported home based 
interventions (Damush et al., 2006; Payne et al., 2008; Nyrop et al., 2014; Boyle et al., 
2016;), three reported on a mixed supervised and home-based intervention (Winters-
Stone et al., 2011; Crane-Okada et al., 2012; Tunay et al., 2012). Of these interventions 
Crane-Okada et al. (2012) encouraged participants to do further exercise at home daily 
throughout the duration of the 12 week intervention, recorded in a diary. Winters-Stone 
et al. (2011) prescribed two supervised classes and one home-based class per week for 
12 months, although the home-based session did not begin until one month after the 
start of the supervised sessions to allow time for the participants to be properly 
96 
 
instructed in the exercise techniques. Tunay et al. (2012) supervised twice weekly 
physiotherapy and exercise sessions with participants instructed to do the given 
exercises daily. Benton et al. (2014) was the only study that was a supervised 
intervention and did not include any home-based exercise or additional physical activity.  
 
4.4.6. Exercise prescription 
Exercise prescription was generally described sufficiently to report the exercise 
programme (See Table 4), although there was a lack of information reported on exercise 
intensity. Exercise modes were split between aerobic and resistance training or a 
combination of both. Four interventions prescribed aerobic only exercises (Payne et al., 
2008; Crane-Okada et al., 2012; Nyrop et al., 2014; Boyle et al., 2016). Three prescribed 
resistance only exercise (Winters-Stone et al., 2011; Tunay et al., 2012; Benton et al., 
2014), with one intervention considering both aerobic and resistance exercises (Damush 
et al., 2006). Walking was the most popular choice of aerobic exercise reported by four 
interventions (Damush et al., 2006; Payne et al., 2008; Nyrop et al., 2014; Boyle et al., 
2016). All used pedometers to encourage increases in aerobic activity but participants 
were not asked to record distance walked or report their usage. Crane-Okada et al. 
(2012) used movement and dance therapy as their exercise programme. Resistance 
exercise was performed using a variety of free weights (Winters-Stone et al., 2011) and 
machine weights (Benton et al., 2014) and therabands for home-based programmes 
(Damush et al., 2006; Winters-Stone et al., 2011; Tunay et al., 2012). 
The general intensity of the exercise programmes was either not described or 
inadequately described. Three interventions did report the exercise intensity that was 
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followed. Payne et al. (2008) described their walking programme as “moderate” with 
only two interventions adequately describing the intensity of the exercise programme; 
Winters-Stone et al. (2011) used ACSM recommendations for resistance training and 
Benton et al. (2014) used a percentage of 1-repetition maximum.  
The duration of prescribed exercise sessions within the exercise studies was varied. Two 
interventions were interested in increasing PA levels and therefore did not specifically 
prescribe a set exercise programme (Damush et al., 2006; Boyle et al., 2016). Aerobic 
exercise interventions ranged from walking 20 minutes per day on four days each week 
(Payne et al., 2008) 30 minutes a day on five days a week (Nyrop et al., 2013). In Crane-
Okada et als’. (2012) study dance and mindful movement intervention was instructor-
led once per week for 12 weeks, although participants were invited to practise at home 
for a minimum of five minutes daily for the first four weeks and gradually increasing to 
15 minutes per day for the final four weeks. The resistance and impact training 
programme was described in detail by Winters-Stone et al. (2011) including frequency 
(2 x week supervised) and home-based (1 x week), intensity 60-70% of 1-repitition 
maximum (1-RM) for 1-3 sets with 8-12 repetitions with 3-4 sets for the upper body and 
3-4 sets for the lower body. Each exercise session lasted between 45-60 minutes. Benton 
et al. (2014) also described the resistance training programme that was followed in 
detail. This eight-week programme, twice a week (16 sessions in total) consisted of three 
sets of 8-12 exercises to utilise all of the major muscles of the body. Exercise intensity 
was set for each exercise and the progression of load was increased 5-10% when 




4.4.7. Quality Assessment 
The median score for methodological quality of all included trials was 2, with a range of 
0-3 (Table 4.1). Using a score or 4 or more out of 8 was to be considered of a high 
methodological quality. No studies included in this review achieved enough of these 
criteria to be considered of high methodological quality. The most common 
methodological shortcomings in the included trials were: inadequate concealment of 
allocation (all eight studies scored unclear); where withdrawals and drop-outs were less 
than 10% (6/8 studies scored “no” or ? = unclear); was the outcome assessment 
described as blind? (7/8 studies scored “no”); and was the method of blinding of the 
assessment of outcomes well described and appropriate? (all studies scored “no”). 
Table 3: Methodological quality assessment of exercise interventions with older BCS  
 
Author (year) 1 2 3 4 5 6 7 8 Total/8 
Benton et al. (2014) ? N N N ? N Y Y 2 
Boyle et al. (2016) ? N N N N N N ? 0 
Crane-Okada et al. (2012) ? Y N N Y Y N N 3 
Damush et al. (2006) ? N N N Y Y N ? 2 
Nyrop et al. (2014) ? N N N Y ? Y ? 2 
Tunay et al. (2012) ? N N N N ? ? ? 0 
Payne et al. (2008) ? Y N N Y N N ? 2 





Key: Y= Yes, N= No, ? = unclear/not reported 
1) Adequate allocation concealment, 2) adequate method of randomisation reported,  
3) blinded outcome assessments, 4) adequate method of blinding, 5) description of 
withdrawals or drop-outs, 6) intention-to-treat analysis, 7) withdrawals and drop-outs < 
10%, 8) adherence (attendance or completion of exercise sessions) >70% (taken from 
McNeely et al. (2006) 
 
4.4.8. The feasibility of exercise interventions with women over 60-years old 
4.4.8.1 Recruitment 
 
Recruitment rates differed for all studies and the reporting of the numbers of 
participants approached, those screened to be eligible to be recruited and those actually 
recruited to start the programme or intervention appeared to be very different. Benton 
et al. (2014) recruited 29 participants but gave no figures for how many participants had 
actually been approached or screened for eligibility. Of the 29 recruited, seven did not 
start the intervention due to: not returning forms (4), Medical Doctor (MD) refusal to 
allow participation, new medical condition diagnosed (1) and scheduling conflict (1). 
Boyle et al. (2016) reported a recruitment rate of 61.6% after approaching 552 eligible 
participants with 340 agreeing to take part. Crane-Okada et al. (2012) reported 
recruitment of 51.6% of the 95 eligible participants, with 49 enrolled on the programme. 
They further reported reasons for not enrolling on the interventions as: scheduling 
conflicts (25), distance to the classes (11), late enquiry (7) and having no interest (3). 
Damush et al. (2006) screened 509 older BCS with 101 being eligible for the study. Of 
these, 43 agreed to take part (42.6% recruitment rate); however, only 34 completed 
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baseline assessments (33.7%), although no reasons were given for the difference in 
numbers between agreeing to take part and actually completing the initial assessments. 
Reason were, however, reported for those not willing to take part; 24 were unreachable 
and 33 were not interested. Winters-Stone et al. (2011) assessed 359 BCS for eligibility, 
with 246 being deemed eligible and from these eligible participants, 106 of these 
recruited on to the study resulting in a 43.1% recruitment rate. Nyrop et al. (2014) had 
the highest recruitment rate of the intervention studies with 64.5% with 31 eligible 
participants and 20 starting the programme, although they did report 24 participants 
consenting to the study but gave no reasons for four not starting. Payne et al. (2008) 
recruited 20 participants from 58 eligible BCS, demonstrating the lowest (35%) 
recruitment rate of the studies in this review. Reasons given for not participating were: 
transport, time commitment to the study and the randomisation process, but no further 
details were given. 
 
4.4.8.2 Sample size 
For this review, study sample sizes were based on the numbers initially recruited for the 
study and not the final number that were used for the statistical analysis. Of the eight 
intervention studies, sample sizes ranged from 20-340 participants, although for six 
studies the average sample size was 30. In the RCTs, the number of participants 




4.4.8.3 Retention  
Home-based interventions and those attempting to increase PA reported better 
retention rates and lower attrition than supervised interventions, where participants 
were required to commit significantly more time in meeting supervised exercise 
schedules. Damush et al. (2006), Payne et al. (2008), Nyrop et al. (2014), and Boyle et al. 
(2016) reported an 88%, 90%, 95% and 80.6% retention rate, respectively, for their 
home-based interventions. Of the supervised exercise programmes, the drop-out rate 
was noticeably higher with Crane-Okada et al. (2012) reporting 21% in their 12-week 
interventions but Winters-Stone et al. (2011), a much higher drop out of 38%; however, 
this was for longer, 12-month, intervention. Benton et al. (2014) reported contrary 




Adherence rates to the supervised or home-based exercise interventions were not 
routinely reported. Those that did not report adherence rates were: Damush et al. 
(2006); Payne et al. (2008); Tunay et al. (2012); Nyrop et al. (2014) and Boyle et al. 
(2016).  Of those that reported adherence rates, Benton reported excellent adherence 
of 98% to the eight-week, twice a week, resistance training programme, whereas Crane-
Okada reported a more modest 64.1% adherence and Winter-Stone et al. (2011) 67% 
for both groups for the supervised exercise intervention and much lower for the home-




4.4.8.5. Reporting of adverse events 
Only two intervention studies reported on adverse events (Winters-Stone et al., 2011; 
Benton et al., 2014). Winters-Stone et al. (2011) reported no injuries or adverse events 
in the weight lifting and impact group (intervention) and the stretching only group 
(control) after 12 months. Also, there were no changes in upper-arm circumference 
measures over time (as an indication of the development of lymphoedema). Benton et 
al. (2014) reported no injuries or changes in arm volume and participants denied any 
exercise-related discomfort, exacerbation or new onset of lymphoedema. 
 
4.4.9 Health benefits of exercise interventions for older women with breast cancer  
4.4.9.1 Endpoints and health outcome assessments 
Two studies examined fatigue as an outcome measure (Damush et al., 2006; Payne et 
al., 2008) and one considered body composition or weight loss (Winters-Stone et al., 
2011). Two studies used PA levels as outcome measures to improve physical and mental 
health (Boyle et al., 2016) and joint pain (Nyrop et al., 2014). Three studies used PA levels 
as an endpoint, along with bone mineral density and bone turnover (Winters-Stone et 
al., 2011, Winters-Stone et al., 2012a) and one year follow up of bone mineral density 
assessments and maximal muscle strength tests (Dobek et al., 2014), functional 
measures such as sit to stand in 30 seconds and a 12 minute walk (Winters-Stone et al., 
2008), maximum bench press and leg press, timed chair stands, handgrip strength, self-
report physical function and fatigue (Winters-Stone et al., 2012b). Two studies used 
quality of life as a primary endpoint (Crane-Okada et al., 2012; Benton et al., 2014) and 
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Damush et al., (2006) included it as a secondary outcome. Further details of these 
studies can be found in Table 4. 
 
4.4.9.2 Benefits of home-based exercise interventions 
Damush et al. (2006) considered the benefits of an oncologist referring BCS to an 
exercise self-management programme to improve PA levels and HRQoL. Participants 
(n=34) received three weeks of structured educational sessions on increasing self-
efficacy and social support to increase PA. Telephone support was also offered 
throughout the programme. They found that this intervention increased weekly 
moderate PA (p<0.04), increased caloric expenditure (p<0.02) and significantly 
improved HRQoL (p<0.001). Other outcomes of exercise barriers, aerobic endurance and 
lower body strength approached significance 
Payne et al. (2008) examined the effects of a home-based walking programme on 
biomarkers, fatigue, sleep and depression in older BCS (mean 64.7 years). They reported 
improvements in sleep (less sleep disturbances) but no other noted improvements. 
Boyle et al., (2016) used accelerometers to measure PA and sedentary time levels of 
older BCS to examine the influence of these parameters on physical and mental health. 
A total of 259 BCS (mean age = 61-years, mean time since diagnosis = three years) wore 
accelerometers for seven days during waking hours. The BCS in this study were 
sedentary for 8.2 hours, engaged in light-intensity PA for 5.8-hours and in moderate to 
vigorous intensity PA for 32-minutes per day, with only 16% meeting PA guidelines.  
A home-based feasibility walking programme developed by Nyrop et al., (2014) 
investigated the effects of walking on joint pain with older BCS (mean age = 71 years). 
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The minimum goal for the participants was to walk for 30 minutes per day, five days per 
week, although, adherence to this target was not reported. Small but not significant 
improvements in joint pain, fatigue and joint stiffness were reported. 
 
4.4.9.3. Benefits of supervised exercise interventions 
Four studies targeting older cancer survivors with supervised exercise interventions 
were conducted by Winters-Stone et al. (2011); Crane-Okada et al. (2012); Tunay et al. 
(2012); and Benton et al. (2014).  
Crane-Okada et al. (2012) used dance and movement therapy to observe the effects on 
QoL with older women with breast cancer (mean 65.6 years). After 12 weeks, the 
intervention group did not significantly differ in the QoL domains of physical, 
psychological, social or spiritual well-being when compared to the control group (no 
exercise), but fear of recurrence was decreased and this appeared to be retained six 
weeks after the intervention was completed. 
In a resistance only intervention Winters-Stone et al. (2011) found that the resistance + 
impact group preserved bone mineral density (BMD) at the lumbar spine (p=0.001) 
compared to the control and increases in lean mass were greatest in women on 
aromatase inhibitors (AIs) compared to controls not on this therapy.  
Tunay et al. (2012) evaluated the effects of a physiotherapy programme including 
exercise with elderly BCS (>65 years) on shoulder function, pain and lymphoedema. 
Participants reported significant decreases in pain and increases in function, range of 
movement (ROM), muscle strength and decreases in lymphoedema volume (p<0.05).  
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Benton et al. (2014) evaluated the effect of age on quality of life in BCS after an eight 
week, twice a week resistance training programme. To examine the effects of age, they 
split the participants into two groups based on age. One group was 40-59 years and the 
second group was 60-80 years old. Both groups improved in chest press (p<0.001), leg 
press (p<0.001), arm curls (p<0.05) and chair stands (p<0.001). Overall adherence to the 
training programme was 98% for both groups, with no adverse events reported, 
demonstrating that older women with breast cancer will attend a supervised exercise 
programme with adherence rates similar to younger women, with no injuries or 
exacerbation of treatment related effects noted between the older women and the 
younger women. Although older women did have significant improvements in strength 
and function, they perceived very little improvement in QoL compared to younger 
women. Limitations to the study were the relatively small sample size (n=20) and the 




Table 4: Brief overview of studies included in the review  
Author, date, 
country 












younger BCS vs 
older BCS on 
effects of 
resistance 




N = 20 
YRT: n=12 (mean 
age = 51.7 years) 
ORT: n=8 (mean 
age = 68.3 years) 
Mean 6.3 ± 1.5 
years since 
diagnosis. 
8-week, whole body 
resistance training 
programme 
2 x week 
3 sets of 8-12 reps 
of 8 exercises 
1-2-1 training 
Body Image & 
Relationship Scale 
(BIRS) 
Arm curl test in 30 
secs 
Chair stand test in 
30 secs 
Non-randomised 98% attendance at 
resistance 
sessions. 
No injuries or 
lymphoedema 
reported 
80% YRT & 99% 
ORT (p<0.001) ↑ 
upper body 
strength 










N = 340 
Mean age = 61 
years 
Mean time since 











Sedentary 57% of 
waking hours 
Low PA 40% of 
waking hours 32 
mins per day in 
MVPA 
>70 years old 
sedentary time 2 x 
high as active time 
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N=49 (29=I, 20=c) 
Mean age 65.6 
years 
Range 50-90 yrs 
Mean 9.8 years 
since diagnosis 
Range 1-32 yrs 
RCT 







Drop out – 21% for 
intervention 
69% attendance 
for 9/12 sessions 
Mean age since 
diagnosis was 






































Mean age 59.6 
years 





3 x week for 3-
weeks educational 
sessions to support 
increasing PA. 
Telephone support 
















of exercise alone 
43% recruitment 
rate 
Freq. of weekly PA 
↑ (p<0.04), 
aerobic endurance 


































N=106 (52=I, 54=C) 
1-year post 
adjuvant therapy 
Mean age 62 years 
Postmenopausal 
Mean time since 
diagnosis 6 years 
 
RCT 
1-year (2 x 



























P=0.001 for POWIR 
group maintaining 
spine BMD and 
FLEX losing spine 
BMD from baseline 
to follow up 




p<0.05 during the 
intervention but 
decreased strength 
during the follow 
up 






Walking to ↑ PA 
levels and ↓ 
joint pain 
N=20 






30 mins / day x 




















from 21% to 50% 
at 6-weeks 
(p<0.001) 
Joint pain ↓ 10% 
Fatigue ↓ 19% 
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RCT vs usual care 




Mean age 64.7 yrs 

























Drop-out (N=2) = 
10% 
Sleep was 
improved in the 
exercise group 
p=0.007. No 
changes in quality 
of sleep for the 
control group 


















3 x 10 reps / day 










Not a randomised 
controlled trial 
Recruitment of 
40 women over 4 
years 
 
Sig. ↓ in pain and 



















N=106 (52=I, 54=C) 
1-year post 
adjuvant therapy 
RCT BMD of the hip 
and spine 
Body-composition 
Lack of a true 
control group 
Retention 62% 







Mean age 62 years 
Postmenopausal 
Mean time since 
diagnosis 5 years 
1-year (2 x 
supervised, 1 x 
home-based) 
Resistance training 







Home based 23% 












Resist + Impact 
group preserved 




↑ in lean muscle 
















N=106 (52=I, 54=C) 
1-year post 
adjuvant therapy 
Mean age 62 years 
Postmenopausal 
Mean time since 
diagnosis 5 years 
RCT 
1-year (2 x 
supervised, 1 x 
home-based) 
Resistance training 







analysis of age and 
exercise on BMD 
of the hip 















BMD ↑ at a 
younger age with 




stopping bone loss 
as age ↑. No 
change in total hip 




Abbreviations: N=Numbers involved in the study; RCT = Randomised Controlled trial; YRT= Young resistance training group; ORT= Older 
resistance training group; BCS= Breast Cancer Survivors; I=Intervention group; C=control group; POWIR= Power & resistance group; 
FLEX=flexibility group; BMD= Bone mineral density.




benefit in total hip 
BMD in POWIR 















N=106 (52=I, 54=C) 
1-year post adjuvant 
therapy 
Mean age 62 years 
Postmenopausal 
Mean time since 
diagnosis 5 years 
RCT 
1-year (2 x supervised, 
1 x home-based) 
Resistance training 






Strength & physical 
function 
1-RM bench press 
and leg press 
Timed chair stands, 
4m walk speed, 
Timed stance tests, 
handgrip, self-report 
physical function & 
fatigue 
 










Attend at supervised 
sessions 67% 
POWIR group sig. ↑ 
max leg and bench 
press strength 
(p<0.02) compared 
to FLEX group 






4.5 Discussion of findings 
The findings from the 11 articles included in this review were inconsistent due to the 
different nature of research questions, the outcomes and endpoints evaluated and the 
types of exercise programme or physical activity intervention prescribed. The 
implications of these inconsistencies are discussed in further detail below; however, 
they do all offer an insight and further understanding of delivering exercise and physical 
activity interventions with this under-researched population. 
 
4.5.1. Feasibility of an exercise intervention with older breast cancer survivors 
It appears that it is feasible to recruit older women with breast cancer onto a supervised 
or home-based exercise programme with differing success rates. From the studies 
examined the mean time since breast cancer diagnosis was 3.1-years. Therefore, it is 
still uncertain whether women newly diagnosed with breast cancer (< 1-year since 
diagnosis) could be recruited onto an exercise programme, due to a lack of evidence at 
this time. Recruitment rates for older women with breast cancer ranged between 35% 
(Payne et al., 2008) and 64.5% (Nyrop et al., 2014). Once recruited onto an exercise 
study, retention to the study was acceptable, although home-based interventions 
generally reported higher retention rates of 80-95% (Damush et al., 2006; Payne et al., 
2008; Nyrop et al., 2014; Boyle et al., 2016). Benton et al. (2014) reported an attrition 
rate of only 9% for an 8-week supervised resistance training programme; however, 
supervised programmes appeared to report higher attrition rates then home-based 
interventions (21% [Crane-Okada et al., 2012] - 38% [Winters-Stone et al., 2011]). 
Although home-based interventions reported better retention rates, supervised 
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exercise interventions actually reported better adherence rates. However, an issue with 
adherence rates to exercise interventions with older women with breast cancer is that 
they were routinely not reported, therefore, evidence is limited. Benton et al. (2014) 
reported an adherence rate of 98% for a supervised, twice a week resistance programme 
with more modest levels reported by Winters-Stone et al. (2011) of 67% and 64% 
reported by Crane-Okada et al. (2012). Adherence to home-based programmes was 
much lower at 23% for the resistance groups and 44% for the stretching only group 
(Winters-Stone et al. 2011).  
A very important part of assessing the feasibility of an exercise programme with older 
women with breast cancer is the safety of exercise for this population exercising during 
and after diagnosis and treatment. It could be suggested that it is safe and therefore 
feasible for women to take part in an exercise programme at this time, as no studies 
reported any adverse events experienced by the women during or after any exercise 
programme. However, this evidence does need to be considered cautiously, as only two 
studies reported on adverse events (Winters-Stone et al. 2011; Benton et al. 2014), with 
neither study reporting any adverse events, onset of lymphoedema or any injuries as a 
result of the exercise programme. No other studies included in this rapid evidence 
review reported on adverse events so it is unclear whether this indicates poor reporting 
by these studies or the absence of any adverse events to report.  
A home-based feasibility walking programme developed by Nyrop et al., (2014) 
investigated the effects of walking on joint pain with older BCS (mean age = 71 years). 
The minimum goal for the participants was to walk for 30 minutes per day, five days per 
week; however, adherence to this target was not reported. They also investigated the 
feasibility of recruitment with this population and attrition rates throughout the study. 
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As a feasibility study the authors do not clearly report all of the primary outcomes linked 
to the feasibility of the intervention. They recruited to target (20 participants) from a 
clinical setting but wanted to know if this was feasible in a five months’ time-frame; 
however, they do not report whether this target was met. Secondary outcomes related 
to joint pain were clearly reported and resulted in small but not significant 
improvements in joint pain fatigue and joint stiffness. 
 
4.5.2. Health benefits of exercise for older breast cancer survivors 
A number of health benefits of exercise for older breast cancer survivors have been 
reported in the literature, although with the evidence being very limited, it is difficult to 
suggest with any conclusiveness, the benefits that an older woman with breast cancer 
can expect to gain from participating in an exercise intervention during or after 
treatment for breast cancer.  
The health benefits reported were wide ranging; with reported increases in weekly 
moderate PA, increased caloric expenditure and improved HRQoL (Damush et al., 2006); 
improvements in sleep (less sleep disturbance) (Payne et al., 2008); reducing the fear of 
recurrence and improved upper body symptoms (Crane-Okada et al., 2012); 
maintenance of bone mineral density of the spine and improved lower body strength 
(Dobek et al., 2014); decreases in joint pain, fatigue and joint stiffness (Nyrop et al., 
2014); reductions in pain, improved function and range of movement and improved QoL 
(Tunay et al., 2012) and improvements in maximal bench press and leg strength 
(Winters-Stone et al. 2012b).  
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However, a number of limitations could have affected the outcomes reported: with 
Damush et al. (2006), it was a small sample size of 34 BCS and was a single group of 
consecutive patients in pre-test, post-test design. Thus, because the patients were not 
randomised, the results cannot be compared against a control group of usual care. Also, 
they reported the group were all Caucasian and of high social economic status. 
Additionally, the intervention included both exercise and social support, and it was not 
possible to determine whether the effects of the study were due to the exercise or social 
support alone. Despite these limitations, this method of referral and exercise self-
management could still be considered to increase PA levels in older BCS and the 
associated benefits they can gain from this. 
Payne et al. (2008) examined the effects of a home-based walking programme on 
biomarkers, fatigue, sleep and depression in older BCS (mean 64.7 years). This was a 
pilot RCT, with an intervention vs usual care design. They reported on improvements in 
sleep but no improvements in the quality of sleep. This was a very small sample (n=20) 
and therefore of limited power. Additionally, the authors did not record if the 
intervention group adhered to the walking programme, so therefore, it is not known 
whether the effects of the walking programme could be attributed to improving sleep. 
Boyle et al. (2016) used accelerometers to measure PA and sedentary time levels of 
older breast cancer survivors to examine the influence of these parameters on physical 
and mental health. Objective measuring of PA levels accurately allows these levels to be 
recorded without relying on the very subjective reporting of these by the use of self-
report. This was a large study recruiting 340 women with breast cancer. Although 
participants had to only wear the accelerometer on their waist band during waking 
hours for seven days, only 49.6% completed the study, which raises questions whether 
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the recruitment sample was representative of those eligible to participate. Also, the 
sedentary time was recorded whether the participant was standing or sitting whilst 
being still, which therefore may over-inflate the actual time a person was sitting 
sedentarily. 
Four studies targeting older cancer survivors with supervised exercise interventions, 
were conducted by Winters-Stone et al. (2011); Crane-Okada et al. (2012); Tunay et al. 
(2012); and Benton et al. (2014).  
Crane-Okada et al. (2012) used dance and movement therapy to observe the effects on 
QoL with older women with breast cancer (mean 65.6 years). After 12 weeks the 
intervention group when compared to the control group (no exercise) did not 
significantly differ in the QoL domains of physical, psychological, social or spiritual well-
being as hypothesized, but fear of recurrence decreased and this appeared to be 
retained six weeks after the intervention was completed. The relatively small sample 
size (n=49), limits the generalizability of the results. 
In a resistance only intervention, Winters-Stone et al. (2011) randomised 106 BCS (mean 
62 years) to a resistance + impact only programme and compared these results to a 
stretching only group. They found that the resistance + impact group preserved bone 
mineral density (BMD) at the lumbar spine compared to the control and increases in 
lean mass were greatest in women on aromatase inhibitors (AIs) compared to controls 
not on this therapy. This study would have benefitted from having a usual care control 
group rather than a control group involved in a stretching only intervention, but the 
authors felt it would be unethical to assign women to a non-exercise control group. 
Retention was 62% which was much lower than other interventions included in this 
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review although the length of the intervention (12-months) was much longer than that 
reported by Crane-Okada et al. (2012).  
Tunay et al. (2012) evaluated the effects of a physiotherapy programme including 
exercise with elderly BCS (>65 years) on shoulder function, pain and lymphoedema. 
Participants reported significant decreases in pain and increases in function, range of 
movement (ROM), muscle strength and decreases in lymphoedema volume. This was a 
single group study design so the findings could not be compared against a usual care 
control group. The data from this study could be used to estimate an effect size for an 
RCT to further evaluate and test the effectiveness of the intervention. As this 
intervention was a multidimensional physiotherapy programme involving complex 
decongestive physiotherapy (CDP), manual therapy and exercise it could not be 
determined to what extent each component had an effect on the overall outcomes, thus 
limiting the generalizability of the results. 
Benton et al. (2014) evaluated the effect of age on quality of life in BCS after an eight 
week, twice a week resistance training programme. To examine the effects of age, they 
split the participants into two groups based on age. One group was 40-59 years and the 
second group was 60-80 years old. Overall adherence to the training programme was 
98% for both groups, with no adverse events reported, demonstrating that older women 
with breast cancer will attend a supervised exercise programme with adherence rates 
similar to younger women, with no injuries or exacerbation of treatment-related effects 
noted between the older women and the younger women. Limitations to the study were 




4.5.3. Strengths and limitations of this review 
This rapid evidence review used a comprehensive and systematic approach to identify 
and evaluate the evidence relating to exercise intervention with older women with 
breast cancer, which was transparent and easily replicable. Limitations to the review 
were the search term dates from 2003-2018 and further limitations were added to the 
searches, such as English language only and the age groups targeted. Additionally, the 
review was limited because of the lack of a full research team to conduct the search and 
appraise the literature; however, an experienced researcher (SB) was involved in the 
checking of articles to be included in the final selection. The absence of multiple 
reviewers in every stage of the methods may have added a degree of selection and 
reporting bias to the process; however, this is allowed in rapid review methodology 
(Grant & Booth, 2009; Khangura et al., 2012). The search found only a small number of 
RCTs that specifically aimed to target and recruit older adults. All these studies were 
found to be of variable and poor methodological quality. This was due to variable study 
designs, which tested different exercise modes of varying durations and a lack of 
uniformity in outcome measures. This variability is probably not so surprising given the 
lack of consensus or guidelines on optimal exercise prescription for this unique patient 
population, but these results make it premature to reach conclusions about the benefits 
of exercise for older breast cancer survivors or to evaluate which physical activity 
programmes are most effective. Despite these limitations, the evidence from this review 
suggests some benefits of exercise interventions in older BCS and the types of 





Exercise could be considered effective in improving physical functioning and in reducing 
the declines in functioning associated with increasing age and cancer diagnosis. Studies 
have demonstrated improvements in QoL, increased muscle size, strength and power, 
along with preserved BMD and increases in lean muscle. Small sample sizes resulted in 
limited study power but they could be used to estimate effect sizes for much larger RCTs. 
Home-based interventions had much better attrition rates (mean 11.25%) compared 
with supervised programmes (mean 25.8%), although all physical activity interventions 
reported in this review appeared to be reproducible and feasible. Benton et al. (2014) 
reported adherence to the exercise intervention of 98% for an 8-week, twice weekly 
resistance training programme and, whereas Crane-Okada et al. (2012) reported an 
attrition rate of only 21%, all suggesting that older BCS appear motivated and willing to 
attend structured and supervised physical activity and exercise programmes on a regular 
basis. Further progress must be made to improve the quality of intervention trials 
targeting older cancer survivors, focusing on adequate randomisation, concealment of 
allocation and better reporting of withdrawals, drop-outs and adherence rates to the 
trials. 
It could be considered that the poor or non-existent reporting of adverse events in most 
of the PA studies with older cancer survivors limits any conclusions about the relative 
safety of exercise with this patient population. Further, the small sample sizes do not 
provide sufficient power to detect differences in rates of adverse events, in particular, 
with the supervised exercise interventions.  
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A further limitation of these studies is with the timing of the exercise intervention in the 
cancer survivorship pathway. No trials have targeted older cancer patients during 
adjuvant therapy or immediately post treatment. The most recent older breast cancer 
survivors were recruited three years after diagnosis (Damush et al., 2006; Boyle et al., 
2016), whilst Payne et al. (2008) and Tunay et al. (2012) did not report time since 
diagnosis. All other PA intervention trials that reported time since diagnosis were many 
years after a cancer diagnosis (mean 7 years post diagnosis). This limits any 
generalizability of findings to recently diagnosed older BCS. 
To conclude this rapid evidence review, the adoption and maintenance of physical 
activity is a challenge for healthy adults and is likely to be even more difficult after a 
cancer diagnosis. With continually improving survival rates, the psychological and 
physiological well-being of cancer survivors is important from a public health standpoint 
(Irwin, 2009). However, long term adherence to exercise by older BCS is limited and the 
benefits they may gain from exercising during or recently after a diagnosis of breast 
cancer is still unknown for this older population of breast cancer survivors. 
 
4.6.1. Gaps in the research evidence 
What remains unclear from the research evidence to date is: 
a) Can older women recently diagnosed with breast cancer be recruited into an exercise 
intervention trial? 
b) Will older women recently diagnosed with breast cancer adhere to an exercise 
intervention trial at this time? 
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c) What benefits can women aged over 60 years recently diagnosed with breast cancer 
gain from participating in a supervised exercise programme?  
d) Can older women with breast cancer derive the same benefits from exercise 
compared to the evidence on younger women with breast cancer?  
e) Are older women with breast cancer more vulnerable to injury?  
These gaps in the evidence will be addressed with this study by investigating the 
feasibility and acceptability of a supervised exercise intervention by specifically targeting 
recently diagnosed older breast cancer patients (aged over 60 years) during and post 
adjuvant treatment. The effects of the exercise intervention on functional capacity, QoL, 
body composition changes and long-term adherence to exercise will also be examined.  
 
Aim of investigation:  
To determine the feasibility and acceptability of a 12-week supervised aerobic and 
resistance training programme on women over the age of 60 who have recently been 
diagnosed with breast cancer. 
 
Objectives: 
 To assess the feasibility and acceptability of the trial and intervention (attrition and 
adherence); 
 To assess the feasibility of recruitment of older women with breast cancer during and 
immediately after adjuvant therapy; 
 To assess and monitor and changes in functional capacity before and after the exercise 
intervention (12-minute walk); 
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 To assess and monitor any changes in quality of life (QoL) outcomes before and after the 
exercise intervention; 
 To estimate and monitor any changes in body composition between the exercise group 
and control during and after the trial; 
 To assess and monitor and changes in PA levels before and after the exercise 
intervention; 





Chapter 5. Design, methodology and theoretical framework 
5.1 Introduction 
This chapter will outline the justification, application and critical evaluation of the 
researcher’s epistemological and ontological position that informs the methodology, 
methods of enquiry and the research process in relation to this study. The Medical 
Research Council framework for the design, conduct and evaluation of complex health 
interventions was selected to be followed to ensure that the study followed a recognised 
and rigorous process (Craig et al., 2008). Following such a framework is in recognition of 
the challenges of understanding and promoting health behaviours (physical activity) in 
an under-researched population (older women with breast cancer) and that a 
pragmatic, step-wise approach was required.  
The researcher’s ontological and epistemological viewpoint is one of pragmatism. 
Pragmatism often avoids the contentious issues of “truth” and “reality” and from a 
philosophical viewpoint strives towards solving “practical” problems without strict 
adherence to only one paradigm, which can often impede progress in resolving these 
problems and finding solutions (Webb, 2007). Pragmatism offers an opportunity to mix 
research approaches to offer the best opportunities for answering the important 
research questions. It focuses on knowledge as the constantly changing and revising of 
experience and as such research design should include quantitative, qualitative and 
mixed methods depending on what method is considered be the most effective way of 
producing knowledge from the data generated or available (Biesta, 2010). By utilising 
the MRC framework that includes both quantitative and qualitative approaches, it is 
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considered the most appropriate way to develop a complex healthcare intervention 
with an under-researched population. 
A pragmatic pilot RCT was selected as the means to assess the feasibility and 
acceptability of such an exercise intervention, as this is often considered the gold 
standard to assess the benefits and potential harm of new medicines and health 
interventions (Cartwright, 2007). Pilot and feasibility work is also extremely important 
to evaluate the viability of an intervention or trial and the feasibility and acceptability of 
the trial design and procedures to be subsequently used. It may prove very expensive to 
run a large-scale trial and little point if the intervention is unlikely to be implemented in 
practice. Also, if trial procedures prove to be unacceptable to participants or unfeasible 
then results may not be valid, therefore leaving policy makers, clinicians or 
commissioners without enough evidence to decide whether to adopt a trial or 
intervention. The MRC recommends pilot and feasibility trials using a process of steps in 
the hope that methodological differences and bias are resolved in advance of any efforts 
to conduct a larger-scale trial (Craig et al., 2008). If the research is novel, as is the 
population for this study, there are often uncertainties regarding recruitment, attrition, 
intervention adherence and whether outcome measures will be suitable. Thus, it is 
critical to understand these key parameters, which if found to be appropriate can be 
used to inform the future design and conduct of any large-scale trials with this 
population or to judge whether or not a large-scale trial is appropriate or ethical to even 
be conducted. Although not commonly reported in pilot studies, because of the novel 
population inferential statistics of the outcome measures will be reported as trends in 
the data, although no conclusions will be drawn from these statistics because of the 
degree of uncertainty with the inadequately powered sample size. Highlighting and 
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acknowledging any potential trends within or between groups in the data will further 
add to the evidence base lacking in this population and provide further information as 
to whether a full definitive RCT with this population should be carried out. 
 
5.2. Pragmatism as a research paradigm 
The popularity of pragmatism within mixed methods research can be somewhat 
explained by its ability as a philosophical vehicle for addressing many of the differences 
and often unhelpful dualisms of the “paradigm wars” (Biesta, 2010). These dualisms 
include assumptions regarding the subjective or objective nature of viewpoints of reality 
and the differences of quantitative and qualitative methods. Proponents of mixed 
methods research offer the integration of quantitative and qualitative research 
approaches. This does not sit comfortably within one or the other “worldviews” of 
positivism/post-positivism and constructivism for purists; however, it focuses on the 
problem to be researched and the consequences of the research (Feilzer, 2010).  
Johnson and Onwuegbuzie (2004) consider pragmatism as an opportunity to mix 
research approaches fruitfully, in ways that offer the best opportunities for answering 
the important research questions. Ormerod (2006) suggests that scientists or 
researchers should turn away from a priori reasons and fixed principles in the quest for 
absolutes and consider only the facts as they exist to the problem encountered. He does 
not suggest logic or rigour should be discarded but that staunchly abiding by 
paradigmatic boundaries blocks the opportunities to move towards a common goal and 
is not in the interest of furthering research and the generation of new knowledge.  
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Pragmatic enquiry focuses on knowledge as the constantly changing and revising of 
experience and as such research design should include quantitative, qualitative and 
mixed methods depending on what researchers consider will be the most effective way 
in producing knowledge from the data generated or available (Biesta, 2010). 
Pragmatism, when regarded as an alternative paradigm, avoids the often contentious 
issues of truth and reality, accepts, philosophically, that there are many realities that are 
open to research and strives towards solving practical problems in the “real world” 
(Creswell, Plano Clark, Gutmann, & Hanson, 2003). By avoiding these methodological 
constraints imposed by having to choose and side with post-positivism or constructivism 
researchers are free and not prisoners of a particular research method or approach 
(Robson, 2002). Webb (2007) considers classic pragmatism as having four salient 
features: pragmatists not believing the viewpoint that knowledge must begin with 
absolute certain truth and all else should be treated with scepticism, thus, scepticism is 
not required in the pursuit of the truth; every belief is subject to being fallible; neither 
knowledge through scientific enquiry nor common sense is privileged as both may be 
relevant to research, considering contexts of perspectives and purposes of inquiry, and 
a pragmatist believes that real things exist without perceiving them but follow regular 
laws of nature; however, theoretical entities do not exist except those that are created 
and used to generate empirical predictions.  
At an epistemological level, pragmatism does pose some methodological concerns, as 
to how a phenomenon with different layers can be observed or measured. However, by 
using mixed methods research it can plug these gaps by using quantitative methods to 
measure some points of the phenomenon and qualitative methods to assess other 
aspects. So, by combining traditional research methods a more complete picture of 
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reality can be observed (Feilzer, 2010). However, all this may still not truly integrate the 
different research methodologies, as Bryman (2007) suggests that lots of mixed method 
researchers are looking at phenomena from different perspectives to gain an enriched 
understanding but then when it comes to the presentation of findings are displaying the 
data explored alongside each other but discussing the findings separately. Bryman 
(2007) continues arguing that good mixed methods research needs to be able to 
demonstrate the dichotomy of quantitative and qualitative methods and data and not 
present them as independent of each other. 
An often unresolved issue within mixed methods research relates to research design and 
a major problem is the plethora of designs in existence. (Teddlie & Tashakkori, 2003) 
identified 35 mixed method research designs alone. In an attempt to simplify the mixed 
design choices, many researchers have developed typologies (Creswell et al., 2003). 
Unfortunately, these typologies appear to lack consistency or are too complicated or 
miss out important criteria for mixed methods.  
Following the Medical Research Council (MRC) guidelines for developing and evaluating 
complex interventions (Craig et al., 2008) and considering a typology of mixed methods 
research designs suggested by Leech and Onwuegbuzie (2009) this study utilised a 
“partially mixed sequential dominant status design”. This is because the research 
involved conducting a study with two phases that occurred sequentially. However 
greater emphasis is given to the quantitative phase by considering the feasibility of 
recruitment and the acceptability of the exercise intervention and the repeated time-
points for follow up. The qualitative phase considers the population’s motives, reasons 
for and barriers against being active during and after treatment for breast cancer.  
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5.3 A framework for designing and evaluating complex 
interventions to improve health 
 
5.3.1. Medical Research Council (MRC) Framework for Complex Interventions 
Complex interventions are widely used by health researchers and in areas of public and 
social policy that have important health outcomes, such as education, transport and 
housing and often may be described as interventions that contain several interacting 
components (Campbell et al., 2000). Designing and evaluating complex interventions is 
often made up of a number of different components that may act both independently 
and interdependently (Craig et al., 2008). In 2000, the Medical Research Council (MRC) 
published a framework to help researchers to recognise and adopt appropriate methods 
when designing and evaluating complex interventions. This guidance was updated and 
extended in 2008 in recognition that complex interventions in health policy involving 
individuals in education, obesity, physical activity, smoking or housing, in practice, may 
not follow the cyclic or linear sequence or a traditional drug trial (Craig et al., 2008). The 
2008 guidance has more emphasis on the development and implementation phases of 
an intervention, as well as the evaluation. However, the MRC still suggests that although 
some aspects of good practice are clear there is still no consensus on exactly what is 
best practice (Craig et al., 2008).  
RCTs are regarded as the “gold standard” for establishing the effectiveness of 
interventions if randomisation is feasible. However, effect sizes do not provide policy 
makers and researchers with information on how an intervention may work in practice 
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or be replicated in a specific context or whether outcome measures will be reproduced 
(Moore, Audrey, Barker, Bond, Bonell, Hardeman, Moore, O'Cathain, et al., 2015).  
According to Craig et al. (2008) although all stages of developing, piloting, evaluating, 
reporting and implementing a complex intervention are very important and can not only 
be a lengthy process, more often than not researchers place too much emphasis and 
focus on the main evaluation of an intervention to the detriment of adequate 
development and piloting work. Also, insufficient emphasis may be placed on 
consideration of the practical issues of the actual implementation of the intervention. 
Without rigorous consideration of these underlying issues, weaker interventions that 
are harder to evaluate and are less likely to be implemented may result. 
 
5.3.2. Developing a complex intervention 
The process of developing a complex intervention should be considered following a 
number of steps or phases. The first step should be to identify what is already known in 
the literature about similar interventions as the one proposed and the methods that 
have been used to conduct and evaluate them (Craig et al., 2008). Reviewing the existing 
evidence ensures that the intervention can be developed to a point where it can 
reasonably be expected to have a worthwhile effect. By carefully and methodically 
reviewing the existing evidence and theory, a theoretical understanding of the likely 
processes of change that are expected and how they can be achieved will be clearer 
from the outset. This underpinning knowledge gained by reviewing the existing evidence 
and theory should be used to identify and develop theory, ensuring that the rationale 
for a complex intervention, changes expected and how these may be achieved is clear 
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from the outset. This step in the MRC framework (Phase 0 – Pre-clinical / theory) has 
been considered in the literature review in Chapters 2-4. 
Modelling (piloting) a complex intervention before a full-scale trial can provide 
important further information about both the design of the intervention and the 
evaluation. An exploratory trial or series of small studies (which may be a mix of both 
quantitative and qualitative) is useful to consider all facets of the design and allow the 
researcher to progressively refine methods before embarking on a full-scale trial. This 
often involves testing the feasibility of delivering the intervention and the acceptability 
to providers and patients. The exploratory trial or series of studies may help to 
determine fidelity (whether the intervention was delivered as intended) and dose (the 
quantity of the intervention implemented) (Moore, Audrey, Barker, Bond, Bonell, 
Hardeman, Moore, O’Cathain, et al., 2015) and may identify weaknesses that can lead 
to cost-saving refinements or even show that a full scale evaluation is not warranted or 
feasible using the existing methods (Craig et al., 2008). 
During this preparatory phase, the package of care or placebo can be decided for the 
control group and also consideration of how this may affect other variables within the 
intervention (e.g. recruitment). This exploratory phase should ideally be randomised, 
Craig et al. (2008) suggest that randomisation should always be considered because it is 
the most robust method of preventing selection bias and thus, a useful measure of 
assessing the effectiveness of the process. The initial pilot trial can provide a sound basis 
for estimating recruitment required in the main trial along with piloting outcome 
variables so investigators can ascertain which outcome measures are relevant to the 
patients and disease and which are important or required by the health care systems 
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(Campbell et al., 2000). Phase 1 and 2 (Modelling / exploratory phases) are referred to 
in Chapters 6 and 7 of this thesis. 
 
5.3.3 Is a feasibility or pilot study necessary? 
Current MRC framework guidance strongly recommends a feasibility and piloting phase 
after an intervention has been developed (Craig et al., 2008). The National Institute for 
Health Research (NIHR) defines feasibility studies as: “pieces of research done before a 
main study in order to answer the question: Can this study be done?” They are used to 
estimate important parameters that are needed to design the main study. These may 
include some or all of the following: willingness of participants to be randomised; 
willingness of clinicians to recruit; number of eligible participants; designing suitable 
outcome measures, response rates to questionnaires; adherence and compliance rates 
and the time and resource implications of data collection and analysis. (Moore, Carter, 
Nietert, & Stewart, 2011) define “pilot studies” as: 
 “preparatory studies designed to test the performance characteristics and capabilities 
of study designs, measures, procedures, recruitment criteria and operational strategies 
that are under consideration for use in a subsequent, often larger study”.  
They suggest that successful pilot studies are crucial in providing pertinent information 
in preparation for a larger study. NIHR (2011) supports this definition and describe pilot 
studies as a smaller version of the main study used to test whether the components of 
the main study can all work together. It considers that the pilot study should resemble 
the larger study in many aspects, including assessing outcome measures and should 
focus on the processes of the main study such as recruitment, randomisation, the 
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treatment (or intervention) and the follow-up assessments to ensure that they all work 
together so that no component could jeopardise the main study. (Arain, Campbell, 
Cooper, & Lancaster, 2010) suggest that feasibility studies do not need to evaluate the 
outcome of interest, as they believe that should be left to the main study. They suggest 
that if a feasibility is a small RCT, it may not have a primary outcome and that a power 
calculation does not need to be undertaken as the sample size of the feasibility study 
should be adequate to estimate recruitment rates to inform a larger study. 
Thabane et al. (2010) consider that pilot trials can be comparative randomised trials 
designed to provide preliminary evidence on an intervention. They suggest that they are 
also commonly known as “feasibility studies” with the aim to assess the safety of 
treatment or interventions; to assess recruitment potential; to assess the feasibility of 
collaboration or the co-ordination of multi-centre trials and are the best way to assess 
the feasibility of a large, expensive full-scale study and consider them almost an 
essential pre-requisite. Thabane et al. (2010) stress the importance of conducting a 
feasibility or pilot study with the main goal of pilot studies to assess feasibility so as to 
avoid possible disastrous consequences of embarking on a large study – which could 
potentially “drown” the whole research effort. This is supported by Leon, Davis, and 
Kraemer (2011) who suggest that pilot studies are a fundamental phase of the research 
process and should be conducted to examine the feasibility of an approach that is 
intended to be used in a larger-scale study. They consider that a pilot trial should be 
used to evaluate the feasibility of recruitment, randomisation, retention and attrition, 
assessment methods and the implementation of a novel intervention.  
Although the value and importance in the research process for conducting pilot or 
feasibility trials, terms that are used interchangeably, before embarking upon a full RCT 
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appear quite conclusive, Shanyinde, Pickering, and Weatherall (2011) found that when 
randomly selecting 50 articles from 3652 that used the terms pilot or feasibility in the 
title only 56% (95% CI, 41%-70%) actually reported and discussed methodological issues 
in substantial depth, only 18% (95% CI, 9%-30%) discussed future trials and only 12% of 
authors were actually conducting one. They suggest that many researchers when 
applying for funding or for publication in journals, having trials that are inadvertently 
underpowered to address clinically meaningful hypotheses may claim to have 
conducted a pilot or feasibility study in the hope of receiving a more favourable review. 
For the purpose of this study, the approach will be to conduct a pilot study following the 
model for complex interventions advocated by the Medical Research Council, who 
explicitly recommends the use of feasibility studies before embarking on a phase III 
clinical trial (a randomised study comparing two or more drugs or intervention strategies 
to assess efficacy and safety), and the iterative nature of the processes of development, 
feasibility and piloting, evaluation and implementation (Craig et al., 2008). 
 
5.4 Summary 
This present study follows the guidance and framework suggested by the MRC (Craig et 
al., 2008). By considering and reporting on the implementation of the intervention, 
examining the quantity and quality of what was delivered and how it was implemented 
in practice, allows for critical consideration of these mechanisms using both quantitative 
assessments in Study 1 and qualitative investigation in Study 2. This pilot study assesses 
the feasibility of recruitment, randomisation, retention, attrition and the assessment 
methods used, along with the implementation of the intervention and long-term follow 
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up outcomes to determine whether any short-term changes persist in Study 1. Study 2 
comprises a qualitative investigation examining motives and barriers to physical activity 
during and after breast cancer treatment. Taking this pragmatic mixed methods 
approach should help to further understand the context in which the complex 
intervention was delivered and any factors external to the intervention which may 
impede or strengthen the outcomes and effects of the intervention and ultimately 
whether a full scale, much larger RCT is warranted.  
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Chapter 6:  Feasibility of the intervention procedures and 
outcome measures of a 12-week exercise intervention for 
women over 60 recently diagnosed with breast cancer 
6.1 Introduction 
This chapter reports on Study 1 - Feasibility and acceptability of procedures for a pragmatic 
pilot randomised controlled trial of a 12-week exercise intervention for women over 60 
years old recently diagnosed with breast cancer. The study was considered to be a 
feasibility study as the population (women over 60 years, < 2-years after a diagnosis of 
breast cancer) had not been specifically targeted to be recruited at this time of diagnosis 
to an exercise intervention.  Therefore, feasibility and acceptability data was first required 
to be collected to assess the design and implementation of an intervention with this 
unique population at this time and whether it would be viable to progress to a larger 
study in future. 
 
6.2 Methods 
6.2.1 Study Design 
Study 1 was designed as a pragmatic pilot RCT of a supervised exercise intervention for 
women aged over 60 years with early stage breast cancer. There was a longitudinal 12-
month follow up of study outcomes, assessed at 3 months, 6 months and 12 months. 
Participants were randomly allocated to either the intervention group (Ex) or the control 
group (Con). Participants in the Ex group completed a supervised exercise programme 
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once a week at the University of Huddersfield and were asked to complete an additional 
30-minute home-based exercise programme twice a week. The control group did not 
access the supervised exercise sessions but were to continue with their normal everyday 
activities, which may or may not have included exercise. As this was a pilot study 
assessing the feasibility of whether such an intervention was possible, recruitment rates 
and timescales, randomisation, adverse events, acceptability of the intervention, 
retention and attrition rates and adherence rates were all collected. Outcome 
intervention measures of functional capacity (12-minute walk), body composition (fat 
mass and fat free mass), Quality of Life (European Organisation for Research and 
Treatment of Cancer EORTC - C30 and Breast Cancer specific questionnaire - BR23) and 
physical activity levels (Scottish Physical Activity Questionnaire - SPAQ) were assessed 
at baseline, 3 months, 6 months and 12 months. The study received ethical approval 
from the University of Huddersfield School of Human and Health Sciences Research 
Ethics Panel and the NHS Research Ethics Committee (Rec Ref: 12/YH/0258; IRAS No: 
57057) (See Appendix 2). 
 
Participants 
Participants were recruited from either the Huddersfield Royal Infirmary (HRI) or 
Calderdale Hospital between October 2012 and July 2014 and through an outpatient 
educational programme delivered by the national cancer charity, Breast Cancer Care, 






 > 60-years old 
 No upper age limit 
 Recently diagnosed with Breast Cancer (< 2 years) 
 During or post adjuvant treatment 
 Any ethnicity 
 > 3-months post-surgery 
 Primary breast cancer 
 No contra-indications to partaking in an exercise programme 
 No mental disabilities that would prevent them from understanding what they are 
agreeing to do 
 Able to fully understand written and verbal English (no translator service available) 
 
Exclusion 
 < 60-years old 
 Not recently diagnosed with Breast Cancer (> 2 years) 
 Males 
 < 3-months post-surgery 
 Secondary breast cancer (metastatic cancer) 
 Any contra-indications to exercise 
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 Any metal disabilities that would stop them from fully understanding what they were 
signing up to 




A consultant medical oncologist at HRI agreed to allow the recruitment of patients from 
the oncology clinics at Huddersfield and Calderdale and to be a clinical supervisor for 
the study. Breast care nurses at the participating hospitals considered the eligibility of 
the patients and gave out information sheets (see Appendix 3) to those who met the 
eligibility criteria following post-surgical review. Patients were asked verbally for their 
permission to allow their contact details to be passed on to the researcher, who would 
contact them, after they had had an opportunity to read through the participant 
information sheet. If the patient agreed, the breast care nurses passed their name and 
contact details to the researcher. The researcher then contacted potential participants 
to answer any questions, after allowing more than five days for the patient to read the 
information sheet. The researcher contacted these potential participants via telephone 
to discuss the study and if they were still willing to participate, a meeting was arranged 
to sign informed consent forms and take part in baseline assessments. This took place 






Breast Cancer Care - Moving Forward course 
Participants were also recruited by the researcher during a four-week outpatient 
educational programme called Moving Forward, designed specifically for women 
recently diagnosed with breast cancer. It covered topics such as the management of 
breast cancer, breast re-construction, relaxation, exercise, lymphoedema and healthy 
eating. The researcher led the exercise session talk on week 3 where all potential 
participants were given information sheets about the study. This session enabled direct 
contact with potential study participants. If agreeable, eligible participants were then 
contacted by telephone to ask if they were interested in participating in the research 
and a date and time was arranged to sign consent forms (Appendix 4) and do baseline 
assessments. This took place at the University of Huddersfield. Randomisation took 
place once consent forms were signed, any questions about the study answered and 
baseline assessments done.  
A cancer history and general health form (ACSM, 2012) was completed by all 
participants. This cancer-specific exercise questionnaire validated by the American 
College of Sports Medicine (ACSM) was completed to ensure clarity of cancer diagnosis, 
treatments and any ongoing side-effects that the participant may have been 
experiencing, along with any other conditions that may affect participation. 
 
Sample Size 
As this study was a pilot trial and the objective was not to prove the efficacy of a 
treatment, a formal power calculation was not undertaken (Lancaster, Dodd, & 
Williamson, 2004; Thabane et al., 2010). Therefore, the sample size formulae used for 
main treatment assessments are not usually applicable to pilot trials (Whitehead, 
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Julious, Cooper, & Campbell, 2016). However, according to Whitehead et al. (2016) 
current methods for setting pilot trial sample sizes are based on a set of rules, which 
they call “flat rules of thumb” and state five different sample sizes from the literature to 
use for a two armed trial. Within these rules, Brown and Marshall (1995) recommend at 
least 30 participants (15 in each arm) or more to estimate a parameter, whereas Julious 
(2005) considers only 12 participants per treatment arm is enough and Teare et al. 
(2014) suggest 35 per treatment arm, so 70 in total. Taking these current methods into 
consideration it was proposed that a sample size of 40 (20 per group) would be adequate 
to meet the primary objectives of the study and not to primarily power the trial to test 
for inferences found from the intervention. Inferential statistics only were used to 
consider any trends in the data. 
 
Randomisation and concealment 
Once a participant had agreed to participate in the research study and a consent form 
had been signed, participants were randomly allocated to either the intervention group 
or control group by a pre-determined block sequence randomisation schedule. 
Randomisation was carried once at least 3-4 participants had been recruited and 
subsequently when another 3-4 participants had agreed and signed consent forms, and 
so on.  
Once consent forms were signed all participants were allocated a code for identity 
concealment only known to the researcher. These codes were passed on to an academic 
member of staff at the University of Huddersfield who was not involved in the research 
study, who then randomly allocated participants to groups using a block sequence 
allocation method. The allocation to groups was kept to no more than four extra in 
141 
 
anyone group at any time. Given the nature of the research and intervention it was not 
possible to conceal the treatment allocation from the participants or to blind the 
researcher from the treatments as it was the researcher who carried out the 
assessments and exercise intervention. No stratification of the participants was 
performed as the group was not considered large enough or significantly heterogeneous 
to provide any additional sub-groups of interest. 
 
6.2.2. Exercise Intervention 
To date, no formal exercise guidelines specific to cancer survivors have been published 
in the UK (Campbell, Stevinson, & Crank, 2012). However, exercise guidelines for cancer 
survivors have recently been published by the American College of Sports Medicine 
(Schmitz et al., 2010), and these were followed in the design of the study intervention. 
These guidelines suggest that cancer survivors should follow the 2008 Physical Activity 
Guidelines for Americans (US Department of Health & Services, 2008), but that specific 
exercise programmes may have to be adapted based on an individual’s health status, 
disease trajectory and treatment-related adverse effects (ACSM, 2010). The US 
Department of Health and Services (2008) guidelines for aerobic activity are a weekly 
accumulation of 150 minutes of moderate intensity activity or 75 minutes of vigorous 
activity. Recommended resistance training comprises two to three sessions per week to 
include exercises for major muscles, with stretching of the major muscle groups on days 




Exercise pre-screening assessment 
A Physical Activity Readiness Questionnaire (PAR-Q) was completed by all exercise 
intervention participants as these participants would be taking part in the supervised 
exercise intervention. It is very important to undertake a professionally guided screening 
process to provide details regarding cardiovascular risk factors and signs/symptoms of 
a broader range of chronic diseases and /or conditions that require further information 
or explanation before engaging in an exercise programme (American College of Sports 
Medicine, 2013).  
During the administration of the PAR-Q the participants may disclose a number of other 
co-morbidities such as a diagnosis of high blood pressure and/or high cholesterol and 
Type II diabetes (under control by medication) as an example. It was the role of the 
researcher (as the cancer exercise specialist) to consider these additional factors which 
may affect the patient’s response or ability to participate in the exercise prescription 
(Woolf-May & Bird, 2006). 
 
The supervised exercise intervention 
The programme structure and content were based on guidelines developed by Palmer-
McLean et al. (2009), Schmitz et al. (2010)  American College of Sports Medicine (2013) 
and to ensure that the programme was evidence-based. Exercise intensity was set at 60-
75% HRR and/or RPE 3-4. Participants in the exercise group took part in a 12-week 
supervised exercise programme, one session per week. Each session lasted 




Table 5: Pilot supervised exercise programme (RPE 3-4 or 60-75% HRR) 
Warm-up  
(15 min) 
5 min – walking on treadmill 
5 min – rowing or cycling 
5 min – mobility exercises/dynamic stretching 
Shoulder circles/shrugs, marching on the spot, squats, lunges, heel taps, side-




1.25 min-1.5 min  
per station 
 
x 2 circuits 
1. Sit to stand  
2. Wall press Ups  
3. Step ups with knee lift 
4. Upper-body resistance exercises  
5. High knees/calf raises/side steps 
6. Lateral step ups  
7. Walking on treadmill 
8. Upper-body resistance exercises 
9. Step backs/lunges  
10. Step ups 




1 x 10 repetitions 











At the end of the 
session 
Drawing in 
Cycling the bike 
Back raises 
Supermans 
Cool down  
(5-10 min) 
Mobility & static 
stretches 
Walking on the spot, heel and toe taps, shoulder circles, head and neck 
mobility 
Static stretches (held for 20 secs) 
Upper-back, chest, inner thigh, hamstrings and calves 
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The exercises were adapted or amended depending on each participant’s current levels of 
























































1.25-1.5 mins per station 





Home-based exercise intervention 
Participants were asked to follow a 30 min x 2-week home-based programme, which 
consisted of 15-20 minutes walking and the following circuit (10 min): 
Table 6: Home-based exercise programme (RPE 3-4) 
 
Warm up (10-15 
min) 
 
Walking/cycling/pulse raising movements 
Circuit (10-min) 
5 x stations 
1 min per station 
2 x circuit 
1. Wall press-ups 
2. Sit to stand 
3. Step-ups 
4. High knees 
5. Calf raises 
 
Cool down (5-min)  
Stretches x 2 
 
Slow walking 
Static stretches (held for 20-sec each) 
Upper back, chest, inner thigh, hamstrings and calves 
 
 
Home-based exercise prescription was based on the guidelines developed by Palmer-
McLean et al. (2009), Schmitz et al. (2010), American College of Sport Medicine (2013). 
The exercises were all based on exercises from the supervised intervention so that the 
participants would be familiar with them and had been taught the correct technique for 
each exercise. From consulting with the population age range prior to the development 
of the intervention, it was considered that 20-30 minutes twice per week would be a 
manageable amount to do. Accelerometers would have been a very useful tool to 
measure objectively home-based physical activity compliance and also monitor 
additional PA levels from both the intervention and control groups. However, the 
University of Huddersfield did not have access to accelerometers so it was not possible 
to access this equipment. If they had been available, it would have helped greatly with 
the monitoring of home-based compliance and of objectively monitoring PA levels. 
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Table 7: Exercise prescription guidelines for cancer patients (adapted from (American 










Should be able to 













Patients unstable on 
their feet may benefit 
from a recumbent or 
stationary bike 
Begin intensity at 50% 
HRR and progress as long 
as RPE is 11-13 or 3-4 
If needed divide exercise 
into two or three 
sessions per day and 






repetition max or 
RPE 3-4 performed 
in an aerobic or 
circuit fashion 
1-2 times/week 







Use machines instead of 
free weight to prevent 
injury from loss of 
control of the weights. 
No valsalva/breath 
holding 















The content of the supervised exercise programme was based on the above guidelines 






Monitoring exercise intensity (intervention participants only) 
Exercise intensity was prescribed using HRR. The target HRR was 60-75%, which is 
equivalent to 3-4 RPE (see table 5 & 6). The participants’ exercising heart rates were 
worked out using Heart Rate Reserve (HRR) a.k.a. the Karvonen formulae: 220 – age = 
max heart rate (MHR); MHR – resting heart rate = HRR; HRR x training intensity% + 
resting HR. Training intensities for the participants were selected based upon the 
guidelines of: Palmer-McLean et al. (2009); Schmitz et al. (2010), American College of 
Sports Medicine (2013) Ehrman, Gordon, Visich, and Keteyian (2018) 
The Hosand heart rate monitoring system was used to monitor heart rate with the first 
two participants in the exercise intervention. This required participants to place a heart 
rate monitor strap across the sternum, just below the bra-line, fastened and held in 
place by an adjustable elastic strap. These monitors would transmit the participants’ 
heart rates to a laptop computer in the room. The exercise instructor could monitor the 
participants’ heart rates and the exercise intensity they were working at by observing 
the laptop screen.;  
Ratings of perceived exertion (RPE) was selected in addition to heart rate monitoring. 
This was developed by Borg (1973). The RPE category ratio scale (0-10) was used for 
ease of understanding (Borg, 1998). Participants were asked to rate how hard they were 
working at varying times during each exercise circuit. Exercise intensity could then be 
adjusted depending on the number they indicated on the scale. Participants’ exercise 
intensity was also monitored after each circuit using this scale, twice in total per exercise 
session. Participants were asked to record the level that they felt they had exercised 
during the circuit. Observations of participants’ exercise levels and intensities were also 
closely monitored throughout the exercise sessions by the instructor using other 
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methods to ascertain exercise intensity level including observing breathing rates, 
sweating, redness and by utilising the talk test. This ensued that the participants were 
working at the correct and suitable intensity levels and utilising the RPE scale correctly 
and safely. Intervention acceptability was also measured using RPE as a surrogate 
marker considering common issues that needed to be evaluated in feasibility studies 




6.2.3. Outcomes  
 
Recruitment 
Staff recruiting from the hospital recorded the number of patients they approached who 
met the inclusion criteria and those who declined to take part in the study. The reasons 
for declining were also recorded. The recruitment time-frame was noted to consider the 
length of time to recruit the numbers who participated. This was done at all sites. 
 
Participant characteristics 
Sample characteristics (age, stature, weight, ethnicity, marital status, employment 
status, stage of cancer, time since diagnosis, time post adjuvant therapy and surgery 
type, and treatment) were recorded at baseline to allow for comparisons with other 
breast cancer populations and other older adult groups (see table 8). 
 
Acceptability of the exercise intervention intensity (experimental group only) 
This was considered using the Ratings of Perceived Exertion Scale (RPE), which allows 
participants to subjectively rate on a scale 0-10 how strenuous they found the exercise 
during the exercise intervention. This subjective score was recorded twice per exercise 
session per participant.  
Field notes of comments that were recorded verbatim from participants in the exercise 
intervention group were collected during the exercise programme sessions to consider 
the appropriateness and acceptability of the intervention and to further inform future 
exercise interventions with this population. Whilst they are not to be considered in-
150 
 
depth qualitative evidence, they offer insight into the thoughts and feelings of the 
participants participating in the exercise programme at the time. Study 2 provides a 
more in-depth examination of the qualitative experiences of this population and 
examines barriers to and motivators for exercise and physical activity. 
 
Adherence to the intervention (experimental group only) 
Intervention adherence was defined as the total number of sessions available to each 
participant to attend compared to the actual number of sessions each participant 
attended. It was calculated by the sum of the total number of participants and the total 
number of sessions attended and compared to the total possible attendances. To 
monitor home-based activity and any additional activity outside of the structured 
exercise sessions participants were also asked to fill in a daily PA diary whilst taking part 
in the 12-weeks of structured activity.  
 
Adverse Events 
Adverse events were considered as anything that may jeopardise the health of a 
participant either temporarily or long-term as a direct consequence of the intervention.  
 
Retention Rate 
Retention rates were defined as the number of participants who remained in the trial at 




Trial Completion Rate 
This was defined as the number of participants who completed all 12-months of the trial. 
 
Intervention completion rate 




Implementation fidelity was defined using five elements: adherence to the intervention; 
exposure or dose; quality of delivery; participant responsiveness; and programme 
differentiation (Dusenbury, Brannigan, Falco, & Hansen, 2003; Mihalic, 2004). 
Adherence is defined as whether the intervention is actually being delivered as it was 
designed to be (Mihalic, 2004). Dosage refers to how much of the intervention is 
received by participants in terms of frequency and duration as described by the 
intervention protocol. Quality of delivery is defined as the manner in which the member 
of staff delivers the intervention. Is this in accordance with design intervention protocols 
or ensuring correct techniques are used or a consistent approach used for all 
participants? Participant responsiveness is measured by the participant’s response to or 
engagement by the intervention and may include judgements by participants about the 
outcomes and relevance of the intervention. Programme differentiation is concerned 
with trying to determine which elements are essential for the success of the intervention 




6.2.4. Intervention outcomes 
To measure and assess the effectiveness of the intervention, outcome measures of 
functional capacity (12-minute walk), body composition, quality of life and physical 
activity levels were collected from all participants (intervention and control) at four time 
points of the study: baseline (week 1), between weeks 12 and 16 (3 months), during 
weeks 26 and 30 (6 months), and during weeks 50 to 52 (12 months). The range of time-
points was due to the availability of participants at the nearest time to the follow-up 
time-periods.  
 
Functional capacity – 12-minute walk 
Participants were asked to walk at what they considered their comfortable walking 
speed. Timing was initiated once the participant indicated they were ready and began 
walking. The walking course was set out around a clinical laboratory at the University of 
Huddersfield in a rectangular pattern. Distance was measured using a linear trundle 
wheel with distances marked on the floor by plastic cones. Participants were advised 
that they could rest, by sitting or standing, at any point during the assessment. The 
researcher recorded the number of complete laps of the walking course the participant 
had managed and any additional distance. The total distance was then calculated and 
recorded.  
 
Body composition - Air Plesythmography (BOD PODTM). 
Air Plesythmography (BOD PODTM) measures the volume of air a person’s body displaces 
while sitting inside a comfortable chamber. The Bod Pod system (Life Measurement, Inc, 
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Concord, CA) included the BOD POD plethysmograph, electronic weighing scales, 
calibration weights and cylinder, computer and software. This technology is 
fundamentally the same as Hydrostatic Weighing (under water weighing) but rather 
than using water it measures the displacement of air. The BOD POD first assesses the 
participant’s mass and volume. From these measurements whole-body density is 
determined. Using these data, body fat and fat free mass are calculated. The BOD POD 
utilises the principles of whole body densitometry to estimate the amount of fat and 
lean tissue in the body. Whole body densitometry is based on the determination of body 
density by measuring body mass and body volume. Body mass is measured on the BOD 
POD electronic scale (outside of the chamber) and body volume is measured whilst 
sitting inside the BOD POD. Once body density is ascertained, the participant’s 
percentage amount of fat and fat free mass are automatically calculated using these 
principles. Prior to completing the test all participants were advised not to eat or drink 
for at least two hours before testing and not to engage in any exercise. Participants were 
also asked to visit the bathroom (if necessary) before testing. All participants wore 
swimsuits for the test and were asked to remove any jewellery or spectacles. A swim 
cap was provided and the participant was instructed to ensure all hair was inside the 
swimming cap and any excess air was pushed out. After body mass had been assessed 
using the BOD POD electronic scale (wearing swimwear only) participants were asked to 
sit in the BOD POD chamber and remain very still, breathe normally and avoid talking 
during the test to ensure as accurate a result as possible. This lasted approximately 3-4 
minutes depending on whether the machine took two or three measurements to 




Quality of Life 
The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 
(See Appendix 7) has become the most widely used questionnaire for patients in clinical 
trials in Europe for cancer patients and is extensively used in America and around the 
world (Fayers, 2001). EORTC QLQ-C30 consists of 30 questions including five functional 
scales (physical, role, emotional, cognitive and social) and nine symptoms scales 
(fatigue, nausea and vomiting, pain, dyspnoea, insomnia, appetite loss, constipation, 
diarrhoea and financial difficulties) with one global health scale (GHS). The BR23 module 
(See Appendix 7) comprises 23 questions specifically designed for quantifying QoL for 
breast cancer. This includes five functional scales (body image, sexual functioning, sexual 
enjoyment, future perspective) and four symptoms scales (breast symptoms, arm 
symptoms, therapy side effects and upset by hair loss) (Saleha et al., 2010). After 
gathering the data from the participants, the raw score for each subscale was calculated 
in accordance with the EORTC Scoring Manual and transferred to 0-100 scales. Higher 
scores of any subscales were considered a higher level of functioning and QoL. Symptom 
scales were the opposite; higher scores indicated a higher level of the symptoms 
(symptoms were worse) and thus, indicated a poorer QoL (Fayers, 2001). 
 
Physical Activity levels - Scottish Physical Activity Questionnaire (SPAQ) 
All participants were asked to complete the Scottish Physical Activity Questionnaire 
(SPAQ) (Lowther, Mutrie, Loughlan, & McFarlane, 1999) for monitoring physical activity 
levels before and during the programme and to record any physical activity that was 
undertaken outside of the structured intervention (See Appendix 8). This questionnaire 
takes a 1 week snapshot of physical activity levels. Everyone completed this at baseline, 
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3, 6 and 12 months. Accurate measurement of PA in ways that reflect the multi-
dimensional nature of people’s lives and that validate their choices for activities is 
difficult. In particular, to accurately do this by physical activity questionnaires (PAQs) 
remain a challenge (Ainsworth et al., 2000). Although the majority of PAQs in use appear 
to have acceptable reliability, validity can only be considered moderate at best. 
However, despite more frequent use of objective assessments methods to measure 
physical activity, PAQs still provide a very practical method to use. More objective 
methods of measuring physical activity levels, such as accelerometers, were not 
available for use. 
 
6.2.5 Data Analysis 
Demographic characteristics of all participants were presented using descriptive 
statistics (means, standard deviations and range of scores). All data were tested for 
normal distribution using a Shapiro-Wilks test of normality. To analyse differences 
between the control group and intervention group, normally distributed data were 
analysed using independent samples t-tests and data found to not be normally 
distributed were assessed using Mann Whitney U. The QoL scores were assessed 
utilising the EORTC QLQ-C-30 and BR23 scoring system which is composed of both multi-
item scales and single-item measures. These include a functional scale, and a symptom 
scale (both of which are specific to these study outcomes), a global health status / QoL 
score. Repeated measures ANOVAs were calculated and these results reported as trends 






Eighty-four women were approached during the time period October 2012 and July 
2014 (22 months) who met the inclusion criteria, resulting in thirty-five agreeing to take 
part in the study (35/84, 41.6%). Figure 4 shows the flow of participants through the 
trial. Of the 35 women who agreed to take part in the study 19 were assigned to the 
control group and 16 to the intervention group through a block randomisation process. 
The majority of those who did not want to take part in the study reported travelling 
distance to the University as the main reason (n=16, 19%) or not interested (n=8, 9.5%). 
A number of other reasons were cited such as: caring duties (n=2) or holidays (n=2). A 
total of 12 (14%) could not be contacted after expressing interest in the study. All other 
reasons for not participating are reported in Figure 4. The time period for recruitment 
lasted a total of 22 months and was stopped because of PhD time-frames for 
completion. This meant the target of 40 participants (20 in each group) was not met. 
Recruitment was initially undertaken by Breast Care nurses at the hospital but with very 
limited numbers through this channel (over the 22 months, 33 were identified as 
eligible, 19 were interested, and 11 recruited, representing a 33% recruitment rate) 
Breast Cancer Care was approached and recruitment by the researcher began in July 
2013 and lasted until July 2014 (over 12 months, 51 were identified as eligible, of whom 
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Mass, (kg) 
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Chemotherapy 1 1 0 
Radiotherapy 26 13 13 
Hormonal Therapy 27 13 14 




Comparison of experimental and control group characteristics at baseline 
Descriptive statistics of the data set at baseline are shown in Tables 11 and 12. All data 
were assessed to see if they were normally distributed. To check to see if the data were 
normally distributed a Shapiro-Wilks test of normality was used as the data set was less 
than 40 participants. Stature, % body fat, % fat free mass and PA levels were deemed to 
be normally distributed. Age, body mass, body mass index (BMI) and distance walked in 
12 minutes were assessed as being not normally distributed. 
 
 
Table 9: Baseline demographics of the study sample  
 
Characteristic Intervention   
(n=14) 
Control   
 (n=14) 
Mean (SD) Age, years 66.36 (2.37) 67.00 (6.37) 
Age range 62-71 60-81 
Mean (SD) Stature (m) 161.5 (8.86) 162.5 (4.54) 
Mean (SD) Mass (kg) 72.23 (18.16) 74.27 (18.87) 
Mean (SD) Body mass index (kg/m2) 27.69 (6.43) 28.09 (6.74) 
Mean (SD) fat mass (%) 40.07(6.80) 39.46 (11.44) 
Mean (SD) fat free mass (%) 59.93 (6.80) 60.27 (11.49) 
Mean (SD) distance walked in 12 mins (m) 













Differences between control and intervention groups at baseline 
To establish whether there were differences between the control group and 
intervention group at baseline (see Table 12), normally distributed data were analysed 
using independent samples t-test and non-parametric data (not normally distributed) 
was assessed using Mann Whitney U.  
For stature, % body fat, % fat free mass and PA levels, there was found to be no 
statistically significant differences between groups at baseline, suggesting that both 
groups were well matched. 
No significant differences (p > 0.05) were noted at baseline between groups for age, 
body mass, body mass index (BMI), 12 minute walk, stature, % body fat, % fat free mass 
and PA levels, suggesting that both groups were evenly matched and that any results 
from the study would not be due to any such differences. 
Comparison between participants who dropped out and participants completing the 
trial 
For all data that were normally distributed, to examine the differences between those 
participants who dropped out and those who completed the study (Table 12), 
independent samples t-tests were used. No difference between the groups for age (p = 
0.705), % body fat (p = 0.136), % fat free mass (p = 0.567) and PA levels (p = 0.056) were 
found, which demonstrated the groups were evenly matched for these measures at 
baseline. 
For data that were not normally distributed, a non-parametric test, Mann-Whitney U 
was used to examine whether there were any significant differences at baseline 
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between the participants who dropped out and all the participants who completed the 
12-month trial. 
There was a statistically significant difference between those who dropped out (Mean 
rank = 11.07) and those who completed all time points (Mean rank = 19.73) for the 12-
minute walk distance. Mann-Whitney U-values was found to be statistically significant 
U = 49.500, (Z =2.000), p = 0.045, and the difference between the groups was moderate 
(r = .34), which may suggest that those who dropped out were of a lower level of fitness 
compared to those who did not drop out and those who went on to complete the full 
study. 
 
Table 10: Baseline demographics of participants who dropped out during the study 
and those who completed all time-points  
Note: Data are presented in mean and (standard deviation) 
 
 




Age, years 68.71 (6.18) 66.68 (4.73) 
Age Range 60-77 60-81 
Stature (m) 1.61 (0.05) 1.62 (6.92) 
Body mass (kg) 75.85 (18.88) 73.25 (18.20) 
Body mass index (kg/m2) 
Fat mass (%) 
Fat free mass (%) 
Walk distance 12-mins (m) 













Acceptability of the intensity of the supervised intervention 
 
Using the Hosand heart rate monitoring system was very time consuming (getting the 
heart rate monitors on, waiting for a signal), and beset with technological issues (heart 
rate signals “dropping out” and randomly spiking or not working). Therefore, using 
ratings of perceived exertion was selected as the sole method of monitoring exercise 
intensity.  
RPE data were collected twice per participant per exercise session to consider how hard 
or easy they were finding the exercise intensity. Using the Borg category ratio scale (0-
10) participants rated the exercise intensity of the sessions between 2 = very light and  
hard = 5 
 
Table 11: Supervised intervention acceptability - Ratings of Perceived Exertion (RPE)  
 
Week N RPE SD 
1 14 3.19 0.83 
2 13 3.07 0.70 
3 12 3.40 0.57 
4 13 3.34 0.65 
5 13 3.75 0.55 
6 14 3.63 0.73 
7 14 3.31 0.75 
8 11 3.36 0.66 
9 12 3.04 0.57 
10 14 3.11 0.45 
11 13 3.12 0.65 
12 14 3.31 
 
0.66 
Note: Data are presented as mean and standard deviation  
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Narrative feedback and comments (participants’ verbatim comments during the 
exercise intervention) 
A number of comments and feedback recorded from the participants who took part in 
the exercise intervention have also been included to further consider the feasibility and 
acceptability of the exercise programme. Participant quotes have been integrated 
within this results chapter to provide further data in relation to the outcomes measured 
and the intervention itself. These have been integrated under common themes of group 
cohesion, improved functioning, improved arm functioning, less pain and feeling better. 
In-depth interviews of participants from both control and intervention groups, along 
with women from the study population are considered in detail in the next chapter.  
Group cohesiveness 
As discussed, participants provided comments about the usefulness of group exercise 
classes. These focused upon group cohesiveness as demonstrated in the excerpts below: 
“You do more with others with you. I like the fact others are here”. (Part 18 – week 1) 
“Like the group environment – makes you focused and motivates you”. (Part 14 – week 
9) 
“Sometimes it is getting here…but once here really enjoy it”. (Part 14 – week 4) 
“Found it hard coming to some sessions but knew that afterwards I would feel better and 
I did. I’d tell the new ladies…a lovely way of doing keep fit in moderation”. (Part 14 week 
12) 
“Really working well. I’m enjoying it”. (Part 29 week 2). 
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Feeling fitter and improved functioning 
Participants in the study commented upon improved functioning and feeling fitter as 
can be seen in the excerpts below: 
“I’m walking much faster. I feel much better. (Part 29 week 3). 
“I can do more –I don’t get out of breath as much”. (Part 12 – week 5) 
“Felt the exercises have really helped my legs. I find going up the stairs easier…think they 
are stronger”. (Part 14 – week 5) 
“I find I have more energy…more energetic”. (Part 13 – week 6) 
“I have found the exercise beneficial but I don’t exactly know why but feel better”. (Part 
6 – week 11) 




Participants in the intervention group commented that:  
“I don’t know how you can’t feel the benefits. It’s really good… (Part 24 week 3) 
“I feel like I’m getting back to myself”. (Part 24 week 4) 
“I’ll feel better tomorrow…the exercise makes me feel better after. I went to the Maze at 
York and was walking lots and climbing with the grandchildren. My husband said you 
wouldn’t have been doing that a few weeks ago. It is confidence…it gives you more 
confidence. (Part 32 week 6). 
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Improvements in arm and shoulder function 
“Starting to feel the benefit of the exercises…paying off now. I found cleaning the bath 
so much easier…normally I struggle with the shoulders…reaching around”. (Part 1 – week 
11) 
“This arm is much better from doing the home exercises…I don’t know if you can 
remember but I couldn’t straighten it above my head…now look! (Part 5 – week 4) 
“What I find is that on a Thursday after the exercise class when I wake up my shoulders 
and arms feel much better and looser. On the other days they are stiff when I wake”. 
(Part 6 – Week 3) 
“Shoulder and arm functions is so much better. Really noticed dancing at a wedding how 
much better it was. Going to do more of a circuit in the gym and do some weights. Found 
it enjoyable and interesting”. (Part 8 – week 11) 
“Definitely feel without a doubt better for it. Now do more walking. Do my arm exercises 
all the time…really feel better, more loose”. (Part 7 – week 11) 
 
Less pain 
“Getting a lot of joint pain before but think the exercises may have eased it…Definitely, 
joint pain is less (Part 13 – week 3) 
“I really find the exercise beneficial for my back. I’m not in as much pain or it doesn’t 
flare up as much (Part 14 week 10) 
“I think the exercises has helped my Lymphoedema. It doesn’t feel as lumpy or hard under 
my breast”. (Part 1- week 4) 
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“I think the same…it is not as hard under my breast”. (Part 3 – week 4) 
“I wasn’t aching so was really surprised! Really enjoyed it. (Part 7 – week 2) 
 
Adherence to the supervised intervention (experimental group only) 
Attendance at every supervised exercise session was recorded. Attendance was an 
average of 87.5% for all participants. Intervention adherence was calculated by summing 
the total possible number of attendances and the actual number of recorded 
attendances. The maximum number of supervised exercise classes available to all 
participants was 192 (16 participants x 12 weeks). Thus, the actual attendance was a 
total of 168 sessions = 87.5% attendances. Attendance rates were higher once the 
participant who dropped out during the intervention was excluded (161/180 = 89.4% 
attendance). Five participants completed all 12 sessions (31% = 100% attendance), five 
completed 11/12 sessions (31% = 92% attendance), one completed 10/12 sessions 
(6.25% = 83% attendance) and four completed 9/12 sessions (25% = 75% attendance). 
10/15 who completed the 12-week intervention had an average attendance of 95.8%. 
Of the 15 participants who completed the 12-week intervention, 15/16 (93.75%) had an 
attendance of 90.5%. Mean attendance rate was 10.3 visits per 12. The reasons for non-
attendance were: holidays; child-minding; family commitments; personal or family 
illness.  
 
Adherence to the home-based intervention (experimental group only) 
The monitoring of home-based PA and compliance to the home-based sessions was 
problematic. The compliance rate was very poor for the first seven participants with only 
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one fully completing the diary. The participants reported struggling to remember to fill 
it in at the time (daily) and found that they were repeating the same activities when 
filling it in at a later date. For this reason, the use of a daily PA diary was not continued 
and the SPAQ was used to record PA levels over a one-week period at all four time points 
with compliance at 100% for this. In hindsight, another method of monitoring the home-
based programme should have been implemented, such as a simple yes or no for 
whether they had done the sessions or not. If available for use, PA monitors 
(accelerometers) would have been a very accurate measure of actual PA levels during 
this time-period. Although probably not appropriate to use for the full 12 weeks it may 




No adverse events were reported during or after the 12 week intervention by the 




Attrition in the control group (n=19) overall was 26% for the whole trial. Five participants 
dropped out during the trial and reasons for drop out included: re-diagnosis; too busy; 
poor health and full-time caring responsibilities; a knee replacement operation and 
severe arthritis and back pain. Control group drop-out to the trial was twice that of the 
intervention group. This resulted in an attrition rate of 20% overall for the study when 
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both groups were combined. The intervention group (n=16), with only one drop-out 
during the intervention (6.25%) and one before the 12-month assessments (6.25%) had 
an overall attrition rate of 12.5% for the whole study. At the 3-month stage 6/35 
participants had dropped out (17.1%). At 6 months no more participants had dropped 
out only and a further one dropped out in the last few weeks at 12 months with a 
diagnosis of secondary breast cancer. 







Baseline 16 19 35 
3-months 15 (1) 14 (5) 29 
6-months 15 (0) 14 (0) 29 
12-months 14 (1) 14 (0) 28 
 
Trial completion rate 
Overall seven participants dropped out of the trial over the 12 months with the majority 
(6/7; 85.7%) dropping out within the first 12 weeks. The trial completion rate was 28/35  
(80%). However, more dropped out from the control group (5/19; 26%) compared to the 
intervention group (2/16; 12.5%).  
 
Intervention completion rate 
In the intervention group, 16 participants started the exercise intervention and 15 
completed the 12-week exercise intervention (93.75%). One participant dropped out for 
health reasons during the exercise sessions (not related to the intervention) and one 
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participant dropped out just before the 12-month follow-up assessments due to a 
diagnosis of secondary breast cancer (although she completed the 12-week exercise 
intervention 11/12). As stated above compliance to the home-based sessions was not 
monitored, thus, an accurate account of the full intervention compliance is not available. 
 
Implementation fidelity 
Considering the five elements according to Dusenbury et al. (2003) the supervised 
exercise intervention was delivered according to  protocol (see Table 5 & 6); however, 
the home-based programme was not monitored, therefore this element did not meet 
the protocol (see 6.4.3) so a true figure of overall intervention adherence is not 
available. Exposure or dose of the supervised intervention received by the participants, 
considering the frequency and duration according to the protocol was a total of 168 
sessions = 87.5% attendances. Of the 15 participants who completed the 12-week 
intervention, 15/16 (93.75%) had an attendance of 90.5%. Mean attendance rate was 
10.3 visits per 12. Again, because home-based sessions were not monitored an accurate 
account of the frequency and duration of home based activity and overall intervention 
adherence cannot be given (supervised and home-based combined). The quality of 
delivery was not independently or objectively assessed, therefore, this element of 
treatment fidelity cannot be assessed,  however, the instructor was an experienced (20-
years+) exercise instructor working with older adults with a range of health conditions 
and trained and qualified as a level 4 cancer and exercise specialist. In hindsight it would 
have been useful and appropriate to have an independent person monitor and observe 
a selection of sessions to verify the quality of delivery and of the exercise sessions being 
delivered as per the protocol. Participants appeared to respond well to the supervised 
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intervention with high adherence rates but found it difficult to monitor and adhere to 
the home-based intervention, resulting in this not being monitored. Comments and 
thoughts about the intervention were reported at the time using field notes (see 6.4.2). 
Programme differentiation was difficult to determine but recruitment via alternative 
channels than the hospital proved essential. The monitoring of adherence to the home-
based programme is also important to give an accurate picture of adherence to the 
whole programme to consider the feasibility of additional unsupervised sessions. This 
would be important for any future trials. 
 
6.3.1 Intervention outcomes 
Comparison of body mass and body composition changes over 12 months between 
experimental and control groups 
 
Table 6: Body mass and body composition changes over 12 months 
 










% body fat 40.07 6.80 39.76 (n=13) 11.44 
% Fat free mass 59.93 6.80 60.27 11.49 
3 months   
Body mass (kg) 71.47 17.82 74.45 (n=13) 18.69 
% body fat 38.56 7.72 40.49 12.14 
% fat free mass 61.44 7.72 59.52 12.16 
6 months   
Body mass (kg) 71.11 17.44 74.42 (n=13) 18.61 
% body fat 40.42 7.19 40.72 12.84 
% fat free mass 59.58 7.19  59.31 12.85 
12 months   
Body mass (kg) 70.63 18.24 74.22 (n=13) 17.57 
% body fat 40.26 7.83 41.51 11.22 
% fat free mass 59.74 7.83 58.49 11.22 
Note: Data are presented as mean and (standard deviations) 
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This Table demonstrates that body mass decreased consistently for the experimental 
group over the four time periods; however, the control group’s body mass did not 
change over the 12 month period. Body fat decreased for the experimental group during 
the 12 week intervention but then increased back to baseline levels by 12 months. 
However, in the control group, body fat increased consistently over the 12-month study. 
Fat free mass increased during the 12-week intervention for the experimental group but 
then returned to baseline levels by 12 months; however, the control group steadily lost 
fat free mass over the 12 months. 
Comparison of distance walked in 12 minutes between the experimental and control 
groups over 12 months 






Baseline 12 min walk (m) 763.93 (105.20) 800.32 (124.26) 
3 month 12 min walk 873.60 (112.63) 873.19 (150.04) 
6 month 12 min walk 896.45 (120.66) 876.25 (135.03) 
12 month 12 min walk 946.50 (116.65) 906.55 (138.63) 
Note: Data are presented as mean and (standard deviations) 
 
There was a significant increase in walk distance in 12 minutes by both groups (p < 
0.001), although there was not a significant difference between groups in walk distance. 
However, the experimental group increased the distance they walked more than the 




Comparison of self-reported physical activity levels over 12 months between 
experimental and control groups 






Baseline SPAQ (mins) 447.93 ± 234.14 545.36 ± 304.44 
3-month SPAQ 575.86 206.20 579.14 319.52 
6-month SPAQ 636.93 300.26 730.00 485.47 
12-month SPAQ 574.86 199.86 501.79 291.79 
Note: Data are presented as mean and (standard deviations) 
Although there was no statistically significant change in PA levels between the groups, 
both groups significantly increased PA levels during the 12 months (p=0.040). As can be 
seen in table 15 both groups increased their PA levels up to 6-months but then both 
groups reduced PA levels between 6-12-months. However, the experimental group still 
maintained higher PA levels than at baseline, whereas the control group had reduced 
PA levels to below those at baseline. 
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Comparison of EORTC–C30 and BR-23 QOL variables between experimental and 
control groups over 12 months 
Table 9: Quality of life changes over 12 months 
 
Quality of Life Outcome Group  
(n=14) 
Baseline 12 months Trend 














































































































All scores have been converted into a score range of 1-100. For the functioning scales, a 
high score (nearer 100) indicated a high level of functioning. For the symptom scales, a 
low symptom score indicated fewer symptoms / problems. Emotional functioning, 
future perspective, breast symptoms and arm symptoms reached statistical significance 
for the experimental group. Trends have been used to demonstrate which scores 
favoured which group. As can been see from table 16, other than fatigue, dysneoa and 
insomnia, all trends were in favour of the experimental group. 
 
6.4 Discussion 
The primary purpose of this pragmatic pilot RCT was to examine the feasibility and 
acceptability of an exercise intervention for older women (> 60-years old) who have 
recently been diagnosed with breast cancer. The collection of this feasibility and 
acceptability data was to help address gaps in the evidence with this population and 
improve trial procedures to allow clinicians and researchers to replicate trial procedures 
or build on these research findings, so as to inform the design and conduct of any future 
large-scale trials with this population. Additional intervention outcomes of functional 
capacity, body composition, physical activity levels and quality of life outcomes were 
also assessed to consider what benefits may result from this intervention.  
 
6.4.1 Recruitment 
Recruitment was much more difficult and time-consuming than anticipated using only 
health care professionals. Breast care nurses recruited only 11/35 participants over a 22 
month period revealing a feasibility issue that would need to be addressed if a future 
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larger trial is to be considered. Recruitment was considerably improved by the 
researcher approaching participants through a cancer charity, Breast Cancer Care, that 
had enrolled onto a 4-week educational programme “Moving Forward”. This 
programme is not available throughout the country, so such a method of recruitment 
should be considered cautiously as a potential alternative or adjunct to using health care 
professionals; however, for this current pilot trial it was a successful method of 
recruitment (24/35 participants).  
Recruitment difficulties appear to be a common problem in this research field 
(Campbell, Mutrie, White, McGuire, & Kearney, 2005a; Demark-Wahnefried et al., 2008; 
Demark-Wahnefried et al., 2006; Payne & Hendrix, 2010). In a pilot study of group 
exercise during breast cancer treatment, Campbell, Whyte, and Mutrie (2005b) 
highlighted some potential reasons for “recruitment not being as successful as 
predicted”. These included a lack of time from nurses and nurses not viewing 
recruitment to the study a priority. Recruitment was also influenced by the nurses’ 
“perception” of whether they considered the cancer patient to be “fit enough” to 
exercise. These may have been similar issues experienced in the present study; however, 
breast care nurses were not interviewed to ascertain if they experienced any issues or 
barriers to recruitment. This information would be useful for any future trials.  
The above recruitment challenges suggest that the setting for the recruitment of 
participants and who actually does the recruitment are very important factors for 
consideration in future studies and the traditional method of recruiting via the 
healthcare professional may not always be the most effective method. Therefore, 
alternative methods of recruitment should be considered. Poor recruitment for physical 
activity interventions increases the chance of the trial being abandoned, with potential 
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important clinical effects of that trial either not being shared or reported (Oliver & 
Mossialos, 2004).  
Although recruitment to the study was challenging, 41.6% of patients approached for 
this study agreed to take part. The biggest reason cited by the breast care nurses for 
potential participants not wanting to be involved in the study was that the University 
(where the intervention and outcome assessments took place) was too far away. It is 
not known whether this was a travel issue due to a lack of transport or a time issue to 
commit to the travelling. The delivery of the exercise intervention and the data 
collection of outcome assessments at only one site, which was a considerable distance 
from one of the hospitals involved in recruitment appeared to have hindered 
recruitment targets and took longer than anticipated. Understanding reasons for non-
participation is therefore important because this information can be used to improve 
consent rates in future studies, and in turn, minimise one of the treats to precision of a 
trial (Hubbard et al., 2016). The ability for data to be collected and the exercise 
intervention to be delivered at multiple sites, making it more accessible and convenient, 
should be considered to improve recruitment in future studies.  
Although the current study had a number of recruitment challenges, recruitment was 
high when compared to a number of other breast cancer and exercise research studies 
(Mutrie et al. (2007)= 18.2%; Daley et al., 2007 = 28.6%; Winter-Stone et al., 2011 = 
29.5%; Courneya et al., 2007 = 33%). It appears that length of time since diagnosis may 
be an important factor in recruitment success. Crane-Okada et al. (2012) recruited 49 
participants with a very favourable recruitment rate of 46.6%. However, the mean time 
since breast cancer diagnosis was approximately 10 years. LaStayo, Marcus, Dibble, 
Smith, and Beck (2011) recruited older cancer patients (but not breast cancer only) with 
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a mean age of 74 years to participate in a three times a week resistance programme. 
Those recruited were on average of 8.4 years post cancer diagnosis. Winters-Stone et 
al. (2011) recruited 102 older women with breast cancer with a mean age of 62 years. 
Recruitment rate was 29.5% with a mean time since diagnosis of 60.5 months, although 
they reported that all participants had to be at least 1 year-post treatment before 
commencing the study, thus, excluding potential participants who were during or 
immediately post-treatment. The reason for ensuring participants were at least 1-year 
post-treatment was not given. This time since diagnosis appears to be an important 
factor in recruitment, especially if participants are still undergoing active treatment and 
therefore may result in lower recruitment rates.  
With no exercise studies specifically targeted older women with breast cancer during or 
immediately post adjuvant therapy it was unknown whether older women would be 
willing to participate during this time-frame and according to the literature it is more 
difficult to recruit during this time. However, this study has demonstrated that it is 
possible to recruit at this time-point, although challenging; older women should be 
encouraged to become more active during or post-treatment for breast cancer. Many 
exercise studies have recruited BCS onto an exercise study with varying degrees of 
success; however, the mean age for recruitment for most exercise and breast cancer 
studies was 51.6 years (Courneya et al., 2007; Daley et al., 2007; Ligibel et al., 2008; 
Milne, Wallman, Gordon, & Courneya, 2008; Mutrie et al., 2007; Penttinen, Nikander, 
Blomqvist, Luoto, & Saarto, 2009). This is an average age of 16 years younger than 
participants in the present study. With so few studies that have specifically targeted 
older women with breast cancer, it could be suggested that age may be a barrier to 
recruitment onto exercise trials.  
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When examining the recruitment rates of exercise trials specifically targeting older 
women with breast cancer, Crane-Okada et al. (2012) recruited 49 participants with a 
very favourable recruitment rate of 46.6%, with a mean age of 65.6 years to a 12-week 
intervention with follow-up after six weeks with questionnaire assessment. This 
demonstrates that it is possible to recruit older women to an exercise study; however, 
LaStayo et al. (2011) reported a very low recruitment rate of only 14% and Winters-
Stone et al. (2011) had a recruitment rate of 29.5%. Demark-Wahnefried et al. (2006) 
managed to recruit older cancer survivors (mean age = 71.7 years) to a 6-month home-
based diet and exercise intervention through a mailed recruitment drive (26% of 
responders). However, the authors did not meet their accrual target, and this was not a 
supervised exercise intervention so there was less involvement from the participants. 
All of these studies highlight the difficulties in recruiting this population of older BCS.  
 
6.4.2 Adherence to the intervention 
Adherence to the 12-week supervised exercise intervention in the present study was 
high (87.5%) in comparison to other breast cancer and exercise studies (Courneya et al., 
2007; Crane-Okada, Kiger, Sugerman, et al., 2012; Daley et al., 2007; Dodd et al., 2010; 
Winters-Stone et al., 2011). However, the reported adherence rates in the above trials 
were considerably lower than reported by LaStayo et al. (2011) with a 95% adherence 
and (Courneya, Bell, Jones, Field, & Fairey, 2003) with a 98% adherence. Winters-Stone 
et al. (2011) recruited older women with breast cancer closer in time to their cancer 
diagnosis, recruiting women who were at least 1-year post-treatment onto a 12-month 
resistance + impact programme to examine the effects of this type of exercise on bone 
mineral density (BMD). Adherence to the supervised sessions was 66.5%, which may 
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suggest that the time elapsed since their breast cancer diagnosis may affect adherence. 
However, home-based intervention adherence was not monitored. Participants at the 
start of the intervention reported difficulties in remembering to fill in the daily activity 
diaries and remembering to do the home-based intervention. Therefore, without any 
home-based intervention adherence data we cannot draw any conclusions as to the 
success of the intervention and overall adherence rates could be significantly different 
if home-based intervention adherence would have been combined in these figures. The 
supervised intervention appeared to be acceptable given the high adherence rates but 
any future study must ensure that all intervention data is collected.  
It could be suggested that older women with breast cancer are more willing to 
participate in exercise the longer they are from the time of diagnosis. However, what is 
not known is whether how many older women with breast cancer have been 
approached to participate in an exercise intervention during or immediately post-
treatment as this has not been reported in the literature and it appears mainly younger 
women have been recruited to exercise interventions. Older women with breast cancer 
who have been involved in exercise trials have been many years post-diagnosis, 
suggesting that the period of time when an older breast cancer patient is undergoing or 
has just finished active treatment may be a difficult time to recruit to an exercise study, 
especially onto a supervised intervention. This view is supported by Young-McCaughan 
and Arzola (2007) who agree that the timing of the intervention in relation to diagnosis 
is important, as it is more difficult to participate in an exercise programme whilst still 
undergoing treatment.  
In an early study, Young-McCaughan et al. (2003) found that 85% of those participants 
who had completed treatment completed an exercise programme, whilst only 40% of 
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those still in treatment completed the programme. Dodd et al. (2010) reported 
adherence rates of 74% to a 12-month home-based exercise intervention started during 
adjuvant treatment but the group that started exercising after completing all treatment 
had a higher adherence rate of 86%, which appears to concur with Young-McCaughan 
et al. (2003), in that it may be more difficult to exercise regularly during active 
treatment. It does appear that adherence rates are higher when participants have 
finished treatment. The reasons for this are often attributed to the cancer or treatment 
side-effects such as cancer-related fatigue, physical deconditioning, loss of range of 
movement or other side effect issues, such as a lack of self-confidence or self-image 
Courneya et al., 2008; Blaney et al., 2010; Blaney, Lowe-Strong, Rankin-Watt, Campbell 
& Gracey, 2013).  
Thus, adherence rates of older adults (>60 years) in exercise interventions during or 
immediately post adjuvant treatment have not been reported in the literature before, 
which is not surprising given that there is a noted lack of studies that have specifically 
targeted this population. Another difficulty when comparing adherence levels between 
exercise interventions with breast cancer patients is the heterogeneity of studies. 
Exercise programmes ranged from eight weeks to 12 months and differed in the exercise 
prescription of frequency; 1 x week – 5 x week, intensity; low, moderate – using RPE, % 
of HR maximum or % of 1-RM loads, time; 20 minutes – 1 hour or progressive over time, 
and type; resistance, aerobic, stretching or combined. Studies were also a mixture of 
supervised or home-based exercise interventions. To add further heterogeneity to the 
studies, participants were recruited during treatment, post-treatment or many years 




6.4.3. Adverse Events 
No adverse events were reported during the trial from either the intervention group 
during the 12-week intervention or by any participants whilst participating in the 
outcome assessments. This is an important finding because although we are aware of 
the safety and efficacy of exercise during and after breast cancer treatment for younger 
women, it was not clear from the literature regarding this older population. The research 
literature on younger women with breast cancer clearly indicates that it is safe for 
participants to exercise during treatment(Courneya et al., 2007; Mutrie et al., 2007; 
Schwartz, Winters-Stone, & Gallucci, 2007), however, no studies with older women with 
breast cancer have recruited participants during this time period so the data from this 
pilot trial adds new evidence to the safety and efficacy of exercise with older women 
with breast cancer during or after adjuvant treatment. 
 
6.4.4. Retention to the trial 
Another trial parameter that indicates imprecision, is loss of participants to a study, 
which may include a combination of factors, such as, participants formally dropping out 
of the trial (retention) or failing to complete the outcome assessments (completion rate) 
or failing to provide data (missing data). Loss of participants during trial follow-up can 
introduce bias and reduce power, thereby affecting the generalisability, validity and 
reliability of results (Grimes & Schulz, 2002; Hubbard et al., 2016). Overall, the 12-month 
trial and 12-week exercise programme had an acceptable retention rate to the whole 
study (both groups combined) of 80%. This included a 12.5% drop-out from the 
intervention group (only one participant dropped out during the 12-week exercise 
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intervention and one at 12 months) and five participants dropping out from the control 
group (26%).  
Possible explanations for this higher drop-out for the control group include: their 
exclusion from the intervention group and therefore being less willing to continue with 
the study; that the time and commitment required for the study was more than they 
initially imagined or that the physical assessment (12-minute walk) were more 
demanding than expected.  
The attrition rate for this study was similar to that reported by Courneya et al. (2007) 
with 83.1% of participants providing data at 6-month follow up, although this follow-up 
data were obtained by a mailed questionnaire, thus did not require the participants to 
come into a centre, in person, as did the present study. At the primary end point follow-
up assessment after the intervention, participant attrition was 7.9%, which is 
comparable to this study at the same time-point (6.5%). Mutrie et al. (2007) reported 
an overall attrition rate of 14% when following up at six months after a 12-week exercise 
intervention had taken place.  
The home-based exercise groups had a better attrition rate of 17.5%, whilst the 
supervised exercise group had an attrition rate of 24%. A possible reason for this higher 
attrition by the supervised intervention group is that the intervention group was 
expected to attend the supervised exercise programme three times per week and also 
exercise at home on at least two other days per week. This is a substantial commitment 
and may have contributed to the higher attrition rates compared to the home-based 
sessions. Cadmus et al. (2009) also reported very low attrition rates of 11% for a 
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supervised exercise intervention lasting six months, which was started during adjuvant 
therapy.  
(Stevinson & Fox, 2006) reported a much higher attrition rate of 25% for a 10-week 
intervention with participants attending a supervised exercise circuit once per week and 
4 x week of home-based activity. With this study being a longitudinal study (12-months), 
with more time points for data collection and therefore, potentially more opportunities 
to drop out, the fact that attrition rates were comparable with other exercise and breast 
cancer studies recruiting younger participants further demonstrates the acceptability of 
the exercise intervention and the outcome measures selected for use in an exercise trial 
with older women with breast cancer. 
 
6.4.5. Retention rates in exercise and breast cancer trials with older women 
One of only a few studies that recruited older women with breast cancer to an exercise 
intervention, Crane-Okada et al. (2012) reported an attrition rate of 12%, and although 
this was a comparable 12-week intervention, follow up was only six weeks and by 
questionnaire. Winters-Stone et al. (2011) recruited 106 older women with breast 
cancer, (mean age of 62 years) and randomised them to a 12-month resistance and 
impact training programme or a control group of stretching only. The retention rate for 
the resistance and impact group at follow-up was 69.2%, and for the stretching only 
group 57.4% at 12 months, with a combined retention of 62%.  
Although retention was lower than the present study (20% compared to 30.8%), their 
intervention was 12 months. Thus, considerable commitment and motivation was 
required of participants to continue with such a long intervention. Considering the 
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retention rates of this study and when compared to other similar breast cancer and 
exercise trials which have recruited both younger and older women with breast cancer, 
all with differing lengths of interventions and follow up, it could be suggested that the 
length of this present trial (with four time points), and the supervised exercise 
intervention was both suitable and acceptable by older women with breast cancer.  
 
6.4.6 Outcome to measure the effectiveness of the intervention 
Walking distance in 12 minutes was statistically significantly improved by both groups 
during the 12-month study. Although both groups significantly increased their 12 minute 
walk distance, there was more of an improvement by the intervention group than the 
control group. The intervention group also managed to maintain this improvement in 
walking distance in 12 minutes at 12 months when compared to the control group. There 
was a statistically significant change over time for PA levels for both groups.  
Both groups increased their PA levels during the study from baselines until 6-months 
but then both groups reported a reduction in PA. The intervention group reported doing 
more than two hours’ additional physical activity at the end of the study compared to 
the start of the study. The control group, however, at 12-months had reduced PA levels 
to below that reported at baseline.  
No statistically significant findings were noted for body composition at any time points 
and between groups. However, an interesting observation was noted in the intervention 
group for body composition, with an observed loss of fat mass and an increase in fat 
free mass during the intervention period, although these changes could not be 
maintained over the 12 month trial. This positive body composition trend was noted in 
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favour of the intervention group throughout the 12 month trial, and may have statistical 
or clinical significance with a larger sample size.  
Quality of Life domains of emotional functioning, future perspective, breast symptoms 
and arm symptoms reached statistical significance for the intervention group only. 
Positive trends in favour of the intervention group were observed for: global health 
status, physical, role, cognitive and social functioning, pain, body image, side effects, 
breast symptoms and arm symptoms. Positive trends noted in favour of the control 
group were noted for fatigue, dyspnoea and insomnia.  
 
6.4.7 Physical activity levels 
There was a statistically significant change in PA levels in both groups over the 12-month 
intervention. Both groups increased their PA levels over the first six months of the study, 
but were then reduced their PA levels between six and 12 months. The intervention 
group reported higher levels of PA at 12-months from baseline levels compared to the 
control group. The control group PA levels had returned to below baseline levels at the 
12-month stage. The intervention group reported doing 127 minutes more PA at 12-
months than reported at baseline, whereas the control group reported a reduction of 
44 minutes less physical activity at 12 months then at baseline.  
The mean time of PA for both control and intervention group at baseline was very high, 
545 minutes and 447 minutes respectively, which suggests those recruited to the study 
group were already very physically active and highly motivated. It may also suggest that 
both groups could have over-estimated their actual PA levels, which could be due to 
self-reporting bias or social desirability or the actual questionnaire used may not have 
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been the most appropriate. Similarly, Mutrie et al. (2007) reported high levels of physical 
activity by their BCS at baseline (365 minutes and 367 minutes) for the control group 
and intervention group respectively, these figures are well above the national guidelines 
for physical activity (Haskell et al., 2007). In the same study both groups significantly 
increased their PA levels over the study duration but the exercise group maintained 
higher levels of physical activity at the 6-month follow up (Mutrie et al., 2007). In the 
follow-up at 18 months and five years, Mutrie et al. (2012) reported that the exercise 
intervention group was still more active than the control group at both follow-up time 
points. 
These findings, albeit over a longer time period than the present study, appear to 
support the suggestion that starting an exercise programme may have positive long-
term effects, not only on increasing PA levels but on other well-known health benefits 
associated with being more physically active. This increase in physical activity levels by 
both groups could have a very important clinical meaning, as indicated by Irwin et al. 
(2003), who reported that PA levels were significantly reduced after a diagnosis of breast 
cancer and they postulated that these lower PA levels had a greater potential for 
increases in weight gain.  
Becoming overweight and/or obese has been associated with poorer overall survival and 
breast cancer survival (Chan et al., 2014). Bellizzi (2005) further alludes to the 
aforementioned points, stating that cancer survivors are less likely to meet the 
CDC/ACSM recommendations of PA (150mins/week) than those without a history of 
cancer. These figures continue to decline with increasing age with only 24.9% of cancer 
survivors over 65 years meeting the recommended levels of PA. M. D. Holmes, Chen, 
Feskanich, Kroenke, and Colditz (2005) in their prospective observation study of 2987 
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nurses concluded that 3-5 hours of PA after a breast cancer diagnosis may reduce the 
risk of breast cancer mortality.  
These findings were supported in another observational study by Holick et al. (2008) 
who demonstrated that women with breast cancer who had greater levels of physical 
activity when compared to sedentary BCS had a significantly lower risk of dying from the 
disease. This dose-response relationship of physical activity and breast cancer mortality 
has been supported by the more recent research of Li et al. (2015) and Zhong et al. 
(2014) in their meta-analyses. Both analyses reported an inverse relationship between 
PA levels and breast cancer recurrence and breast mortality.  
Li et al. (2015) suggested that breast cancer patients who are physically active up to 10 
metabolic equivalent task (MET)-h/week may result in a risk reduction of breast cancer 
recurrence or mortality by 25%. Zhong et al. (2014), however, offered a slightly lower 
risk reduction of approximately 18%. Li et al. (2015) continued to suggest that being 
active over an equivalent of 15 MET-h/week may even offer a 30% risk reduction. These 
very recent meta-analyses of 69,011 cancer patients (Li et al., 2015) and 42,602 breast 
cancer patients (Zhong et al., 2014) both support the importance of BCS becoming 
physically active and at the very least trying to meet the ACSM recommended physical 
activity guidelines (Haskell et al., 2007). Therefore, it appears important for anyone with 
a diagnosis of cancer to increase their physical activity levels in order to reduce these 
poorer outcomes.  
The data from this study demonstrate that older women with breast cancer can increase 
their physical activity levels during or immediately after a breast cancer diagnosis. 
Furthermore, it could be suggested that if breast cancer survivors start a supervised 
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exercise programme they may maintain higher PA levels than women who do not start 
a supervised programme, even if they do not continue with the supervised sessions after 
the intervention period. This interesting finding indicates that there is a need for further 
research in this area, as it would appear that by attending an exercising programme in 
the short term it may lead to longer lasting increases in PA compared to somebody who 
does not start a programme. This increase in PA, if maintained over time, could have 
important clinical meaning in terms of reducing breast cancer recurrence and breast 
cancer mortality.  
 
6.4.8. Functional capacity (12-minute walk) 
Both the intervention and control group significantly increased their 12 minute walk 
distance over the duration of the study. Although there were no statistically significant 
differences in walk distance between the groups, the intervention group increased their 
distance from 763.93 metres to 946.50 metres, a total increase of 182.57 metres, an 
improvement in walk distance of 23% over the 12-months. The control group managed 
an increase of 106.18 metres from 800.32 metres to 906.55 metres, an improvement of 
13% over the 12 months. Thus, the intervention group had an improved walk distance 
of 58% compared to the control group, which may suggest that the exercise intervention 
did have some degree of benefit and success in improving functional capacity when 
compared to the control group.  
Mutrie et al. (2007) reported very similar findings, both their intervention and control 
group improved their 12 minute walk distance over the duration of the study, with the 
intervention group having a more pronounced improvement, mirroring the findings of 
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this study. Their control group increased walk distance by 38 metres over six months, 
whereas, their intervention group increased by 130 metres. This was a 29% increase in 
walking distance compared to the control group. A possible explanation for this increase 
in 12-minute walk distance by both groups could be due to self-selection bias and the 
non-statistical differences between control and intervention group may be due, in part, 
to the small number of participants in this study and therefore further supports the need 
for a larger trial with greater numbers which may lead to significant findings.  
With so many reported functional limitations with which BCS may have to deal as a 
consequence of cancer treatment and the association of increased fitness with 
improvements in mortality and morbidity, the importance of maintaining and improving 
cardiovascular fitness would appear to be essential. Sweeney et al. (2006) reported that 
women who were cancer survivors of less than two years reported more functional 
limitations than before diagnosis. Long-term cancer survivors when compared to non-
cancer adults were much more likely to report that they were unable to perform heavy 
household duties (42% versus 31%), unable to walk half a mile (26% versus 19%) and 
unable to walk up or downstairs (9% versus 6%). Ness, Wall, Oakes, Robison, and Gurney 
(2006) study concurs with these findings, further demonstrating the functional 
limitations that cancer survivors experience. They reported that cancer survivors were 
1.5-1.8 times (53% versus 21%) more likely to have physical performance restrictions 
and participation limitations than those with no history of cancer.  
Thus, improving walking capacity after a diagnosis of breast cancer could have many 
important health implications for older women and may support older women with 
breast cancer to live a disease-free and functionally unlimited existence. The improved 
fitness of the participants in this study may also have a positive impact on the ability of 
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older adults to perform activities of daily living, such as walking up and downstairs, 
general household tasks, cleaning, preparing meals and shopping.  
 
6.4.9. Body composition changes 
Body composition was improved by the intervention group during the 12 weeks of the 
supervised exercise intervention, but this was not a statistically significant 
improvement. Also, the reduction in percentage body fat and increase in fat free mass 
was not maintained over the 12 months by the intervention group. However, the 
improvements observed in body composition during the 12 week intervention period 
appeared to have an important effect on the actual amount of body composition change 
over the subsequent nine months of the trial for the intervention group.  
The interventions group’s body composition was the same at 12 months as it was at 
baseline. This was in contrast to the control group whose percent body fat increased 
and fat free mass decreased consistently at all time-points over the 12month study 
period. If this trend of increasing fat gain and muscle loss continued for the participants 
in the control group, this could lead to sarcopenic obesity – increased fat and a 
subsequent loss of muscle and bone tissue - or other health conditions associated with 
increased weight. Again, despite non-statistical significance, this trend could have an 
important clinical meaning.  
Excess or increased adiposity is linked to poorer prognosis through increases in 
circulating oestrogens, insulin and insulin growth factors (Sheean, Hoskins, & Stolley, 
2012) and an increased risk of breast cancer recurrence and higher risk of breast cancer 
mortality compared to maintaining a normal weight after diagnosis (Chan et al., 2014; 
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Irwin et al., 2009). Garner and Erck (2008) in their small pilot study (n=11) used air 
plethysmography (BODPOD) to assess body composition, they also found no significant 
changes in percent body fat during an eight week aerobic and resistance training 
programme. However, a number of other studies have reported significant changes in 
body composition.  
In a study comparing land-based exercise to water-based exercise, with a usual care 
control group exercising three times a week for eight weeks, Fernández-Lao et al. (2013) 
found that the land-based intervention group reported a statistically significant 
decrease in percent body fat when compared to the other groups. Burnham and Wilcox 
(2002) reported significant changes in body composition in their 10 week, 3 x week 
aerobic exercise intervention when compared to a no exercise control group, although 
this was a small number of participants (n=18) of both males and females. Similarly, 
Schmitz et al. (2005) reported significant increases in lean mass and significant 
decreases in percent body fat with a 12 month, twice weekly resistance training 
programme with recently diagnosed breast cancer survivors. If the effects of the 
exercise intervention on body composition could be maintained either by a more 
frequent intervention (3 x week), which the literature suggests, or by the continuation 
of the supervised sessions (longer duration), the differences between intervention 
group and control group in this present study may have been clinically meaningful.  
It would appear that those studies with a supervised exercise intervention greater than 
1x week reported significant changes on body composition. Schmitz et al. (2005) 
considered that if behaviour change could be maintained over time, the differences in 
body composition that they observed between BCS who continued to exercise and those 
who did not may have clinical significance. However, all the participants in the previously 
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mentioned articles that reported a significant improvement in body composition 
(n=201) had a mean age of 51 years, which may indicate that increasing age has an effect 
on the ability to significantly change body composition. This observation has direct 
implications for the participants in the present study. Therefore, we cannot ascertain 
from the results of this study or from the current literature what effect increasing age 
may have on the ability to change body composition for older BCS.  
It is unknown from the literature with older breast cancer patients if an exercise 
programme can have significant effects on body composition or attenuate the negative 
side-effects of cancer treatment. However, from the present study, it was very 
promising and interesting to note the positive changes in body composition in the 
intervention group, during the 12 week intervention period. A larger trial, recruiting 
higher numbers of older women with breast cancer, would offer more statistically 
reliable results and would add more evidence to this important area of research with 
this under-researched population.  
 
6.4.10. Quality of Life 
The results of this study demonstrate that some QoL variables did change during and 
after the exercise intervention. However, only emotional functioning, future 
perspective, breast symptoms and arm symptoms were statistically significant in the 
intervention group compared to the control group (in a positive direction). No other QoL 
variables reached statistical significance; however, global health status/QoL, physical, 
role, cognitive and social functioning, pain, body image and side effects all demonstrated 
positive trends in favour of the exercise intervention group. Quality of Life variables of 
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fatigue, dyspnoea and insomnia appeared to have a positive trend in favour of the 
control group.  
Similar to these findings, Courneya et al. (2007) offered both resistance and aerobic 
training with 242 breast cancer patients during chemotherapy for 17 weeks and found 
no significant improvements in cancer-specific QoL (assessed by the Functional 
Assessment of Cancer Therapy – Anaemia scale). In the UK, Mutrie et al. (2007) also 
conducted an aerobic and resistance training programme with two supervised and one 
home-based session per week for 12 weeks and followed up at six months and also did 
not report a significant effect of the 12 week intervention on QOL using the Functional 
Assessment of Cancer Therapy (FACT) questionnaire. 
Courneya et al. (2003) reported a beneficial effect of exercise on QoL on 
postmenopausal BCS who took part in aerobic training 3 times per week for 15 weeks. 
Courneya et al. (2003) used the Functional Assessment of Cancer Therapy-Breast (FACT-
B) to assess overall QoL. In this instance, it may suggest that increasing the frequency of 
the supervised sessions may lead to an improvement in QoL. However, Cadmus et al. 
(2009) found that exercise did not affect QoL after conducting two RCTs, one during 
adjuvant treatment and one post-treatment. These participants exercised five times per 
week at an exercise club. Three exercise sessions were supervised and two additional 
sessions were at the club or on their own. These findings suggest that the frequency of 
exercise does not affect QoL. Thus, the intensity of exercise may be a crucial factor in 
improving QoL.  
Adamsen et al. (2009) used the EORTC-C30 to assess QoL and found significant effects 
on fatigue, vitality, physical functioning, role emotional, mental health, physical 
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component scale and mental component scale, but consistent with this study they found 
no improvements in global health status/QoL. This was a large exercise study recruiting 
269 cancer patients (all types, mean age 47 years) onto a six week, four times a week 
multimodal intervention of high intensity exercise, relaxation, body awareness training 
and massage, totalling nine hours per week. The exercise activities consisted of high and 
low intensity equivalent to 43 metabolic equivalent of task (METs) hours per week. 
However, the applicability of this intervention is questionable. Forty-three METs is 
equivalent to moderate intensity walking for 14 hours per week. This appears to be a 
very unrealistic programme considering the challenges of encouraging cancer survivors 
to meet the government guidelines of 150 minutes of moderate exercise and the 
translation of this research into mainstream practice would be questionable (Belizzi et 
al., 2005). 
These conflicting findings help demonstrate that it is still unknown as to what dose of 
PA can lead to an improvement in QoL; with no targeted research into older adults with 
breast cancer this is an area requiring much more research to try and establish the most 
effective dose relationship response for exercise to improve QoL. The present study did 
not significantly improve global health status/QoL, and this may be explained, in part, 
by a number of different reasons. The small numbers recruited into the study make 
findings difficult to generalise and do not have the power to ascertain if the results were 
not influenced by chance. This factor applies across the study and demonstrates that a 
much larger study is required. Nonetheless, the QoL trends found will be discussed and 
considered as to how they align with other research findings. The effects of the exercise 
intervention in this study may have been partly diluted by an insufficient amount or 
volume of exercise or an insufficient intensity of exercise.  
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 Mischra et al. (2012) in a meta-analysis of 56 exercise studies during cancer treatment 
suggested that positive effects of exercise interventions are more pronounced with 
moderate or vigorous intensity versus mild intensity. In the current study, participants 
were guided to exercise within the category of moderate intensity (RPE 3-4), although 
the intensity would not have been considered vigorous. As the supervised intervention 
was only once per week and home-based exercise was not monitored, it could be 
suggested that the frequency of exercise may not have been optimal to improve QoL. 
However, other exercise studies of increased frequency did not elicit an optimal QoL 
response (Cadmus et al., 2009; Courneya et al., 2007; Mutrie et al., 2007) Another 
possible explanation could be that participants were simply functioning very well at 
baseline and thus, further improvements in QoL would be difficult to obtain. All 
participants reported very high functioning scores and low symptom scores when 
compared to reference values for the general population and cancer population 
(Zebrack, Yi, Petersen, & Ganz, 2008).  
All participants reported high PA levels at baseline with both groups significantly 
exceeding the PA guidelines of 150 mins/week (Haskell et al., 2007). Both Chen et al. 
(2009) and Ferrer, Huedo-Medina, Johnson, Ryan, and Pescatello (2011) reported that 
those cancer patients reporting higher PA levels also reported higher QoL scores, 
suggesting a correlation between the two variables. Another reason why the group may 
have reported such high levels of QoL at baseline and throughout the study could have 
been attributed to the age of the participants in the present study. For example, Zebrack 
et al. (2008) stated that older cancer respondents reported better overall QoL and better 
mental health than younger cancer participants. With the age of the participants in this 
study all over 60 years old (mean = 67 years) this may have been another factor why QoL 
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was not affected. Zebrack et al. (2008) continued to suggest that QoL is often less 
interrupted for older people, possibly relating to greater life experiences in handling 
stressful events and better coping skills. 
 
6.5. Study Limitations 
6.5.1 Home-based intervention 
One of the main study limitations was not being able to fully assess the feasibility of the 
intervention because home-based exercise adherence and additional PA outside of the 
supervised intervention was not fully monitored. Therefore, we do not know how 
effective the overall programme was. Therefore, the feasibility and acceptability of this 
part of the intervention is unknown. Although the supervised sessions of the 
intervention appear to have been successful on their own, it is not known whether a 
combined supervised and home-based intervention is effective, feasible or acceptable. 
In an attempt to address some of the shortcomings of not having home-based 
intervention data, study 2 was devised to consider barriers and motivators to exercise 
with this group. Additional physical activity outside of the intervention (during the 12-
week supervised intervention) should also have be monitored for this reason and 
activity trackers or accelerometers would make an objective and accurate way of 
monitoring PA levels instead of daily PA diaries that participants in study 1 found to be 




6.5.2 Selection bias 
Those participating in health studies appear much more health conscious and motivated 
(Krishna, Maithreyi, & Surapaneni, 2010a), thereby willing to maintain, adopt and 
adhere to new health regimes causing a self-selection bias. There is always the 
possibility of selection bias within a study of this nature. The participants who 
volunteered to be in the study may have been of better health and may have been more 
physically active compared to the general older breast cancer population. Volunteers 
for health trials often tend to be more motivated and concerned about their health 
(Krishna et al., 2010a). Thus, it could be suggested that if the participants were more 
interested in health and motivated to be more active after their breast cancer diagnosis 
this may have attenuated the possible effects of the supervised exercise that the 
intervention group received. However, the nature of the randomisation process and 
assessing that both intervention and control groups were homogenous at baseline 
attempted to control for any potential bias in the outcomes and results. Both groups 
were socio-demographically homogenous and reported high levels of physical activity 
at baseline and therefore, may not be a representative sample of the overall population 
of older BCS. In future studies, alternative strategies in which to recruit under-
represented populations must be considered. 
 
6.5.3. Contamination of the control group  
Contamination of the control group (Courneya et al., 2004), could also be a possibility in 
this research, whereby, the control group participants adopt, to some extent, the 
intervention and start exercising or increase their exercise levels. According to Courneya 
et al. (2004) contamination of the control group refers to the extent that the control 
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group actually adopts the exercise intervention, which can severely endanger the 
findings of well-constructed trials as much as poor adherence. It is possible in the 
present study that participants randomised to the control group may have started their 
own exercise programme or increased their physical activity levels in response to the 
study. Indeed, the majority of participants 27/35 (77%) were recruited after the 
researcher gave an educational talk to a breast cancer charity on the benefits of being 
physically active during and after treatment for breast cancer, before randomisation 
occurred.  
This may have added to the “teachable moment” effect (Demark-Wahnefried, Aziz, 
Rowland, & Pinto, 2005), whereby women after breast cancer diagnosis evaluate their 
lifestyles and may make positives changes to increase their PA levels (Schwartz et al., 
2001). Therefore, participants in both groups will have been aware of the importance of 
increasing physical activity levels to reduce potential breast cancer related side effects 
and the association with PA levels in reducing breast cancer recurrence and breast 
cancer mortality. 
 Courneya et al. (2003) reported that 22% of mixed cancer survivors in the control group 
averaged at least 60 minutes of moderate-strenuous exercise over a 10 week period. 
Mock et al. (2001) highlighted a considerably higher number of 50% of BCS who adopted 
the study protocol of 90- minutes/week for three or more sessions over a six week to six 
month period, thus, potentially influencing the outcomes of the study. Courneya, 
Friedenreich, Sela, Quinney, and Rhodes (2002) also reported contamination in the 
control condition, with 22% of them averaging at least 60 minutes of moderate to 
vigorous exercise over a 10 week period.  
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Although maximising adherence rates is important to the success of any RCT, minimising 
contamination rates is equally important. It cannot be fully ascertained, in the present 
study, whether or not anyone in the control group who did not already exercise adopted 
an exercise programme or purposely started to exercise as a result of the study. 
However, the participants in the control group did significantly increase their physical 
activity levels from baseline over a six month period and significantly improved their 12 
minute walk distance, which could be suggestive of a positive effect of either the 
educational talks on increasing exercise levels or the effect of enrolling onto an exercise 
study which may have attributed to this increase in physical activity. 
 
6.5.4. Self-report questionnaires 
PA levels were self-reported through the use of a questionnaire (SPAQ) and therefore 
can be viewed as being subjective. With both the intervention and control groups 
reporting such high levels of physical activity it could be considered that these reported 
figures were either over-estimated or the questionnaire misinterpreted. Participants 
sometimes reported any physical activity rather than just physical activity that was of a 
moderate to vigorous intensity. Self-reported PA questionnaires are frequently prone to 
measurement error and bias due to misreporting, by either deliberate (social desirability 
bias) or because of cognitive limitations due to recall or comprehension (Helmerhorst, 
Brage, Warren, Besson, & Ekelund, 2012). Participants have the capacity to over or 
underestimate true physical activity levels, which often may result in the inability to 
capture actual levels of physical activity.  
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Direct (objective) measures of physical activity are believed to offer more precise and 
accurate estimates of energy expenditure and remove the recall and response bias and 
consist of such measures as direct and indirect calorimetry (doubly labelled water), 
physiological markers such as measurement of cardiorespiratory fitness and motion 
sensors and monitors. Despite the potential advantages of using these direct methods, 
they also possess their own limitations of being time and cost intensive and intrusive, 
often require considerable researcher interaction, which can create a source of bias, 
require specialised training and physical proximity of the participant for data collection. 
In addition no single “gold standard” exists for measuring physical activity (Prince et al., 
2008). Because of the limitations and feasibility of using any direct ways to measure PA 
levels it was considered that a self-reported PA questionnaire was an appropriate and 
valid method to assess PA in this population because of the practicality, convenience 
and low cost but it has also been demonstrated to be reliable and to hold strong validity 
and limited criterion validity (Lowther et al., 1999). 
 
6.6. Study strengths 
6.6.1. Trial Design 
According to Altman (1996) randomised controlled designs are the best way to compare 
the effectiveness of different interventions, allowing valid inferences of cause and effect 
and have the potential to affect patient care directly through single trials with large 
numbers and to produce clinically meaningful outcomes. This may often be the result of 
combining a number of similar RCTs’ findings by meta-analysis. RCTs are the most 
commonly used research designs in medical research. This study adopted this approach, 
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considering it not only an acceptable and traditional scientific method to use, but also 
the most appropriate way to assess the feasibility and acceptability of a trial of this 
nature to inform future larger intervention studies, whilst attempting to minimise the 
effects of bias and confounding variables, provide rigour, robustness, reliability and 
precision with the measurement equipment used. The study methods described are also 
transparent to ensure that the study could be replicated by others.  
 
6.6.2. Age group 
A strength of the study was the novel population recruited. It is the first ever study to 
recruit older women only (>60 years) very recently diagnosed with breast cancer onto a 
supervised exercise intervention and longitudinally follow them for 12 months. A small 
number of studies have specifically targeted older women with a supervised exercise 
intervention but these participants were recruited many years (mean 6.4 years) after 
their cancer diagnosis and treatment (Crane-Okada, Kiger, Sugerman, et al., 2012; 
LaStayo et al., 2011; Tunay et al., 2012; Winters-Stone et al., 2011). Although, many 
exercise and breast cancer trials have recruited some women in the age category 
selected by the present study, the mean age of breast cancer and exercise studies 
appears to be approximately 50 years. Thus, until now we were not aware of the 
acceptability and feasibility of such an intervention with older women recently 




6.6.3. Novel measures 
BODPOD, a novel measurement technology, was used to assess all participants’ body 
composition using air plethysmography. This was the first study to use this measure with 
older women with breast cancer and to follow up participants for nine months after the 
intervention to assess any ongoing body composition changes. The assessment of body 
composition is very important in BCS as those who gain weight after breast cancer 
diagnosis may be at an increased risk of poorer prognosis and outcomes. Obese BCS 
have a 30% higher risk of breast cancer mortality, when compared to leaner women, 
regardless of when BMI is ascertained (Chan et al., 2014; Ligibel, 2011; Protani, Coory, 
& Martin, 2010). In the present study positive changes in percent fat and fat free mass 
were observed for the intervention group during the 12 week intervention but for the 
control group a worsening of body composition (increase in fat mass, decrease in fat 
free mass) was noted throughout the 12 months. These trends were interesting to 
observe. A larger sample size followed over a longer period may have resulted in a 
statistically significant meaning but more importantly be of clinical significance with the 
associations of increasing body fat and body mass with a poorer prognosis and increased 
breast cancer mortality (Chan et al., 2014). 
 
6.7. Conclusion 
Although aspects of the supervised intervention components went well and the 
outcome measures appeared to be acceptable, the success of the pilot trial can only be 
inferred because of the lack of home-based intervention adherence and retention data. 
A slight amendment to the original protocol was that heart rate data was not collected 
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because of issues with equipment, thus, no HRR or HR max data is available.  This 
demonstrates the difficulties of using this method of monitoring exercise intensity. 
Using RPE was a more pragamatic approach. Heart rate data would have been useful to 
report for any future trials, although RPE data was still collected which does infer an 
equivalent heart rate intensity.  Recruitment difficulties would need to be overcome to 
ensure appropriate recruitment timescales were adhered to, something that would 
need to be in place for a larger trial. Accordingly, “stop” and “go” procedures would 
need to be considered in accordance with the guidelines set down by (Eldridge et al., 
2016) who suggest that criteria on which to decide whether or not to proceed to the 
next stage of research should be included. For future research it would be pertinent for 
investigators to have clear criteria on which to base decisions to carry on to the next 
stage of research (i.e. a larger trial) as to whether thresholds that may determine 
progression have not been met. This pilot study should have set some progression 
targets for recruitment (timescales) and also set thresholds linked to other feasibility 
outcomes such as retention and particularly relating to intervention adherence to the 
supervised and home-based exercise (Avery et al., 2016; Eldridge et al., 2016). This 
would have allowed for further consideration and discussion as to whether this pilot trial 
should proceed to a larger trial. These criteria could have been viewed as guidelines 
rather than strict thresholds as not meeting a target may not necessarily indicate that 
the trial is unfeasible but rather that an aspect of the design or protocol may need 
reviewing or changing (Hopewell et al., 2008). Although the strengths of a pilot RCT 
design are noted to collect feasibility and acceptability data to inform trial procedures 
for a larger RCT, this approach could not explore what is going on in a person’s life and 
the relationships that influenced them to make some of their decisions (Broom & Willis, 
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2007). Therefore, utilising more of a qualitative approach to data collection would 
provide further data about how the selected population would feel about taking part in 
an exercise intervention, the potential barriers and possible motivators to becoming 
more active after a recent diagnosis of breast cancer. The next chapter explores the 
views of a selection of women over 60 years old with breast cancer; some were very 
recently diagnosed and still undergoing treatment; some had taken part in the feasibility 
trial either in the intervention group or control group and others were active exercisers. 
These views all add to the feasibility data collected and provide more evidence about 




Chapter 7. A qualitative exploration of older Breast Cancer 
Survivors’ views of the barriers and motivators to physical 
activity and exercise participation 
 
7.1 Background  
The rehabilitation needs of BCS have increased significantly over past decades in line 
with improved survival (Luoma et al., 2014). The important role regular physical activity 
can play in ameliorating the physical and psychological effects of the disease within this 
population is well documented (Brunet, Taran, Burke, & Sabiston, 2013b). Specifically, 
previous research has shown that regular physical activity produces improvements in 
fitness, strength, quality of life, fatigue, weight loss and psychological variables such as 
depression and anxiety (Fong et al., 2012; Schmitz & Speck, 2010). In addition, physical 
activity has been shown to reduce breast cancer recurrence, cancer-specific mortality 
and all-cause mortality (Li et al., 2015; Zhong et al., 2014). Thus, it is important that BCS 
initiate and maintain physical activity levels for beneficial health outcomes.  
Physical activity guidelines and recommendations have been developed for cancer 
survivors (Schmitz et al., 2010) and BCS (J. Brunet, Sabiston, & Meterissian, 2012). These 
breast cancer specific guidelines suggest that women should engage in aerobic activity 
at least three times per week for 30 minutes, participate in strength training at least 
twice per week taking a whole body approach including all major muscles and do 
flexibility training three times per week for 50-60 minutes. Despite the known benefits 
of exercise, physical activity levels appear to fall significantly for many women after a 
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diagnosis of breast cancer and remain below the recommended levels following the 
cessation of treatment (Harrison, Hayes, & Newman, 2009). Other recent studies have 
also reported that cancer survivors are more sedentary than age-matched healthy 
individuals without cancer (Kim et al., 2013; Williams, Steptoe, & Wardle, 2013). 
Although structured exercise has emerged as an important factor in cancer survivorship 
(Luoma et al., 2014), physical activity advice and exercise rehabilitation programmes are 
not offered as part of standard clinical management following a cancer diagnosis in the 
UK (Lakoski, Eves, Douglas, & Jones, 2012). 
To date, most of the research in this area carried out is quantitative in nature and thus, 
any interaction involving interviews and questioning to try and understand behaviours 
that cannot be controlled, measured or counted, appears to be lacking in the research 
literature (Midtgaard et al., 2015). Limited attention from researchers and clinicians has 
been given to understanding subjective experiences of older BCSs’ views in taking part 
in an exercise programmes or their experiences and views of physical activity during and 
after treatment for breast cancer. Therefore, it is not yet well understood which factors 
are important in a BCSs’ willingness to take part in physical activity and exercise and how 
taking part in exercise or physical activity may contribute beneficially to the 
enhancement of health and well-being during cancer rehabilitation (Luoma et al., 2014).  
Furthermore, as stated in earlier chapters of this thesis, very few RCTs to date have 
specifically targeted the recruitment of older BCS and therefore, this population appears 
to be severely under-represented in the qualitative exercise literature as well. 
Qualitative research which explores the motivators for and barriers to exercise and 
physical activity in older women with breast cancer, may help to develop a broader and 
deeper understanding of physical activity participation. All of which may be important 
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in understanding any issues that older BCS may experience during and after treatment, 
to help improve the application and implementation of any structured exercise and 
physical activity programme targeting this population (Midtgaard et al., 2015). 
 
7.2 Brief qualitative literature synthesis 
In order to briefly review the qualitative literature on this topic a focused search was 
undertaken which identified six studies. A range of qualitative methods were used 
including individual interviews (Brunet, Taran, Burke, & Sabiston, 2013a; Bulmer, 
Howell, Ackerman, & Fedric, 2012) and focus groups (Crane-Okada et al., 2012; Luoma 
et al., 2014) with Whitehead and Lavelle (2009) utilising both interviews and focus 
groups as methods of data collection. Midtgaard et al. (2015) examined the qualitative 
literature in a meta-synthesis of 19 qualitative research studies. Studies included in this 
brief synthesis were conducted in a range of countries including: USA (Bulmer et al., 
2012; Crane-Okada et al., 2012;), Canada (Brunet et al., 2013), the UK (Whitehead & 
Lavelle, 2009), Finland (Luoma et al., 2014) and Denmark (Midtgaard et al., 2015).  
All of the primary studies included only BCS, whereas, Midtgaard et al’s (2015) meta-
synthesis included other cancer survivors. Whitehead and Lavelle, (2009) and (Crane-
Okada, Kiger, Anderson, et al., 2012) were the only two studies that targeted older BCS 
(mean age 66.5 years). The other studies (Bulmer et al., 2012; Brunet et al., 2013; Luoma 
et al. 2015) reported a mean age of 54 years old of the participants. Whitehead and 
Lavelle, (2009) specifically targeted older BCS (mean age 66.5 years) to find out their 
views and preferences for physical activity and to consider their PA levels before 
diagnosis, during and immediately after treatment.  
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Crane-Okada et al. (2012) interviewed 48 older women with breast cancer (mean age 
66.3 years), in focus groups to examine the women’s perceptions of the effects of a 
Mindful Movement Programme (MMP). This programme consisted of dance and 
movement therapy and mindfulness. Participants attended 12 weekly 2-hour sessions. 
A typical session consisted of 15 minute walking/moving; 10 minute group dialog; 15 
minute group circle discussion on mindfulness; 15 minute warm-up; 15 minute slow 
movements; 15 minute quicker and larger movements; 10 minute partner movement 
exercise; 5 minute verbal sharing with a partner; 10 minute active energetic moving; and 
10 minute closing circle.  
Bulmer et al. (2012) interviewed 45 women during and after the treatment for breast 
cancer to find out their experiences with exercise, particularly examining their 
perceptions of the benefits of taking part in an individualised programme. The 
individualised programme consisted of a weekly supervised aerobic exercise 
programme and participants were encouraged to do similar activity three times per 
week at home over a 12 month period. Brunet et al. (2013) interviewed nine BCS who 
had identified themselves as being “physically active”, although no definition for this 
was given. Luoma et al. (2014) interviewed 25 BCS who had participated in a 12 month, 
once a week supervised aerobic exercise session and who were encouraged to do a 
further three aerobic exercise sessions at home per week although they did not report 




7.2.1. Barriers to physical activity with breast cancer survivors 
When examining the barriers to physical activity from the identified articles, a number 
of common themes were reported. These themes and sub-themes were primarily 
related to physical, psychosocial and environmental or organisational barriers to 
becoming more physically active or staying active. Although the named titles of the 
themes and sub-themes differed in the individual studies and appeared to be different 
to the above-identified common barriers, on closer inspection the barrier had often 
been identified and included under the theme heading.  
 
7.2.1.1 Physical barriers to physical activity 
A number of physical limitations from cancer treatment were reported as factors which 
hindered the women in maintaining PA and consisted of mobility limitations due to the 
side-effects of treatment, shoulder range of movement problems, pain, strength losses, 
weight gain, fatigue and a lack of energy (Bulmer et al., 2012; Brunet et al., 2013; 
Midtgaard et al., 2015). Luoma et al. (2014) considered changes in appearance as a 
result of surgery as a barrier to joining an ordinary exercise group, whereas they felt that 
a tailored intervention for breast cancer survivors helped them to join an exercise 
because change in appearance was a common issue in the group. They also reported 
reduced fitness levels and fatigue contributed to reduced physical activity after 
treatment. Whitehead and Lavelle, (2009) reported that the main physical barrier to 
becoming more physically active or staying active was “getting older” and feeling stiff. 
Also, during and immediately after treatment their physical activity levels were greatly 
reduced due to soreness and pain after the operation, not feeling well after 
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chemotherapy or radiotherapy or generally just not feeling like doing anything. They 
also reported that a lack of muscle tissue following surgery or re-construction hindered 
their ability to return to physical activity. 
 
7.2.1.2 Psychosocial barriers to physical activity 
Brunet et al. (2013) identified a number of psychosocial factors that stopped or 
obstructed their breast cancer patients from being more active. These were: not having 
an exercise partner, a lack of motivation and low confidence in their ability to do the 
activity. Bulmer et al. (2012) concur with a lack of self-confidence to engage in activity 
as a barrier to starting exercising but also noted the stress of a breast cancer diagnosis 
ranging from mild anxiety to debilitating periods of depression. Another barrier they 
offered was the fear of dying and feeling fearful and vulnerable. According to Midtgaard 
et al. (2015) cancer survivors may not wish to only exercise with other cancer survivors 
although they appreciated the opportunity to exercise where their physical limitations 
or altered body appearance caused by the disease or treatment were accepted and 
sympathetically understood. Midtgaard et al. (2015) reported how the motivational 
aspects of exercising in a group was reported by most studies they included in their 
meta-synthesis and therefore would support the implementation of group-based 
exercise to help reduce this barrier. However, they did offer some caution, suggesting 
that post-intervention adherence is often modest or sub-optimal and that participants 
may become too dependent on the instructor or support from the health care 
professionals to continue with activity outside of the intervention period, thus, reducing 
their levels of activity when the intervention or supervised sessions finished. Whitehead 
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and Lavelle, (2009) cite lack of motivation by their older breast cancer women as a 
reason PA levels were reduced along with post-treatment depression and a number of 
other psychological barriers; of being self-conscious while actually exercising; fear of 
overexerting post-illness; fear of getting lymphoedema; fatigue and feeling low. What 
was interesting with this research specifically targeting only older women with breast 
cancer is that more barriers to physical activity were identified than the perceived 
benefits of physical activity. 
 
7.2.1.3. Environment and organisational barriers to physical activity 
Brunet et al. (2013) found weather to be the main environmental factor to affect 
outdoor activities such as walking. However, the women in Crane-Okada et al. (2012) 
considered the setting of the activity – outdoors or just it being in public could be 
distracting and off putting, along with the temperature, privacy and cleanliness of the 
facility - were important. Other reported barriers that could hinder physical activity 
compliance were the cost of exercise classes or equipment, inadequacy of facilities and 
the safety of the area. Organisational factors that the women felt compromised the time 
available to be as active as they would like included work and employment, caregiving 
and/or household responsibilities, a lack of time because of busy lives with family 
commitments and for some the side-effects from medications (Whitehead & Lavelle, 




7.2.2. Motivational factors for physical activity 
From a motivation perspective, the studies identified a number of different factors that 
encouraged the starting, or maintenance, of a physical activity programme, these were 
included under two main themes of physical factors and psychosocial factors. The 
benefits of exercising in a group, particularly with other BCS and the importance of the 
instructor was also highlighted as a key factor in physical activity adherence and 
maintenance.  
As an example, Midtgaard et al. (2015) reported on three main categories that they felt 
summarised and reflected the benefits of exercise rehabilitation according to cancer 
patients: emergence of continuity; preservation of health; and reclaiming the body. The 
findings suggested the potential for exercise to contribute to rebuilding structure in 
everyday life (organisational and environmental), creating a normal context 
(psychosocial) and re-establishing trust in their own body and physical potential 
(physical and psychosocial). These were important qualities recognised by participating 
in exercise or physical activity after a diagnosis of cancer and further add to the 
understanding of how meaningful exercise rehabilitation can be for a cancer patient. It 
highlighted that cancer survivors prioritise and benefit from exercise by considering 
exercising to be a “normalising” experience, an important point also supported by 
Luoma et al. (2014), “gaining a sense of normality”, helping them to re-build or maintain 




7.2.2.1. Physical motivators of physical activity 
A range of physical motivators to becoming or staying active were reported, which 
included the participants’ perceptions of exercise improving their health and it helping 
to manage cancer symptoms and preventing further illness rehabilitation from surgery; 
improving confidence to go back to pre-cancer activities and the discovery of their 
physical capabilities. Exercise was considered by some as a way to get back in shape and 
return to pre-cancer energy levels; build and tone muscle and achieve a healthy body 
weight; for others it helped improve energy, strength, flexibility, sleep and clarity of 
thought were contributing factors for breast cancer survivors in maintaining PA (Bulmer 
et al., 2012; Brunet et al., 2013). Whitehead and Lavelle, (2009) and Luoma et al. (2014) 
considered increased well-being and energy levels as one of the most important 
motivators and benefits of exercising.  
Another benefit of PA was the ability to reduce and manage weight and that being 
physically active had prevented them from gaining weight whilst on hormone therapy. 
They felt PA helped them to carry on with their normal daily activities; for some this 
related to fighting the ageing process and for others being fit for purpose, such as 
looking after the grandchildren. Crane-Okada et al’s (2012) women spoke of “freedom” 
in the sense of the mindful movement programme giving them liberation, acceptance 
of their disease and current health status, permission to try new activities and 
movements without fear, safety of an experienced instructor and no judgement from 
other participants as all were in treatment or recovering from breast cancer. The theme 
“rediscovering” was described as how the programme allowed them to re-connect or 
re-capture the feelings and experiences of fun and enjoyment from past pleasures 
through the dance movements and music. 
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7.2.2.2. Psychosocial motivators of physical activity 
Brunet et al. (2013) highlighted the importance for some BCS of having a positive 
attitude towards exercise before diagnosis that helped to motivate them to stay active 
and the enjoyment and fun of taking part in the activity. Social support and making 
friends or meeting others were central to activity maintenance. Body image and 
managing or improving appearance was also a strong motivator to routine exercise. 
Bulmer et al. (2012) reported the psychological benefits of activity as a motivator; 
relating to the exercise sessions as “empowering”. This was considered in a number of 
different guises, feeling proud of having done something positive and proactive towards 
their health; adding structure to their lives, getting them out of the house; taking their 
mind off their focus on the disease; acting as a respite from anxiety, fear and depression. 
For some women exercise was considered essential in regaining self-confidence and 
moving forward after their breast cancer diagnosis with an exercise programme acting 
for some as a factor that might reduce their risk of the disease returning.  
Luoma et al’s. (2014) findings supported some of Bulmer et al’s. (2013), suggesting that 
participating in exercise helped to gain a “sense of mastery” over their disease, gaining 
better psychological functioning and improved mood. Bulmer et al. (2012) also reported 
that socially, exercise also was positive for the women interviewed, who suggested the 
benefits of interactions with exercise programme staff and other women with cancer. 
They found the giving and receiving of social support from peers in a non-cancer 
environment was important. They valued the relationships with exercise trainers as a 
source of social support as well as providing a sense of safety and security and instilling 
confidence. Whitehead and Lavelle (2009) concurred with this as the social element of 
exercise gave their participants a reason to get out of the house and meet other people.  
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Crane-Okada et al. (2012) reported participants’ descriptions of how they felt the 
movement, dance and mindfulness sessions allowed them to connect their physical 
bodies with their own perceptions of themselves, becoming more aware of their body 
and their feelings through exercise and activity. The focus group interviews resulted in 
four themes: freedom; rediscovering; body sense in moving; and in the moment. This 
final theme related to the women finding the programme as a source of stress relief and 
often as a way to lighten their mood, making them feel less fearful and happier by giving 
them the ability to slow down, concentrate on the present and focus on everyday tasks. 
All this helped them to worry less and decrease their fear of a breast cancer recurrence. 
 
7.2.2.3 Group benefits and importance of the instructor 
The benefits of exercising in a group environment and with an experienced, 
understanding and knowledgeable instructor were also highlight by the studies. Bulmer 
et al. (2012) described how interacting with exercise programme staff and other cancer 
survivors was a benefit of the exercise programme and how the giving and receiving of 
social support in this non-cancer environment was highly valued. They also noted how 
the exercise trainers were spoken of in high regard, whose expertise helped them to 
regain their fitness or range of movement and by having knowledge about their 
condition gave women the confidence that the prescribed exercise would enhance 
recovery.  
Brunet et al. (2013) agreed with this point, suggesting in addition to these perceived 
barriers and motivators to activity, the women also considered the expertise and 
personality of the instructor as vitality important, along with the location and setting of 
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the exercise programme. They also considered that exercise and physical activity 
programmes should be offered in convenient, non-hospital settings. Whitehead and 
Lavelle (2009) reported that women emphasised the importance of having an instructor 
who understood the issues faced after a diagnosis of breast cancer and also understood 
the issues of being older which may bring its own health complications. They liked the 
idea of a tailored programme which could be suited to their needs and expressed a 
preference to the programme to be exclusive to their age range.  
Crane-Okada et al’s. (2012) participants enjoyed the benefits of a breast cancer only 
group, although they did report that they were grateful it was not a support group. They 
also expressed the importance of an instructor who had the ability to lead and create a 
welcoming and motivating environment. The importance of the group instructor was 
echoed by Luoma et al. (2014) whose participants recognised and appreciated that the 
instructor understood the crucial issues for recovery from breast cancer and this allowed 
them to feel safe in the knowledge that what was being asked of them was suitable for 
them. 
 
7.2.3 Summary of the qualitative literature 
It appears from the literature that a number of motivators and barriers to physical 
activity for BCS have been identified; however, very few studies have targeted older BCS 
and therefore this information is lacking. Worryingly, particularly, within these older 
adult studies, more barriers to being physically activity were identified than motivating 
factors to being active (Whitehead & Lavelle, 2009). 
217 
 
When considering and developing a research intervention with a population that is 
under-researched, such as older BCS, the Medical Research Council strongly suggests a 
piloting and feasibility phase first, in an attempt to establish recruitment, retention and 
attrition and outcomes measures, along with a qualitative assessment of the 
intervention, which may consider factors that influence the population’s willingness to 
participate in a research intervention during or after treatment (Craig et al., 2008). Given 
the limitations to qualitative research with older women during and after breast cancer 
treatment, a qualitative approach is required to gain a further understanding of these 
potential obstructions to physical activity and motivators for older women with breast 
cancer to become more active and to examine any other potential issues (Brunet et al., 
2013; Luoma et al., 2014). Thus, the objectives of this qualitative study were to explore 
the barriers to and enablers of the initiation and maintenance of physical activity during 
or after treatment in older women with breast cancer. The knowledge gained from this 
research may enable healthcare professionals, the fitness industry and researchers to 
extend their understanding of the barriers and motivators to exercise and physical 
activity for older women with breast cancer when developing interventions to increase 






This was a qualitative study design using semi-structured face-to face individual 
interviews, utilising the framework analysis method developed by Ritchie and Spencer 
(1994). 
 
7.3.2. Participant recruitment 
A purposive sampling strategy was used to recruit fifteen women aged over 60 years 
with breast cancer. Participants were recruited via a national breast cancer charity who 
had enrolled on a four-week breast cancer educational workshop or by attendance at a 
weekly exercise programme based at the University of Huddersfield. The exercise 
programme participants had all previously attended the breast cancer charity’s 
education workshop. All participants were interviewed individually. 
 
7.3.3. Inclusion and exclusion criteria 
Participants were all women aged over 60 years who had been diagnosed with primary 
breast cancer stage I-III. All participants were either currently undergoing treatment or 
had finished initial adjuvant treatment other than ongoing hormone therapy. Women 
were recruited who were recently diagnosed with breast cancer (< 12-months) and also 
women who were already regular attenders at an exercise class who were mean 36 
months since diagnosis. Women were excluded if they were not over 60 years of age 
and were more than 5-years post diagnosis and treatment. 
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7.3.4. Data collection 
All interviews were recorded using a portable recording device (ALESIS Palm Track MP3). 
The interviews took a semi-structured format and examined current and previous 
physical activity levels, physical activity motivators and barriers to exercise after a breast 
cancer diagnosis and support to be physically active. By using semi-structured interviews 
and following a topic guide (Table 17) ensured the interviewed remained focused on 
meeting the study objectives. The questions were open-ended to not limit the 
interviewee’s responses or choice of answers (J. Johnson, Gubrium, & Holstein, 2002). 
Interviews were held at either a venue of the participant’s choice, the University of 
Huddersfield or the venue of the breast cancer charity’s educational workshop. The 
purpose was to provide the interviewer and interviewee a comfortable setting where 
the topic could be discussed in detail without distraction. The interviewer made use of 
cues and prompts to help direct the interviewee into the research topic area to enable 
the gathering of in-depth or detailed data set (Creswell, 2003). At the end of the 
interview participants were asked if there was anything further they would like to add 
or discuss.  
 
7.3.5. Development of the topic guide 
A topic guide was developed to help inform the interview questions, from a priori issues 
identified from Study 1 and by considering behaviour change models and frameworks 
and other exercise and cancer interventions. An important issue for public health is to 
try and understand why the majority of adults are insufficiently active to improve health 
(Marshall & Biddle, 2001). According to (Miller, Trost, & Brown, 2002)) studying 
“determinants” or correlates of physical activity is an important prerequisite for 
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designing policy and effective intervention programmes. A well-recognised and popular 
behaviour change model, the Transtheoretical Model of Behaviour Change (TTM) 
postulates that people change behaviour in five stages that consider current behaviour 
with intention to maintain or change behaviour (DiClemente & Prochaska, 1998). Three 
factors are hypothesized to mediate change process. These are the individual’s self-
efficacy for change - one’s confidence in one’s ability to take steps necessary to be 
regularly active, the decisional balance of perceived advantages and disadvantages of 
changing behaviour and the strategies and techniques individuals use to modify their 
thought and feelings towards a behaviour (Marshall & Biddle, 2001). (Bandura & 
Wessels, 1997) cites self-regulatory self-efficacy – one’s belief in one’s ability to 
maintain physical activity in the face of challenges, as key to becoming a regular 
exerciser. He also considers environmental factors such as social support by family and 
friends, support from activity partners and feedback from exercise leaders as crucial to 
adherence to physical activity. Questions based around confidence to be active and any 
concerns and apprehensions about exercising were explored to consider self-efficacy. 
Reasons for participating in exercise and reasons for not being active were considered 
for the decisional balance aspect, which included side-effects of treatment and benefits 
of exercise and expectations of becoming physically active. Meeting public health 
guidelines for physical activity has been demonstrated to improve breast cancer 
outcomes and morbidities (Zhong et al., 2015); thus, questions were developed around 
activity levels, considering current physical activity levels and PA levels before diagnosis. 
Social support – the perceived support by others, such as family and friends - has been 
associated with increased physical activity (Courneya & McAuley, 1995), so a theme 
based on social support to be active was developed and questions relating to support 
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from family or friends and health care professionals were asked. More recently (Michie, 
Van Stralen, and West (2011) proposed a new framework to inform behaviour change 
interventions considering the existing literature and developing a “behaviour system” 
involving three essential conditions: capability, opportunity, and motivation – what they 
have termed COM-B. They define capability as the individual’s psychological and 
physical capacity to engage with the activity concerned whether they have the necessary 
knowledge and skills to do the activity. Questions were developed around this construct 
which included side-effects of treatment, self-confidence to exercise, concerns and 
expected benefits of exercise and preferred types of exercise. Motivation is defined as 
all those brain processes, emotional responses and decision making; therefore, 
questions considered reasons, barriers and motivators to being active or not. 
Opportunity considers all the factors that lie outside the individual that make the 
behaviour successful or prompt it. Specific questions were considered about social 
support and the different opportunities that were offered to be active. This topic guide 
has been constructed from existing behaviour change frameworks in an attempt to 
overcome previous limitations of often only considering one behaviour change 
construct. It has the benefit of being derived from classifications and concepts already 
considered important and by considering the “behaviour change wheel” it is hoped to 
improve the translation of research into practice and to inform those designing 





Table 10: Interview topic guide  
 
Theme: PA levels 
Currently, how physical active / how much exercise do you do per week? 
Active 
What do you do? How often? 
Were you active before your BCa 
diagnosis? 
What did you do? How often? Did 
you do more before your diagnosis 
than now? 
Why did you decide to take part in 
an exercise programme? 
What did you expect may happen 
once you started exercising? Did it 
meet your expectations? 
Did you have any concerns before 
exercising? If so, what were these? 
If not, why did you think like this? 
Inactive 
Were you active before your BCa diagnosis? 
What did you do? How often? 
Reasons for not exercising since diagnosis? 
Would you be willing to take part in a 
structured, supervised exercise session? 
Do you have concerns about exercising? If not, 
why not? If so, what are these concerns? 
Theme: Reasons for participating 
in PA 
Reasons for not participating in PA 
Why are you active?  
What are the reasons you are 
active / exercise regularly? 
Any reasons you are not active? 
Have you any apprehensions to becoming more 
physically active? 
 
Theme: side effects of BCa treatment 
Have you or are you currently experiencing any side effects from your cancer 
treatment?  
Did you have any during or after treatment?  
If so, what were they?  
How did they make you feel? 
 
Theme: Benefits of exercise 
Are you aware of any benefits of exercise in relation to your BCa diagnosis? 
Do you consider exercise / PA an important part of your BCa treatment? How? Why? 
 
Theme: Confidence to take part in PA / exercise 
Active Inactive 
How confident did you feel in 
taking part in an exercise 
programme?  
How confident would you be in going along and 
starting an exercise programme?  
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What would / may stop you from 
being a regular exerciser? 
 
What would / may stop you from starting or 
maintaining an exercise routine? 
Theme: Intervention assessments 
 
Active (intervention participant) 
 
Inactive (non-research participant) 
How did you find the intervention 
assessments? 
12-minute walk? 
Body Composition – BODPOD? 
Would you take part in an exercise research 
intervention? 
How would you feel doing a 12- min walk 
assessment? 
How would you feel having your body 
composition assessed, in which you would have 
to wear a swimsuit in front of a female 
technician? 
Theme: Supervised exercise 
 
Active Inactive 
How do you find the supervised 
exercise programme?  
What do you like / dislike about it?  
Anything you can think of to 
improve it? 
Would you prefer to exercise in a supervised 
programme or do your own exercise at home 
when you want?  
What are you reasons for this? 
How did you find the intensity of 
the exercise programme?  
Did you feel it was suitable at the 
time after your diagnosis?  
Would you prefer to exercise as part of a group 
or on your own? Reasons? 
Do you prefer exercising in a group 
or on your own? Reasons? 
 
 
Theme: opportunities for exercise/PA 
 
Do you feel there are enough opportunities for you to go along to exercise classes or 
be more physically active after a diagnosis of BCa?  
What stops you from going?  
What would encourage you to go? 
 
Theme: Support for PA 
 




Who was this from?  
What did they advise / recommend? 
 
 
Summary of topic guide themes 
Reasons for participation; Reasons for apprehension to PA intervention; Benefits of 
physical activity; Side effects of breast cancer; Importance of PA in relation to health; 
Confidence in taking part in PA; Intervention assessments; Supervised exercise; Home-
based exercise; Exercise intensity; Opportunities for PA; Activities of daily living; Support 




7.3.6. Ethical Considerations 
All participants were fully briefed before they were interviewed and given participant 
information sheets to read before agreeing to the interviews. All participants had one 
week to read the information sheets and ask any further questions before the interview 
took place. Opportunity was given for participants to ask any further questions before 
consent forms were signed. All interviews were audio recorded at the time with the 
permission of the participants, who were informed that they were free to finish the 
interview when they so wished and that all recordings would be transcribed verbatim to 
help with remembering what was discussed and for analysis for the research. All 
transcriptions were made by the researcher or an experienced research administrative 
assistant and only the research team had access to the data. Transcribed data had any 
identities, venues or places removed to eliminate the possibility of identification 
through inference. All audio recordings were stored on a password-protected computer 
format for transportation, transcription and reviewing. Identities were protected using 
pseudonyms and information regarding the identity of the participant was stored 
separately and securely under password protection. Participants were informed that all 
data would be stored securely for a period of five years after PhD publication. Ethical 
approval for this part of the PhD study was granted by the University of Huddersfield 
Research Ethics Committee, School of Human and Health Sciences. 
 
7.3.7. Data Analysis 
All recordings were transcribed verbatim which enabled the researcher to understand 
and analyse each record. The data were analysed using Framework Analysis which was 
developed in the late 1980s by qualitative researchers working in social policy (Ritchie 
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& Spencer, 1994), as a pragmatic approach for real world investigations (Ward, Furber, 
Tierney, & Swallow, 2013). This approach identifies common themes and differences in 
the qualitative data, before focusing on the relationships between the different parts of 
the data gathered, whilst attempting to draw explanatory or descriptive conclusions 
from these themes (Gale, Heath, Cameron, Rashid, & Redwood, 2013). To ensure 
accuracy of transcriptions and to ensure familiarisation with the content of the 
interviews, all recordings were listened to again alongside the transcript. This process 
also allowed the researcher to consider any nuances within the interviews that the 
transcription may not have recorded (Seale, Gobo, Gubrium, & Silverman, 2004).  
7.3.8. The process of carrying out Framework Analysis 
Framework Analysis allowed for a structured and systematic approach to data analysis 
to be followed. Being flexible, systematic and rigorous, it offered a transparent audit 
trail of the research findings (Ward et al., 2013), and allows findings to be reviewed to 
understand how the final interpretation was developed (Ritchie & Spencer, 1994). There 
were a number of different stages that were followed, consisting of: familiarisation with 
interview transcripts, developing /identifying a working analytical framework, coding or 
indexing, charting and mapping the data into the framework matrix and interpretation 
/ synthesis of the data.  
 
7.3.8.1. Familiarisation 
The analysis started with a familiarisation process of the data transcripts, which involved 
making notes of the main recurring themes and grouping these together to develop into 
an analytical framework. The researcher familiarised himself with all transcripts and 
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undertook all interviews which helped to speed up the time to become fully familiar 
with the data. After two interviews had been conducted, one of the researcher’s 
supervisors listened to the interviews and provided useful guidance and direction to 
help improve interviewing skills. According to Srivastava and Thomson (2009) not every 
transcript needs to be reviewed at this stage, but the researcher felt that the sample 
size was small enough for all transcripts to be reviewed. This ensured that all the data 
from all the transcripts were reviewed and considered and nothing overlooked. This 
added time to the process but it was deemed extremely useful as the researcher was a 
novice in the use of Framework Analysis and it was thought that some of the data might 
be missed if not all of the data were reviewed. After nine interviews had been conducted 
a further meeting with supervisors was arranged. A sample of transcripts was given to 
the group. This allowed the researcher to learn from the more experienced supervisors. 
It was noted at this stage that with there being a noticeable difference between 
participants’ length of time since diagnosis, the researcher should consider a question 
focused on physical activity levels during treatment and not just to consider current PA 
levels and PA before diagnosis. This would help to consider barriers to exercise during 
treatment. 
 
7.3.8.2. Coding and Identifying / developing an analytical framework 
Codes were identified utilising both a deductive and inductive approach. Utilising a 
deductive approach, a number of codes were identified utilising a priori themes, from 
the behaviour change literature, which helped to inform the topic guide, and from the 
research intervention. Others were identified in the familiarisation process and 
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subsequent interview analysis once the researcher was “immersed” in the transcripts. 
This inductive approach allowed emergent themes to be included as codes which both 
approaches then formed an analytical framework (Ritchie & Spencer, 1994). All 
transcripts were uploaded into NVivo, a computer software programme. This allowed 
the researcher to read each transcript line by line and apply a label or “code” that 
described the interpretation of the passage or something that they considered 
important for analysis. With this study being more deductive in nature (using a priori 
issues, specific area of interest to the intervention and the background literature) a 
number of these codes had been already considered and developed through the 
familiarisation process but it was still considered an important process not to miss out 
and subsequently many additional codes emerged from the data. Coding aims to classify 
all of the data so that they can be compared systematically with other parts of the data 
set (Gale et al., 2013). At this stage, one of the researcher’s supervisors also 
independently coded two of the transcripts and these were compared and discussed 
with the researcher to obtain clarity of thinking, offering an alternative viewpoint and 
ensured that not only one perspective was taken or was to dominate. This led to an 
agreement of a set of codes to apply to subsequent transcripts. Table 18 shows the 




Table 11: Coding Process  
 
Deductive Approach – codes considered 
before interview analysis, utilising a priori 
themes / behaviour change evidence / 
research intervention 
Inductive Approach – codes 
developed once “immersed” in the 
transcripts (emerging from the data) 
Barriers to activity 
Benefits of exercise 
Confidence to exercise 
Consequences of treatment 
Current amount of PA 
Exercise preferences 
Expectations of exercise 
Home based exercise / intervention 
Motivators to be active 
Opportunities to be active 
PA levels before diagnosis 
PA levels during treatment 
Research intervention / assessments 
Supervised vs unsupervised PA 
Support to be PA 
Type of activities 
Body image 
Healthy living 
Outlook of treatment & diagnosis 
Time to heal 
Time to suggest PA 
Group exercise benefits 





7.3.8.3. Charting data into a framework matrix 
Charting allowed for the identification of portions or sections of the data that 
corresponded to a particular theme. All the coded themes were arranged into charts 
that consisted of headings and sub-headings that were developed during the coding and 
analytical framework stage (see examples in Appendix 9). Utilising NVivo allowed for the 
interviews and framework headings to be combined to be generated into a spreadsheet 
or matrix. The data (responses from each participant) were then “charted” into the 
matrix by the researcher summarising the data by “code” from each transcript and 
placing under the relevant sub-heading in the matrix. This required an ability to reduce 
the volume of data, yet not miss out any important issues and to retain the “original” 
meaning of the interviews (Gale et al., 2013). 
 
7.3.8.4. Interpreting the data 
Mapping and interpretation of the data was the final stage and involved analysis of the 
key characteristics drawn up in the charts (Srivastava & Thomson, 2009), to define 
concepts and provide explanations for the findings. This was influenced by the original 
research objectives and the themes that emerged from the data. This stage highlights 
the transparency of Framework Analysis as each stage can be checked back to the 
original data (Ward et al., 2013). 
 
7.3.9. Study rigour 
Qualitative research has often been criticised for being too subjective to individual 
interpretation and is often considered anecdotal, with the absence of facts (Silverman, 
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2000). If these criticisms are to be accepted then it would appear that there is little place 
for qualitative research in the nursing, exercise or medical community. However, to 
counter these arguments and assumptions, guidelines, scientific standards, criteria and 
checklists have been developed to judge the quality of this qualitative research (Clissett, 
2008; Guba & Lincoln, 1989; Lincoln & Guba, 1989). Applying the criteria suggested by 
Guba and Lincoln (1989) of: credibility, transferability, dependability and confirmability, 
also known as the trustworthiness criteria to this study allows for the scientific rigour to 
be judged. Reflexivity was an additional quality criteria suggested by Malterud (2001) 
and will also be discussed.  
In an attempt to achieve credibility and ensure that the interviews were a true and 
accurate reflection, two participants were given access to their own verbatim interview 
transcripts and time to read the questions asked and their subsequent answers. Each 
participant considered her transcript to be an accurate representation of what she had 
said and meant. However, the further analysis of the transcripts, with codes, sub-themes 
and themes were not shared with the participants; thus, the extent to which the 
participants were happy with the final interpretation is unknown. Interpretation of 
these interview transcripts was done following the Framework Analysis approach 
developed by Ritchie and Spencer, (1994) and accordingly at the coding stage a member 
of the supervisory team independently coded two transcripts, with the subsequent 
codes compared and discussed with the researcher to ensure that no one perspective 
dominated or focussed on aspects peripheral to the research question (Clissett, 2008).  
The transferability of the findings is somewhat limited due to the size of the population 
(n=15) and the nature of the older population (aged over 60-years) of BCS. Although 
numbers were relatively small, data saturation was reached with no new themes, 
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categories or explanations emerging after 15 participants. With all participants being 
white European, economically secure and diagnosed stage I-III breast cancer, this may 
further narrow down the transferability of the results; however, with very limited data 
from this population the reader will have to make a decision about the applicability of 
the findings to the population.  
Dependability is very difficult to achieve in qualitative research as the interactive nature 
of interviews would make it impossible to replicate exactly in the future; however, 
detailed methods have been described as to the setting of the interviews, the interview 
questions and the participants.  
Confirmability has been achieved by the transparency of allowing the original data and 
all the processes used to draw the interpretations and conclusions from the data to be 
viewed (Appendix 9). Although it is accepted that different researchers may deduce 
different assumptions and constructs from the same data (Glaser & Strauss, 1971) the 
process that has been followed in this study is available for review. 
As a newcomer to qualitative data collection and interpretation, reflexivity rather than 
purely reflection played an integral role in data generation and in the subsequent 
interpretative analysis. Reflexivity has been defined in a variety of ways depending on 
the philosophical or pragmatic approach of the writer. To further understand reflexivity, 
the reflection to reflexivity continuum, described by (Woolgar, 1988) was particularly 
useful. It is important to understand the participants’ experiences within the context in 
which they happen, thus allowing us to make sense of these experiences and ourselves, 
albeit bound by time and/ or place (Shaw, 2010).  
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As we all experience and interpret our world from a particular perspective and this 
perspective will always have an ingrained subjectivity, as Gadamer (1975) suggests, we 
have our own set of beliefs, preconceived ideas and these make up our own 
understanding and interpretation of events. By considering our views and feelings about 
the research and its relationship to us both personally and professionally we can 
appreciate the nature of the investigation and our relationship as a researcher and as 
someone experiencing the world of the participants from whom we wish to gather data.  
The researcher did have to consider his own personal preconceptions before embarking 
on this qualitative research study and his background and experience, having worked 
with breast cancer patients for a number of years and having already delivered the 
exercise intervention for Study 1. The researcher had already worked with a number of 
the participants with whom he had already established an exercise instructor / 
researcher relationship and was very familiar with some of the participants who had 
been attending the exercise classes. However, the recently diagnosed women recruited 
via the breast cancer charity were unknown to the researcher so this may have affected 
their responses during the interviews and their willingness to be open.  
In order to consider whether the interviews were accurate descriptions of events 
described and important contextual details were not missed, all interviews were 
recorded and transcribed verbatim. Two participants were involved in checking their 
transcripts to ensure accuracy and originality. These reflexive steps, participant and 
supervisory involvement in the coding process helped to minimise any biases or pre-
conceived judgements that the researcher may have had that could have affected the 




A total of 15 participants with breast cancer were interviewed individually for the study. 
Table 19 details participants’ characteristics. All women were aged over 60 years, range 
60 – 77 years (mean 67.3 years, SD 5.14 years). One participant was currently 
undergoing chemotherapy treatment, four were within 11 months of completing 
treatment and the others were all within five years of completing treatment (range 36-
58 months). Seven participants had already been recruited onto the pilot RCT reported 
in Chapter 6 (2 = control group; 5 = intervention group). The other eight participants had 
not taken part in the previous study. All participants were white British, most were 
retired (87%) with one still working full time (6.5%) and one on long-term sick leave 
(6.5%). The duration of the interviews ranged from 13-38 minutes, with the mean length 
being 21 minutes. In terms of medical characteristics, all had been diagnosed with breast 
cancer stage I-III disease. All had undergone surgery, with the majority having 




Table 12: Study Participant characteristics 
 
Characteristic All participants (n=15) 
  








Did not complete high school 















Single, never married 
















































Hormonal Therapy 14 






Three main themes and eight sub-themes were identified. Specifically, barriers affecting 
physical activity, factors enabling physical activity and the wider environmental context. 
These main themes and sub-themes are presented in Table 20. The main theme, Barriers 
affecting physical activity, included sub-themes of: accommodating other features of the 
life world; negative consequences of treatment and environmental influences. The main 
theme, Factors enabling physical activity consisted of the sub-themes of: perceived 
health and wellbeing impact; personal and inter-personal considerations and 
environmental influences. The main theme, Wider environmental context, cuts across 
both of the other main themes but included some of the codes that have / could be 
included in the sub-themes. These are: timing of exercise advice and family and 
friendship support. 





   
Barriers affecting 
physical activity 
 Accommodating other 
features of the life world 
Negative consequences of 
treatment 
Environmental influences 
Factors enabling physical 
activity 
 Perceived health and well-
being impact 
Personal and inter-personal 
considerations 
Environmental influences 
The wider environmental 
context 
 Timing of exercise advice 





7.4.1. Barriers affecting physical activity 
Factors that acted as a barrier or obstruction to being or becoming more physically 
active were: accommodating other features of the life world, negative consequences of 
treatment and environmental influences. 
7.4.1.1. Negative consequences of treatment 
The often debilitating side-effects of breast cancer treatment was the most limiting 
factor reported by the participants to starting or maintaining a physical activity or 
exercise routine. These included aching muscles and joints, joint pain, fatigue, hair loss, 
range of movement difficulties in the shoulder and other joints and the negative effects 
on self-confidence. Joint pain and range of movement difficulties were the major 
physical activity barriers that contributed to participants’ reported reasons for struggling 
with physical activity and exercise: 
 
“I had quite a lot of physio to get my shoulder sorted, so I wasn’t doing any, I think where 
I’m falling down is I’m not doing any sort of muscle building…[also], I had a lot of very 
aching legs, when I was having my treatment and after” (SCS, 60-yrs, 22-months post 
diagnosis).  
 
A participant described the effects of her chemotherapy treatment:  
 
“I had the first of my second chemo and that was the one that was really, really 





Another participant considered the effects of surgery on her whole body:  
“I was very, very stiff, as a body as a whole and I wanted that, I wanted some of the 
suppleness back, if I could, so yeah. I had a frozen shoulder at the left side, which was a 
problem, which I had quite a lot of physiotherapy for” (FMF, 69 years, 48-months post 
diagnosis).  
 
A number of participants expressed their thoughts about the effects of hormone 
treatment for breast cancer on energy levels and joint pain and thus, the negative effects 
it had on their ability to be physically active:  
 
“I did start to realise that the more I take Anastrozole and I realised that I was really 
affected by fatigue and that’s made it more difficult as the time has gone on for me to 
continue to be as active as I would want”. (ADA, 64-years, 41-months post diagnosis).  
 
Also, another expressed joint pain from the drugs and the possibility of the hormone 
treatment having caused osteoporosis: 
 
“Side effects from the drugs probably, errmm, a bit of pain at first, hip pain mainly… 
yeah, I think with the tablets. It does say with the side effects that you can have some 
pain. Also, I’ve now got Osteoporosis, and that’s well we don’t know really, probably 
from the drug or I don’t know really, might have got it anyway I suppose, I don’t really 




The effects of hair loss after chemotherapy had a detrimental effect on decisions to be 
active: 
 
“Partly, I think I mentioned earlier, like doing Pilates, I had, I lost all my hair, so I had a 
wig or a hat and I was worried that when you’re bending down and going upside down 
it would fall off and I didn’t particularly want everybody to know…and still I think I’m still 
a bit, although my hair has grown back, there’s not a lot of it and some people aren’t 
always very tactful when they see you for the first time and then it’s like do you explain 
or do you just ignore them and it can be tricky”. (HMH, 62-years, currently on-
treatment). 
 
7.4.1.2. Accommodating other features of the life world 
For some of the participants the knowledge of what type of exercise or how much they 
should they be doing hampered their ability to engage with physical activity when they 
so wished and this lack of knowledge appeared to reduce their confidence to attend 
exercise classes or be more physically active because of the not knowing what was safe 
or suitable exercise. One participant described it as: 
 
“wondering what I should do and what I shouldn’t do”, she continued, “so I think I 
probably kind of toned it down…after the surgery, so I think I became less active”. (SCS, 
60 years, 22-months post diagnosis) 
 
Long-term conditions and previous illness or injuries separate to a cancer diagnosis 
limited some participants’ activity levels and attendance at exercise classes:  
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 “well the only thing that would stop me would be if my arthritis got worse”. (MAM, 74 
years, 36-months post diagnosis) 
 
For one participant bereavement was a particular barrier to continuing with her activity 
because she attended the gym together with her husband as a couple:  
 
“Well I mean dealing with bereavement isn’t easy and I gave up going to the group that 
we were going to, because we weren’t a couple anymore and I didn’t want, I just didn’t 
want to go really…I’ve just become less active, there’s less motivation to do it, I think 
that’s part of the problem, you know”. (SJS, 70 years, 58-months post diagnosis) 
 
7.4.1.3. Environmental Influences  
The environmental influences that negatively affected performance were as follows: 
inclement weather, no friend to go with, unclear about what activity they could or 
should do in the form of information or health care professional advice, a protective (or 
over-protective partner) who may discourage activity. As one described the effect of 
inclement weather on going out walking:  
 
“So really, I push myself to go out actually and if it’s pouring down with rain and I’m 






Another participant also found that it was important for her to have a friend to attend 
with – even if the other person stopped coming but to have that support at the start:  
 
“…but then you’re thinking but I don’t know anybody, so I says right, I’ll meet you and I 
started coming…even though she stopped coming…it was just that very first coming on 
your own”. I knew I wouldn’t go myself, on my own”. (MAM, 74 years, 36-months post 
diagnosis). 
  
This barrier was further alluded to by a number of other participants demonstrating the 
importance of social support to start or maintain PA. 
 
Not knowing what exercise or physical activity to do acted as an obstruction to some 
women: 
 
“wondering what I should do and what I shouldn’t do…but it was the booklet really, 
rather than physically advising. I was reading the booklet and that was saying things 
that cause lymphoedema, sort of repetition if you like, things like you wouldn’t want to 
do, like cleaning your windows, ironing, made me concerned”. (SCS, 60 years, 22-months 
post diagnosis). 
 
A protective partner may unintentionally discourage or actively stop physical activity 
and exercise participation because they considered it not to be safe to be active during 
or immediately after treatment:  
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“since he retired and cos I don’t drive I’d use to have to and I mean it’s three 
quarters…what 20 minutes to the bus, you know downhill or uphill but now he’d say “no 
you’re not going for the bus” You know, he’s sort of partly stopped me”. (MSM, 72 years, 
57-months post diagnosis)  
 
Another reported her own concerns as to what activity to do and her husband’s 
involvement:  
 
“wondering what I should do and what I shouldn’t do and then husband sort of, don’t do 
that, when you’re doing that” (SCS, 60-years, 22-months post diagnosis). 
 
Health care professionals also appeared to play a vital role in potentially affecting 
physical activity levels as when one participant was asked: “Could you expand on who 
were the people who were saying about resting or not to do too much?  
 
“staff on the Chemotherapy Unit, Radiotherapist people”. (MRM, age 66, 45-months 
post diagnosis) 
 
Another participant stated:  
 
“You know the surgeon said don’t ever get out of breath, you know, don’t be silly just be 




This lack of knowledge about the safety of physical activity and exercise during or after 
treatment for breast cancer from friends, family and health care professionals was 
responsible for a number of women not being physically active or reducing their physical 
activity levels.  
 
7.4.2. Factors enabling physical activity 
Factors which were considered to motivate or encourage exercise or physical activity 
consisted of the following sub-themes: perceived health and wellbeing impact; personal 
and inter-personal considerations and environmental influences. The most influential 
motivating factors were those aimed at improving the negative consequences 
experiences by the treatment for breast cancer.  
 
7.4.2.1. Perceived health and well-being impact 
Those reported consisted of losing weight, improving fatigue and having more energy, 
improving joint pain, recovering from breast cancer treatment, strengthening the body 
and regaining or improving shoulder range of movement. One participant described the 
tiredness and her reasons for starting exercise: 
  
“think because I was so tired and I felt so out of sorts in myself, I got really lethargic, …I 
knew that the exercise would make me feel better, in every way…it was the fatigue and 
I knew that I needed to do something to stop it getting worse…”. (ADA, 64-years, 41-




Another considered the additional energy she felt exercising gave her was motivational 
to continue:  
 
“You know, when I first started I was really tired when I left but I found now I’ve got used 
to doing these things that I feel more energised, I do really feel more energised”. (BJB, 
70 years, 57-months post diagnosis). 
 
Joint pain and range of movement difficulties affected a number of participants and 
exercising or doing physical activity to try and combat this pain was a reason reported 
by a number of women:  
 
“The joint pain, I just, I kind of manage that…and I do find that exercise helps me with 
my joint pain”.(ADA, 64 years, 41 months post diagnosis). 
 
One considered exercise as a way to help recover from the breast cancer treatment:  
 
“Well I’d heard about how it was really important in the recovery from breast cancer, to 
do exercise and I thought well, you know, this is something really simple that I can try 
and what amazed me really was how much better I felt quickly after starting the 




7.4.2.2. Personal and inter-personal considerations 
The following were all considered as ways in which they helped with activity 
maintenance or the reason for starting to exercise and consisted of: having 
grandchildren to look after, enjoyment, the social side of exercise and physical activity 
and previous activity levels:  
 
“having my grandson to look after and so I’m out walking with him and because that’s a 
lot of joy around that, so I needed a bit of a motivator and he was probably the 
motivator”. (ADA, 64 years, 41-months post diagnosis).  
 
A number of women reported the actual enjoyment they found from being active and 
was important for motivation to continue:  
 
“Because I enjoy it and I have friends who I meet there, you know, we all play Badminton 
together, four of us, five of us and just to get back to normality really”. (MJM, 77 years, 
11-months post diagnosis). 
 
“The main thing is that I really enjoy it. I’ve found something that I really enjoy so it’s not 
a really a…don’t think it a…oh no it’s Wednesday and I’ve got to go and do this. I just love 
it. I just enjoy exercise. Yeah”. (RMR, 66 years, 45-months post diagnosis). 
 
The social side of being active in a group was really important for a number of 




“Well I’ve always been better off in a group, rather than a solo player. I need motivation 
and I find that in a group”. (FMF, 69 years, 48-months post diagnosis).  
 
“I feel, I don’t want to be doing this on my own, or something on your own, particularly 
if you live on your own, which I do. Just being with others and seeing what we’re all doing 
and seeing that we’re doing pretty much the same things and it’s taking it at your own 
pace, I mean it’s not a race is it?”. (BJB, 70 years, 57-months post diagnosis) 
 
A consistent reason for being active and staying active after a diagnosis of breast cancer 
for some women was the fact that they had always been active previously and that 
exercise and being physical active was a way of life for them:  
 
“Well it’s kind of my, like it’s always been my lifestyle, so you know, most of my friends 
have always been involved in sport. I played hockey, you know, from being a child up 
until I was in my thirties. I then sort of started playing golf”. (DCD, 60 years, 4-months 
post diagnosis) 
  
“Because I just, I’ve always been sort of active but since my breast cancer I just want to 
make sure that I’m just keeping myself as physically fit as I can because I don’t know if 
it’s going to come back so I want to be as strong to fight it if it does”. (RMR, 66-years, 




“it’s just the way I’ve been brought up I suppose to be active I think and because I’ve 
never driven I’ve had to make my own way to various places and things”. (MSM, 72 years, 




7.4.2.3. Environmental influences 
The environmental influences that worked positively to encourage physical activity and 
that acted as an enabler to starting or doing more exercise was as follows: the positive 
support from friends and family and the feeling of normality that being physically active 
produced. 
 
“She dragged me here, yeah, I wouldn’t have come on my own accord, I know I wouldn’t, 
although I was interested, I wouldn’t have made the effort to come on my own”. (SSJSS, 
68 –years, 36-months post diagnosis). 
 
One participant pointed out how physical activity and in particular sport had always 
been part of her life:  
 
“Well it’s kind of my, like it’s always been my lifestyle, so you know, most of my friends 




“I have friends who I meet there, you know, we all play Badminton together, four of us, 
five of us and just to get back to normality really”. (MJM, 77-years, 11-months post 
diagnosis). 
 
7.4.3. Wider environmental context 
A number of codes were considered which could act either positively as enabling or 
negatively as obstructing physical activity and exercise, depending on the participant’s 
viewpoint. These were related to the timing of when exercise and physical activity 
education or advice was given and the role of family or friends in physical activity 
support. 
 
7.4.3.1 Timing of exercise advice 
The timing of being given exercise advice or encouraged to be active in relation to 
diagnosis and treatment may have encouraged some to become more active earlier 
whereas some thought it would not have made a difference, although a number of 
participants felt they did not know what type of exercise or how much physical activity 
they could do, so this acted as a barrier to being more active. 
 
One reported on the timing of the exercise information and the leaflet format and it not 
being the right time to consider it: 
 
“every time you see anybody, they give you another leaflet and another leaflet and 
another bit of information. To be honest, I shoved most of them in a bag and I didn’t look 
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at them. So there might well have been something about exercise, but if there was, I 
don’t, I didn’t want to know at the time”. (HMH, 62-years, 8-months post diagnosis). 
 
Another participant felt that when recovery was complete would be a good time to give 
exercise advice: 
 
“I think you’ve got to get people, give people time to physically heal from where they 
are, because they do the exercises that they’ve given in the hospital, we all do those, 
because you want to get better and then I think maybe a couple of months after the end 
of their treatment, when they’re beginning to try and start to think about how to get 
back to a normal, whatever that normal is, so give them time to recover from the surgery, 
then maybe a couple of months and then maybe is a good time, because that’s when you 
start to readjust and think”. (ADA, 64-years, 41-months post diagnosis). 
 
For some the education and knowing what exercise was safe or appropriate was 
important and because that was missing it stopped them from being more active, as one 
participant described: 
 
“So I think it would be the confidence to, if I’d have gone to that gym that day and if 
somebody there had said oh yeah, we can do, you know, with the treatment you’ve had, 
etc and this is the right programme, I probably would have done it…” (SCS, 60 years, 22-




No consensus of when would be the best time or the “correct” time to give exercise 
advice or encouragement to be more active was noted. For some, they may have 
benefited from exercise advice straight away during diagnosis and treatment but others 
felt they would not have considered exercise at this time then but would have benefited 
a few months after treatment had finished. 
 
7.4.3.2. Supportive or over-protective partner 
A supportive or over-protective partner could again act as a barrier to or enabler of 
physical activity, depending on the family or partner’s views on the benefits of being 
active during treatment or after and their subsequent encouragement or 
discouragement to be active. A supportive partner was noted as being helpful to being 
more active, although some also felt that some over-protective partners / family may 
have discouraged them from doing more activity: 
  
“Yeah, my husband nags! Yes, it’s much easier, if he didn’t want to go out, then it would 
be that much harder for me”. (RBR, 69 years, 60-months post diagnosis). 
 
“I mean my husband was just really protective and so you know, but he knows, in some 
respects, pull me back, because you know, he was always where’s your mother, oh she’s, 
you know, she’s in the garden or brushing up”. (SES, 61 years, 10-months post diagnosis). 
  
“I didn’t want to go on the Moving Forward class…I didn’t want to do that. It was 
[husband] that made me go, ‘oh yeah, I think you should go, I think you should go’, but 
it’s not something that, group activities are not really me. So, did you feel your husband 
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helped with that motivation [researcher]. Yeah, yeah, it’s just totally different lifestyle 
now, yeah”. (SJS, 70-years, 58-months post diagnosis) 
 
 




This qualitative study gives a unique insight into the barriers to and enablers of exercise 
and physical activity for older women with breast cancer. The perspectives of older 
women with breast cancer, recently diagnosed (< 12-months) and older women mean 
36-months since diagnosis, who had taken part in an exercise research study and were 
currently active were examined. Research to understand factors that may support or 
obstruct the maintenance of physical activity and exercise is crucial. To date, very few 
studies have examined the factors that influence the initiation or maintenance of PA and 










Therefore, the aim of this study was to find out what are the barriers and obstructions 
that may halt or hinder women aged over 60-years with breast cancer from starting or 
continuing an exercise programme and the factors which help to motivate and enable 
this population to start or continue being physical active during and after treatment for 
breast cancer. The findings from this study confirm there are multiple factors which can 
aid or obstruct older women with breast cancer from starting or continuing with a 
physical activity programme during or after treatment.  
 
7.5.1. Barriers to physical activity 
The main barriers to exercise and physical activity evident from this study can be 
attributed to the consequences of breast cancer treatment, a unique set of barriers 
experienced by breast and cancer survivors, which supports previous literature 
(Whitehead & Lavelle, 2009; Blaney et al., 2010; Crane-Okada et al., 2012). Participants 
in the study reported the main barriers to starting PA or maintaining a physical activity 
programme were perceived obstructions that ranged from the negative consequences 
of breast cancer treatment (shoulder problems, pain, joint pain, stiffness, fatigue, hair 
loss), to a lack of knowledge surrounding exercise (what type of exercise was safe, how 
much exercise and knowing what to do), to environmental and inter-personal issues 
(poor weather, no partner/friend to accompany them or over-protective partner).  
These findings recognise multiple perceived barriers which can inhibit the ability to start 
an exercise programme or hinder the maintenance of regular physical activity. 
Furthermore, they appear to be consistent with previous research with breast cancer 
survivors (Courneya et al., 2008; Ottenbacher et al., 2011; Whitehead & Lavelle, 2009), 
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highlighting the unique barriers to physical activity relevant to BCS during and after 
treatment.  
With many physical symptoms, such as pain, aching and stiffness and range of 
movement difficulties as a result of treatment being reported as an obstacle to starting 
or maintaining physical activity, researchers and health care professionals should seek 
to develop or improve symptom management, along with other strategies to reduce 
cancer specific obstructions to support women in maintaining a physically active lifestyle 
after a breast cancer diagnosis.  
Given the findings that a barrier to exercise was not having a friend or partner to go to 
an exercise class or take part in physical activity alongside, it may be helpful if health 
care professionals discussed with their patients enlisting social support from individuals 
who are reliable and willing to provide support in establishing or maintaining their 
exercise behaviour. They could also identify different ways that this support could be 
provided, e.g. through social media, telephone support and local cancer support groups.  
A lack of drive, motivation or will power to be active was reported by a number of 
participants in the present study. This was one of the most commonly-reported barriers 
to exercise in a number of other studies (Courneya et al., 2008; Ottenbacher et al., 2011; 
Brunet et al. 2013), suggesting this is an important barrier to be address in any future 
research. Milne, Guilfoyle, Gordon, Wallman, and Courneya (2007) noted a lack of 
motivation as one of their most frequently reported barriers to activity. However, having 
a “lack of willpower” or motivation is a difficult construct to understand and measure, 
therefore it may be more productive to consider this alongside other barriers that are 
more tangible such as “unsure or what type of exercise to do” or “how much exercise is 
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safe?”. These barriers could be addressed by educating participants on exercise 
prescription and exercise efficacy.  
A lack of motivation or drive to be physically active or engage in regular exercise could 
also be related to cancer related fatigue (CRF), something a number of women in this 
study reported as a barrier. Fatigue was at the centre of the majority of barriers that 
Blaney et al’s. (2010) participants experienced, but it was the combination of fatigue and 
physical deconditioning that they felt contributed the most to declines in physical 
activity. They postulated that the experience of CRF, physical de-conditioning and this 
subsequent decline in physical activity, can lead to a cyclic reduction in PA levels, which 
may be further exacerbated by advice to rest and take things easy (Lucía, Earnest, & 
Pérez, 2003). Milne et al. (2007) considered fatigue as a recurrent theme that had a 
significant impact on physical activity levels as well as it interfering and affecting 
everyday tasks.  
Bulmer et al. (2012) reported that participating in a cardiovascular and resistance 
training programme provided many psychological and physical benefits, with some 
women considering “feeling better” being synonymous with having more energy and 
exercise helping to “re-vitalise” and return to pre-cancer energy levels. Whitehead and 
Lavelle, (2009) reported fatigue as a key influence on physical activity levels, that also 
acted as a barrier to returning to exercise and physical activity. However, a number of 
participants perceived reduced fatigue as a benefit of already being physically active as 
opposed to a motivator to become active. This positive effect of exercise on fatigue 
levels and vitality should be used as a tool to motivate breast cancer patients to start 
becoming more active or to return to exercising and taking part in physical activity. 
Cancer-related fatigue was reported as one of the top exercise barriers (Courneya et al., 
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2008) for breast cancer patients during chemotherapy treatment. They also 
demonstrated that over 50% of all reported barriers to missing exercise sessions were 
disease and treatment related and that addressing the side-effects of chemotherapy and 
cancer treatment is a crucial issue in improving exercise adherence during treatment.  
Another barrier to exercise reported by participants in this study was a lack of 
knowledge about safe and effective exercise and “knowing what to do”. This was also 
supported by Sander, Wilson, Izzo, Mountford, and Hayes (2012)who reported in their 
study that participants believed the information provided from the health care team 
about safe and effective exercise was insufficient and advice regarding resistance 
training was inconsistent depending on which member of the care team they had 
spoken to. Thus, ensuring more education for patients and health care professionals 
regarding exercise may be beneficial in reducing this barrier. 
 
7.5.2. Factors enabling physical activity 
The perceived motivators for becoming more physically active or exercising noted from 
this present study were mainly related to helping to counteract the side-effects of 
treatment consequences (joint pain, fatigue and recovering from treatment) and weight 
gain. Brunet et al. (2013) reported improving health and symptom management as 
contributory factors to physical activity maintenance and motivation to stay active, 
along with weight management being a key motivator to routine physical activity. 
Increases in body weight and in particular body fat is a frequent side effect of breast 
cancer treatment either due to chemotherapy, hormone therapy or treatment-related 
menopause (Holmes & Kroenke, 2004)) or related to reductions in physical activity 
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(Demark-Wahnefried et al., 2001). Nock et al. (2015) reported breast cancer patients 
citing body composition and improvements in strength and function as motiving factors 
in becoming more active.  
The social aspect of exercising in a group where all others had a shared experience was 
a motivational aspect for a number of women in this present study. The group benefits 
were reported in a number of ways by the participants; “…meeting friends…the social 
side…not doing it on your own…then you go and have a coffee and a chat”. The benefits 
of exercising in a group environment are supported by a number of other studies (Luoma 
et al., 2014; Martin et al., 2015; Midtgaard et al., 2015). Martin et al. (2015) reported 
that the group bonding developed during the exercise sessions allowed for more open 
discussions and sharing and that the group became the main source of enjoyment and 
motivation for the patients to continue exercising. Luoma et al’s. (2015) participants 
reported that because the tailored exercise programme was only for breast cancer 
patients they felt it was much easier to join and any anxieties over their altered 
appearance and poor fitness after treatment was not so important. They experienced 
the exercise group as a source of practical and psychological support and beneficial for 
sharing experiences and gaining a sense of normality. Midtgaard et al. (2015) supported 
the implementation of group-based exercise because of the motivational aspect of a 
group environment.  
However, they offer a caveat to the benefits of group exercise, and suggest that the 
time-limitedness of many structured programmes may explain the often sub-optimal 
levels of post-intervention adherence once the programme is finished. They suggest that 
research into cancer patients becoming too dependent on their exercise instructor is 
required and whether this dependence on the instructor has a negative effect on 
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becoming autonomous and independent exercisers outside the group setting. However, 
they further suggest that more research is required to demonstrate whether 
unsupervised and less structured programmes offer the same physical and psychological 
benefits as group instructor supervised programmes.  
Enjoyment of being active and exercising was another factor that was a key motivator 
to women interviewed in this study. As one described it “The main thing is that I really 
enjoy it. I’ve found something I really enjoy!”. Brunet et al’s. (2013) breast cancer 
patients described how they were motivated to engage in physical activity because of 
the enjoyment and fun they experienced from participating. Nock et al. (2015) reported 
that for a number of breast cancer patients simply “liking the exercise” and having “fun” 
were motivating factors to continue and maintain an exercise routine. Whitehead and 
Lavelle (2009) identified four main motivators for physical activity with enjoyment being 
one. For women who found an activity they particularly enjoyed this was their main 
reason for taking part. The older women interviewed in Whitehead and Lavelle’s study 
also acknowledged that forcing oneself to participate in exercise or an activity that was 
unenjoyable would not lead to prolonged adherence.  
Instructor support was also considered an enabler to becoming active and engaging with 
an exercise class, as a number of participants noted how knowing that the instructor 
was supervising the activity made them feel safe and gave them confidence to 
undertake the activity and exercises. This instructor support was a key motivating factor 
reported by a number of other studies (Whitehead & Lavelle, 2009; Bulmer et al., 2012; 
Luoma et al., 2014), who described the benefits of having an instructor who understood 
the issues faced by those who have had breast cancer. Sander et al’s. (2012) participants 
wanted safe and effective exercise guidelines from exercise providers who understood 
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the risk of developing lymphoedema and Blaney et al’s. (2010) participants described 
the need for an exercise programme to be supervised by trained health care providers 
with the knowledge that they would not prescribe exercise that would prove 
detrimental to them. Bulmer et al. (2012) reported that the women found working with 
personal trainers knowledgeable about their condition gave them confidence that the 
prescribed exercises would enhance their recovery and not complicate it. 
 
7.5.3. Limitations 
Although the use of in-depth interviews provided a great deal of rich data on older 
women recently diagnosed with breast cancer and on women having participated in an 
exercise research study it was not without its limitations. Although the sample size 
allowed for a wide range of opinions to be expressed, it was a small sample size (n=15), 
with all of the participants being white European, economically secure women over 60 
years old. Therefore, this limits the results of the study as we cannot be sure whether 
the views expressed in this study would be a true representation of other ethnicities 
with breast cancer. All the participants were patients with stage I-III breast cancer with 
no other diagnoses or further staging.  
Future qualitative studies targeting older women with breast cancer should aim to 
include a wider range of stages, including secondary breast cancer, and aim to recruit 
participants from varying backgrounds and ethnicities. Selection bias may have occurred 
in that those recruited through the breast cancer charity who were recently diagnosed 
may have had an interest in a study about physical activity and therefore more likely to 




The findings of this study highlight the barriers to and motivators for starting or 
maintaining physical activity or an exercise routine in both older women (>60-years old) 
recently diagnosed with breast cancer and active older women who had taken part in 
an exercise research pilot study. BCS have high rates of physical inactivity, which can 
lead to increased risk of chronic conditions (Irwin et al., 2003). Additionally, some 
treatments can increase a women’s risk of osteoporosis (Bulmer et al., 2012).  
As breast cancer survivorship increases so will the cost of treating inactivity-related 
diseases in this population if healthy lifestyles including regular physical activity are not 
adopted. Therefore, encouraging women diagnosed with breast cancer to start or stay 
physically active is an important public health priority given the known physical and 
psychosocial health benefits of regular activity (Furmaniak et al., 2016; Lahart, Metsios, 
Nevill, & Carmichael, 2018).  
The main barriers found in this study were related to the cancer and treatment side-
effects in particular joint pain, range of movement difficulties as a consequence of 
surgery and fatigue but also appearance issues of hair loss and how they may look whilst 
exercising. On a positive note, many reasons for starting and maintaining physical 
activity were offered, notably the benefits that they experienced in helping to reduce 
treatment related issues, benefits, such as weight loss, less fatigue and more energy and 
improved recovery from treatment. The social side of group activity was identified as a 
reason for continuing to be active and attend an exercise programme, along with the 
benefits of an exercise professional knowledgeable about safe exercise programming 
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with their disease and treatment gave participants the confidence that the exercise 
would enhance and not complicate their recovery.  
A further positive of this study is that the majority of barriers identified by older women 
with breast cancer can be alleviated by exercise (fatigue, weight gain, range of 
movement difficulties) or reduced through education (not sure what to do, how much 
exercise, partner fears). Although a vast amount of both quantitative and qualitative 
research has identified the benefits of exercise and physical activity during and after 
treatment for breast cancer, very little research has targeted older BCS. Even with the 
publication of the ACSM roundtable of exercise guidelines for cancer survivors (Schmitz 
et al., 2010), motivating and finding suitable exercise programmes for breast cancer 
survivors and particularly older breast cancer survivors remains a challenge. 
An interesting observation from this study is that the barriers and enablers to physical 
activity identified by this older population of BCS was similar to those reported in other 
studies that targeted younger BCS, such as more energy and less fatigue (Bulmer et al., 
2012); more education and advice about the type of exercises that were suitable (Sander 
et al., 2012); improving health and improving side-effects (Brunet et al., 2013); changes 
in body composition, often by losing weight but also by improving strength (Nock et al., 
2015) and the social benefits of exercise (Martin et al., 2015). This demonstrates that 
this older population of BCS still experiences often the same barriers and enablers to 
becoming more active as younger BCS and therefore, ensuring that these barriers are 
considered when designing any exercise interventions for breast BCS will benefit all ages 
during and after treatment.  
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A routine lack of regular exercise, medical co-morbidities and concerns about efficacy of 
exercising and a lack of knowledge about the safety of activity can all interfere with an 
older person’s willingness to start or maintain a regular exercise programme (Crane-
Okada et al., 2012). The evidence presented in this study should contribute to the 
further development of exercise and physical activity programmes for older women with 
breast cancer, whether newly-diagnosed or many years after-diagnosis. For these 
programmes to be successful, careful consideration of these barriers and enablers to 
exercise should support with the development of successful programmes. Ensuring 
better education for patients and health care professionals at all stages of diagnosis, 
treatment and recovery will allow for more opportunities to engage with physical 
activity and the promotion of locally, supervised, cancer specialist instructor-led, group 
exercise sessions will give more options for the support to become active may assist 




Chapter 8 General Discussion 
 
8.1 Overview of thesis rationale and purpose 
The effects of exercising during and after treatment for breast cancer has been 
extensively researched over the last 20-years suggesting the importance of being active 
during and after a diagnosis of breast cancer on physical and psychosocial health (Fong 
et al., 2012). Although older women are diagnosed with breast cancer more often and 
have poorer outcomes than younger women, the exercise research has predominantly 
been conducted on younger women with breast cancer (circa. mean age 50-years). 
Therefore, there is very limited evidence of the benefits that older women with breast 
cancer may experience from taking part in exercise. In recognition of this, this PhD 
research examined the feasibility and acceptability of an exercise programme during or 
after treatment for breast cancer for older women (> 60-years old). To do this the 
Medical Research Council framework for designing complex health care interventions 
was used as a guide (Craig et al., 2008). 
 
8.2 Summary of key findings and contribution to knowledge 
Study 1 was designed to examine the feasibility and acceptability of a 12-week exercise 
intervention targeting women over the age of 60 years who had recently been 
diagnosed with breast cancer with a longitudinal follow-up over 12 months. As this study 
was the first to target this population, considering the age and time since diagnosis, the 
Medical Research Council suggests feasibility testing before a full RCT should be 
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considered. As very little is known about this population, from an exercise perspective, 
a pragmatic pilot RCT was designed in order to find out important information as to 
recruitment, randomisation, adherence and acceptability of an exercise intervention 
with this population.  
A recruitment rate of 41.6% (35 participants out of 84 approached) appeared to be good 
when compared to other breast cancer and exercise studies (Courneya et al., 2007; 
Daley et al., 2007). However, the length of time taken to recruit the participants (22 
months) and the low numbers recruited by the breast care nurses (11 participants) may 
bring into question the viability of a large-scale RCT using only this method of 
recruitment from local general hospitals.  
What served as a useful method of recruitment was approaching a national breast 
cancer charity that was offering a 4-week education programme to women newly-
diagnosed with breast cancer from the two local hospitals. This method of recruitment 
resulted in 24 participants (69% recruitment rate) over a shorter time period (12 
months). The Medical Research Council guidelines advocate using stop-go targets for 
recruitment to studies (Craig et al., 2008). This ensures that numbers and timescales can 
be accounted for and that if these targets are not being met either weekly or monthly, 
then alternative plans or procedures could be offered. If these targets continue to not 
be met, then it would put the study in jeopardy of continuing as it may not be financially 
or ethically feasible. These targets and stop/go indicators were not put in place for the 
current study; however, for future studies it would be pertinent to consider setting 
targets for timescales for recruitment, acceptable retention and adherence rates based 
on previous research, which will better inform the time taken to recruit the number of 
participants required and whether retention and adherence rates are acceptable. Given 
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the level of difficulty in recruitment through the breast care nurses and the lack of home-
based exercise intervention data then these are important learning points from this 
study.  
These barriers to recruitment would need to be carefully considered and overcome if a 
larger study was to be considered and a recruitment target would be required. In order 
to try and improve recruitment the researcher offered to lead an education session on 
exercise and physical activity; however, because the researcher delivered an 
educational session on the benefits of exercise and physical activity, this may have 
added an element of selection bias to the recruitment process.  
Although recruitment was difficult and time consuming, once the participants were 
recruited to the study attrition rates were acceptable (20% to the whole study; 26% for 
the control; 6.25% for the experimental group) when compared to similar breast cancer 
and exercise intervention studies (Stevinson & Fox., 2006; Courneya et al., 2007; 
Cadmus et al. 2009). Intervention completion rate (93.75%) and adherence rates to the 
12-week supervised intervention were very favourable with an overall attendance rate 
of 87.5%, although 15/16 participants had an attendance rate of 90.5%.  
The supervised exercise programme could be considered acceptable by the participants 
by the use of Ratings of Perceived Exertion (RPE) used to monitor exercise intensity 
levels. The range for all sessions was between 2 (very light) and 5 (hard) with the mean 
of 3 (somewhat hard) for each session, suggesting that the exercise intensity was 
suitable and appropriate and that each session was delivered at an intensity meeting 
exercise guidelines for older people and for cancer survivors (Schmidt et al., 2013).  
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Unfortunately, home-based attendance was not monitored after the first seven 
participants complained of poor compliance and commitment to filling in the 7-day 
physical activity recall diaries. In hindsight, another method of monitoring the home-
based intervention should have been utilised. Although, PA levels were monitored via 
the SPAQ, compliance to the 2 x week home-based intervention was not; therefore, the 
total acceptance of the exercise intervention and overall adherence was not known.  
An important and valuable finding from the study was that no adverse events were 
reported by any participant during or after the 12-week exercise intervention or by any 
participant whilst doing the physical outcome assessments. This demonstrates the 
safety of a supervised exercise programme during or immediately after treatment for 
breast cancer, supporting the findings from exercise studies with younger BCS (Mutrie 
et al., 2007; Schwartz et al., 2007; Cadmus et al., 2009).  
Although the testing of outcome measures and the use of inferential statistics to 
demonstrate the efficacy of an intervention is not the main priority of a pilot study, but 
rather to assess the design and implementation of study procedures, a number of 
outcomes were analysed. The comparison of body mass and body composition between 
groups demonstrated a consistent loss of body mass (-1.6kg) over the 12 months for the 
experimental group, whereas, the control group did not change body mass (-0.05kg) 
over the 12 month period.  
An interesting observation was the changes in body composition between the groups 
over the 12-week intervention and the 12-month study period. Body fat decreased (-
1.51%) for the experimental group during the supervised 12-week intervention but then 
returned to near baseline levels at 12 months (+0.19%). In comparison the control group 
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increased body fat over the 12 months (+1.75%). The opposite effect was observed for 
fat free mass, with the experimental group increasing fat free mass (beneficial) whereas, 
the control group lost fat free mass (negative).  
Sarcopenic obesity has deleterious effects and after breast cancer treatment women 
face challenges relating to the loss of bone and muscle tissue and the corresponding 
increase in fat mass (Harvie et al., 2004; Demark-Wahnefried et al., 2005). However, 
optimal frequency, duration and intensity of exercise sessions that may be required to 
elicit body composition changes, remain unknown, and given the importance of body 
composition after a breast cancer diagnosis on QoL, recurrence and mortality, exercise 
studies focusing on body composition warrant further investigation. 
Walk distance over 12 minutes was significantly increased by both groups. A number of 
reasons could explain this. For some it could be due to the learned effect of repeating 
assessments (Roediger III & Karpicke, 2006), for others, an increased confidence to be 
more active and exert themselves more physically as time from diagnosis increased, or 
it may be the characteristics of the participants who volunteered to come on the study, 
as those who volunteer for health interventions are usually more motivated and 
interested in improving their own health (Krishna, Maithreyi, & Surapaneni, 2010b).  
Both groups also significantly increased their PA levels over six months. However, both 
groups then reduced PA levels up to 12 months, although the experimental group still 
maintained higher PA levels than at baseline, whereas the control group PA levels 
dropped to below baseline levels.  
Quality of Life scores demonstrated some significant differences in favour of the 
experimental group for emotional functioning, future perspective, breast symptoms and 
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arm symptoms, although, the majority did not reach significance, most were in favour 
of the experimental group (see table 16). The fact that QoL was not really altered 
significantly over the study period may be because the participants demonstrated good 
functioning and low symptom scores at baseline and thus, the exercise intervention did 
not have enough of an effect to change these significantly. 
Study 2 examined the barriers to physical activity for older women with breast cancer 
and the reasons that motivated some to start being active or to maintain their PA levels 
during and after treatment. Limited evidence was available of research that had 
targeted older breast cancer patients, considering barriers to and motivators of PA with 
this population (Whitehead & Lavelle, 2009; Crane-Okada, 2012). Given that adherence 
data to the home-based exercise intervention was not collected after the intial 
participants struggled with commitment and motivation to do the exercise and/or fill in 
the log book, study 2 was important to consider any barriers like this that the nature of 
study 1 would not examine. 
This qualitative study examined the views and opinions about starting or continuing 
exercise and physical activity from women who were still undergoing treatment or had 
recently been diagnosed but may have finished adjuvant treatment and women who 
were currently active exercisers and attending an exercise class.  
The main barrier to physical activity reported was the negative, debilitating, physical 
consequences of treatment, such as, shoulder mobility problems, aching muscles and 
joints, joint pain, fatigue and the effects of hair-loss. Other obstructions that had a 
negative effect on physical activity were not knowing what exercises to do, inclement 
weather and not having a friend or partner to go and exercise with.  
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A number of factors that were described as a motivation to start exercising or to 
continue to be active were related to trying to improve or overcome the negative 
physical barriers from treatment. These were: improving fatigue and having more 
energy, improving joint pain, strengthening the body and improving shoulder mobility 
and losing weight. The psychosocial benefits and motivators reported were: enjoyment, 
the social side of exercising with others and the routine of always having been active 
before diagnosis.  
Some factors were considered as an obstruction to physical activity, whilst others found 
that they could be positive to becoming active, so acted as a motivator. These were the 
timing of exercise advice and a partner who was supportive or may be over-protective. 
For some, knowing what exercise to do and getting exercise advice early in the 
treatment process would have been useful to encourage them to start exercising earlier 
after diagnosis; however, others felt that advice needed to be given later when 
treatment had finished. For some a partner / friend was instrumental in encouraging 
them to be active, whereas others reported that their partner may have been over-
protective and may have discouraged them from being more active.  
The barriers to and motivators of becoming more physically active during or after 
treatment for breast cancer in older women were supported by the literature 
(Whitehead & Lavelle, 2009); however, if appears that the majority of barriers reported 
were unique to breast cancer patients as they were related to their cancer diagnosis and 




8.3 Implications for clinical practise 
Clinicians need to be made aware of the benefits that taking part in physical activity can 
have on breast cancer patients from both a physical and a psychosocial perspective, 
especially in relation to the negative consequences that the treatment itself may cause 
and how exercise may alleviate these. Older women diagnosed with breast cancer have 
poorer clinical outcomes than younger women; however, to date, less research has been 
undertaken with this population.  
The recruitment of this population was difficult and unfortunately the nature of the 
difficulties that breast care nurses or health care professionals may face around 
discussing or encouraging PA with older newly diagnosed patients remain largely 
unknown. Future research should consider the difficulties that HCPs may face when 
asked to recruit to an exercise study or daily clinical barriers to giving routine exercise 
and physical activity advice to patients. 
This PhD study demonstrates that once recruited onto an exercise intervention, older 
women are willing to attend and have high adherence levels similar to younger women 
with breast cancer (Courneya et al., 2007). However, advocacy from clinicians is required 
to ensure enough older women are encouraged to be active to give them the 
opportunity to gain the possible benefits associated with being active and alleviate 
treatment-related side-effects.  
Additional education of health care professionals regarding exercise would be beneficial 
to ensure they are knowledgeable and confident to advocate PA during and after 
treatment. Also, exercise professionals need to work more closely with oncology 
professionals to ensure pathways are available for breast cancer patients to start or to 
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continue to exercise after a diagnosis of breast cancer. Limited opportunities to access 
safe and structured exercise will only act as a barrier to PA, as this study demonstrated, 
as the main reason for not participating in study 1 was reported as the distance to the 
exercise programme.  
Older breast cancer patients reportedly enjoyed the group social side of exercise with 
people of a similar age and condition so did not feel “different” because of treatment-
related appearance changes (hair-loss, weight gain). They also appreciated a 
knowledgeable instructor in whom they felt confident who understood their treatment 
and condition and could prescribe appropriate and safe exercise. Exercise and 
recreation professionals need to ensure that a similar environment can be replicated 
with an appropriately trained and experienced exercise professional leading the classes. 
With increasing evidence of the relationship of exercise on reducing breast cancer 
recurrence and related cancer mortality, along with improving survival rates, there is 
never a more important time for health care professionals to be promoting exercise and 
PA and for exercise professionals to be offer more opportunities for breast cancer 
patients to become more active. 
 
8.4 Limitations and future research 
One of the main study limitations was not being able to fully assess the feasibility of the 
intervention because home-based exercise adherence was not monitored. Therefore, 
we do not know how effective the overall programme was and whether the supervised 
sessions of the intervention were successful on its own or whether it needs to be 
combined with a home-based programme for more beneficial outcomes. However, 
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although home-based intervention adherence was not monitored, the qualitative study, 
which considered barriers to and motivators of exercise, attempted to address some of 
the shortcomings of not having home-based intervention data. Future interventions 
should collect both supervised intervention data and home-based PA data to ensure that 
any benefits of an exercise intervention programme can be attributed to the actual 
intervention. Additional activity outside of the intervention should also be monitored 
for this reason and activity trackers or accelerometers would make this more accurate 
and probably less of a burden than the daily PA diaries that participants in study 1 
stopped using. 
Another limitation of this study was not recruiting enough participants in study 1; 
therefore, it was not possible to draw any firm conclusions as to the benefits of the 
supervised exercise intervention. Stop/go indicators should be set for any future 
complex intervention research with unfamiliar populations. This would ensure that 
additional data is available as to the feasibility of recruiting to timescales and attrition 
within a study. Furthermore, it is still unclear as to the range of benefits an older woman 
with breast cancer can gain from being active during and after treatment due to the lack 
of research with this population.  
However, as a feasibility study, it provided evidence and information as to the design 
and implementation of an RCT with this population and the difficulties that need to be 
overcome before a full trial can be implemented. Other limitations to the study are the 
generalisability of any results, as only white European women, who were economically 
stable and reported high levels of physical activity participated, so self-selection bias 
may have been evident and because of this it may not have been a representative 
sample of older women with breast cancer.  
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Although a valuable way to recruit participants was through the educational programme 
of a national breast cancer charity, because the researcher delivered an educational 
session on exercise and physical activity, this may have caused some contamination of 
the control group. It is not known in the present study whether anybody in the control 
group did start an exercise programme or increase PA levels as a result of being recruited 
onto the study; however, participants in the control group did significantly increase PA 
levels over six months and improved their 12-minute walk distance.  
Study 2 was again limited by a small sample size, although it appeared data saturation 
was reached when no new themes or information emerged from the later interviews. 
Also, this study only recruited white European women who were stage I-III so again, this 
limits the generalisability of any findings. 
Future work should aim to improve recruitment strategies to ensure that sufficient 
numbers can be recruited within appropriate time-scales. Future targets for 
recruitment, retention and adherence to either the supervised intervention or the 
home-based intervention should be considered according to Avery et al. (2017), who 
suggest a traffic light system, whereby a trial can proceed with modifications rather than 
just a stop/go basis.  
The supervised exercise intervention must be available at multiple venues to ensure that 
distance to the supervised exercise programme is not a barrier. Interviews with oncology 
professionals would be useful to examine their opinions as to the difficulties of 
recruitment of newly-diagnosed older women with breast cancer to find alternative 
ways to support this method of recruitment.  
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An interesting observation related to the increase in fat free mass and decrease in fat 
mass for the experimental group during the 12-week supervised intervention. As weight 
gain and sarcopenic obesity in particular are negative side-effects and increase risk of 
breast cancer recurrence and mortality, future work targeting older women and 
examining the effects of exercise on body composition are warranted.  
 
8.5 Conclusion 
To summarise, the main purpose of this PhD research was to establish whether it was 
feasible and acceptable to offer an exercise intervention to women aged over 60 years 
during or immediately after treatment for breast cancer. This study was the first in the 
UK to specifically try and recruit women over the age of 60 after a very recent diagnosis 
of breast cancer on to an exercise trial.  
This study demonstrated that it was feasible to deliver a supervised exercise 
intervention during this time, although recruitment of this population via clinical 
channels was very difficult and time-consuming. Therefore, in order to recruit a larger 
number of participants for a full-intervention trial, satisfactory methods of recruitment 
need to be established. This may be by having designated clinical recruiters across 
multiple hospital sites.  
The intervention must also be offered at multiple sites to ensure that travel or distance 
to the exercise site is not a barrier. The study found that once recruited the older 
participants adhered to the supervised intervention well and with no adverse events 
reported, which suggested that a supervised exercise programme at this time was safe. 
Retention to the full study from both groups was also acceptable.  
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Barriers and obstructions to being physically active at this time were generally unique 
to a breast cancer diagnosis and treatment; however, the majority of barriers to activity 
could be overcome with regular physical activity. Therefore, it further demonstrated the 
importance of promoting and advocating exercise and physical activity for older women 
during or after treatment. Although, to do this, better education of the patients, health 
care professionals, friends and family regarding exercise is required to ensure a lack of 
knowledge of safe exercise is not a barrier to becoming active. 
However, much research with this population is still required. Only white European, 
economically stable women, diagnosed with breast cancer stage I-III were recruited to 
studies 1 and 2, therefore generalisability to the whole older breast cancer population 
is limited. Secondly, home-based exercise was not monitored, therefore the 
effectiveness of the whole intervention cannot be determined, only the effect of the 
supervised exercise programme. Finally, because heart rate monitoring was unable to 
be carried out, these data would have been useful, alongside the RPE monitoring to 
further understand the acceptability of the supervised exercise intervention. 
With limited evidence as to the effectiveness of exercise on physical and psychosocial 
factors with this population and not knowing if there is an optimum type or intensity of 
exercise, duration or frequency of intervention on beneficial outcomes with this 
population, additional studies are therefore still required with this increasing population 
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Appendix 1: Search terms for rapid review 
 
AMED 
(Breast AND cancer).ti,ab OR (Breast AND neoplasms).ti,ab OR 
(Breast AND carcinoma).ti,ab OR (Breast AND ductal).ti,ab) AND 
((aerobic AND training).ti,ab OR (cardiorespiratory AND 
training).ti,ab OR (physical AND fitness).ti,ab OR (endurance AND 
training).ti,ab OR (resistance training OR weight training OR 
weight lifting OR strength training).ti,ab OR (strength AND 
training).ti,ab OR (resistance AND training).ti,ab OR (weight AND 
training).ti,ab OR (weight AND lifting).ti,ab OR (exercise OR 
physical activity OR physical therapy OR physical fitness).ti,ab)) 
AND ((Older breast cancer survivors OR breast cancer 
survivors).ti,ab OR (older AND elderly).ti,ab OR ((post AND 
menopausal) AND cancer).ti,ab OR (older AND cancer).ti,ab OR 
















Appendix 4. Informed consent form   
UNIVERSITY OF HUDDERSFIELD 
Exercise for women over 60 treated for breast cancer 
Exercise Programme Consent Form 
            Tick 
Box 
I have been fully informed of the nature of this research by reading the Participant 
Information Sheet version 4 June 12 and by asking the researcher any questions 
I understand that I have the right to withdraw from the research study at any time 
without giving any reason and I have a right to withdraw my data if I wish 
   
I give permission to be quoted (by use of a pseudonym)     
I understand that my identity will be protected by the use of a pseudonym and that no 
information will be included in any research report or publication that could reveal my 
identity 
I understand that information about me will be retained and used in the research even 
if I am no longer able to continue participation due to worsening health 
I understand that relevant sections of medical records/data collected during the study 
may be looked at by individuals from the University of Huddersfield, from regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this 










I agree to my GP being informed of my participation in my study 
 




Name of researcher 
Signature 
Date 
Researcher contact details: 
Kevin Kipling, Senior Lecturer, Division of Health and Wellbeing, University of 
Huddersfield, Harold Wilson Building HW3/13, Queensgate, HD1 3DH. Tel: 01484 





















Appendix 7. EORTC C30 and BR23  
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Appendix 9. Analytical framework charting stage of framework 
analysis from NVivo  
Benefits of Exercise 
 
 
A : benefits of exercise B : Expectations of PA activity 
C : Group 
exercise benefits 




doing your, your arm exercises, maybe that’s, you 
know, that’s helped, 
 
So I think the exercises, especially your arm exercises 
are important, to make it that you’ve got your full 
movement of your arms afterwards. 
 
AM: I think its just the social part as well, because as 
you’re doing your exercises, you’re chatting as well, 
unless you tell us we’ve to shut up, keep quiet and get 
on with it, but you know, you can have a little chat as 
well, you see, as you, especially when you’re on the 
treadmill. When you’re on, you know, on the weights 
and that, you’re just saying then, you know, have 
Well just that I would feel a bit 
better, but also it was like the 
meeting people and you know, like 
if you’ve any little problems, you 
chat with them to see whether 
they’ve had it and it were, so you 
could interact with them, 
  
 
Motivators to physical activity 
11 : 
JSun_190417 
1. A friend to attend with 2. Health benefit (weight loss, feel fitter) JSun: She dragged me here, yeah, I wouldn’t have come on my own accord, I know I wouldn’t, 
although I was interested, I wouldn’t have made the effort to come on my own. But after the Moving Forward class, we left our email addresses, if you wanted to get in 
touch and after a week or two, Paula emailed me and said do you want to meet for a coffee and I said yeah, so we did and she was telling me about the class and how 
she’d lost quite a lot of weight and I thought oh that sounds alright. So I came along with Paula and so that’s, that’s how I came. 
 
KK: Right, so it was that support with [JSun: yeah] a friend [JSun: that’s right, yeah, yeah].  So you, so once you started coming [JSun: mmm], what did you hope to get 
out of the class and did you maybe find? 
 
JSun: I don’t know what I hoped to get out of it really, perhaps to lose some weight, which I haven’t, but just generally just general exercise, just generally feeling fitter, 
yeah, yeah, nothing in particular. 
 
KK: So would you say you’re trying to be active [JSun: yeah] for health benefit or [definitely, yeah, yeah, definitely] 
12 : 
MF_100417 
1. Group element / dynamics 2. Improving cancer treatment outcomes MF: Well I’ve always been better off in a group, rather than a solo player. I need motivation 
and I find that in a group and the fact that I’d had my lymph nodes removed and my immune system was fairly well shot, I thought that if I could strengthen the body as 
a whole, it may help to keep infection at bay, whether that’s of any consequence, I don’t know. 
13 : 
MH_150517 
1. Not letting down a friend 2. Commitment through having already paid. Probably its, perhaps not groups, but its easier to do it with somebody else. I find when I 
used to run every week, I ran with a friend and if I’d been going on my own, a lot of the time, I’d think oh I can’t be bothered, but because you’re going with somebody 
else, you make the effort and same with like group Pilates. If I paid for a course up front, we used to, you’d pay half a term at a time, that motivates you to go, instead of 
paying on the day in some ways, because you’re sort of committed to it. 
14 : 
MR_190417 
1. Fit to fight cancer recurrence 2. Enjoyment 3. To be as fit as possible for health MR - Because I just, I’ve always been sort of active but since my breast cancer I just want to make 
sure that I’m just keeping myself as physically fit as I can because I don’t know if it’s going to come back so I want to be as strong to fight it if it does. 
 
MR - The main thing is that I really enjoy it. I’ve found something that I really enjoy so it’s not a really a…don’t think it a…oh no it’s Wednesday and I’ve got to go and do this. I just love 
it. I just enjoy exercise. Yeah. 
 
MR - Well, I think exercise is a benefit is beneficial to general health anyway so I just presumed that, you know, just get myself generally fit you know it’ll help anyway. 
 
MR - Just like I’ve said, you know, to be fit and get my body fit, errrr, because, I think having a fit body will only be beneficial really, you know to be as fit as possible. 
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Title: Supervised exercise for older women treated for breast cancer. Preliminary 
results from a pilot randomised controlled trial. 
Kipling, K.N., McCluskey, S., Kirshbaum, M.N., Garbutt, G. and Boduszek, D. (2014) 
Background: There is compelling evidence of the benefits of exercise in cancers 
survivors and older populations but very limited research on exercise interventions 
conducted with older breast cancer survivors. Aims: The study investigated whether a 
supervised exercise intervention (1 x week) and home based (2 x week) lasting 12-weeks 
with older women treated for breast cancer (>60 years) during and post-adjuvant 
therapy improved functional capacity (walking ability), body composition, quality of life 
(QoL) and levels of physical activity over 12 months. Methods: A pilot randomised 
controlled trial assigned 35 recently diagnosed female breast cancer patients (mean = 
67 years; SD = 5.02) to either a supervised exercise intervention (n = 17) or a control 
group (n = 18). Outcome measures were assessed at baseline, 3, 6 and 12 months. 
Results: Preliminary analyses of walking distance, body composition and physical 
activity for the first 3-months of the study were conducted. The intervention group 
significantly increased their walking distance (p<0.001) and their physical activity levels 
(p<0.05) but there were no significant differences in body composition between groups. 
The control group also significantly increased their walking distance (p<0.01). 
Conclusion: The intervention group significantly improved walking distance and daily 
levels of physical activity over 3-months with no adverse events reported. It will be 
interesting to observe whether these changes can be maintained to have a positive 
effect on health, functional capacity and QoL and whether this increase in daily physical 
activity levels will have any effect on body composition. 
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Appendix 11. British Association for Sport and Exercise Sciences 
(BASES) Poster and Abstract publication  
Supervised exercise for older women treated for breast cancer. Results from a pilot 
randomised controlled trial. 
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KEVIN N. KIPLING1*, SERENA McCLUSKEY1, MARILYNNE. N. KIRSHBAUM2, GED 
GARBUTT1,3 & DANIEL BODUSZEK1 
1University of Huddersfield, 2Charles Darwin University, 3Penine Acute Hospitals Trust, 
North Manchester General Hospital. 
*Corresponding author: kevin.kipling@hud.ac.uk @k_kipling 
There is compelling evidence as to the range of benefits that breast cancer survivors 
(BCS) can experience by participating in physical activity during or post cancer treatment 
(Campbell et al., 2012, a concise evidence review, Macmillan Cancer Support). Research 
involving younger cancer survivors and older “cancer free” adults has demonstrated that 
exercise can play an important part in ameliorating some of the effects of cancer 
treatment and of the ageing process (Courneya et al., 2004, Critical Reviews in 
Oncology/Hematology, 51, 249-261). However, evidence from older BCS is extremely 
limited, despite the higher incidence of diagnosis and lower survival rates in this 
population. Therefore, the aim of this study was to investigate whether a supervised (1 
x week) and home based (2 x week) exercise intervention, lasting 12-weeks with older 
women (>60 years) being treated for breast cancer, improved functional capacity (12-
min walk), body composition, quality of life (QoL) and levels of physical activity (PA) and 
could be sustained over a 12-month period. The feasibility of recruitment, adherence 
and acceptability with this population was also assessed. Ethical approval was obtained 
from the local university and NHS panels. Thirty-five participants (mean age = 67 years; 
SD = 5.02) were assigned to either a supervised exercise intervention group (n = 17) or 
a usual care control group (n = 18). Outcome measures were assessed at baseline, 3, 6 
and 12-months. Statistical analyses of walk distance, body composition, physical activity, 
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and QoL for the four time points of the study were conducted using descriptive statistics 
and mixed between-within subjects ANOVA. No significant interaction terms were 
detected. Both intervention and control groups significantly increased their walk 
distance and physical activity levels over 6 months (P<0.05) but there was a decrease at 
12 months. Participant’s global health status/QoL improved over 6 months but 
decreased slightly at 12 months in both groups. There were no significant differences 
between control and treatment groups on any of the measures at any time point. 
Attrition rates to the study were good (80%) with no adverse events reported by the 
intervention group and adherence to the supervised exercise sessions was high (>85%). 
Recruitment onto a supervised exercise intervention with older BCS was feasible with 
high adherence levels without any adverse events. Future studies should incorporate 
larger sample sizes to evaluate whether PA can improve and maintain physical function 
and QoL and how this can be sustained in this under researched population. 
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